adr_usa_0212|GSK|Short Name|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|average_shares_outs_diluted|eps|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|price_next_month|
adr_usa_0212|GSK|Long Name|GlaxoSmithKline PLC Total Current Assets (Quarterly) (USD)|GlaxoSmithKline PLC Cash and Short Term Investments (Quarterly) (USD)|GlaxoSmithKline PLC Inventories (Quarterly) (USD)|GlaxoSmithKline PLC Net PP&E (Quarterly) (USD)|GlaxoSmithKline PLC Goodwill and Intangibles (Quarterly) (USD)|GlaxoSmithKline PLC Total Liabilities (Quarterly) (USD)|GlaxoSmithKline PLC Total Current Liabilities (Quarterly) (USD)|GlaxoSmithKline PLC Total Long Term Liabilities (Quarterly) (USD)|GlaxoSmithKline PLC Total Deposits (Quarterly) (USD)|GlaxoSmithKline PLC Book Value (Quarterly) (USD)|GlaxoSmithKline PLC Retained Earnings (Quarterly) (USD)|GlaxoSmithKline PLC Treasury Stock (Quarterly) (USD)|GlaxoSmithKline PLC EV to Revenues|GlaxoSmithKline PLC EV to Earnings|GlaxoSmithKline PLC EV to Free Cash Flow|GlaxoSmithKline PLC EV to Assets (Quarterly)|GlaxoSmithKline PLC PS Ratio|GlaxoSmithKline PLC PE Ratio|GlaxoSmithKline PLC Price to Book Value|GlaxoSmithKline PLC PEG Ratio|GlaxoSmithKline PLC Debt to Equity Ratio|GlaxoSmithKline PLC Dividend Yield|GlaxoSmithKline PLC Shareholder Yield (TTM)|GlaxoSmithKline PLC Percent of Shares Outstanding Short|GlaxoSmithKline PLC Average Diluted Shares Outstanding (Quarterly)|GlaxoSmithKline PLC EPS Diluted (Quarterly) (USD)|GlaxoSmithKline PLC Dividend Per Share (Quarterly) (USD)|GlaxoSmithKline PLC Revenue (Quarterly) (USD)|GlaxoSmithKline PLC Gross Profit (Quarterly) (USD)|GlaxoSmithKline PLC SG&A Expense (Quarterly) (USD)|GlaxoSmithKline PLC Pre-Tax Income (Quarterly) (USD)|GlaxoSmithKline PLC Net Income (Quarterly) (USD)|GlaxoSmithKline PLC Net Interest Income (Quarterly) (USD)|GlaxoSmithKline PLC Price (USD)|GlaxoSmithKline PLC Total Return Price (USD)|GlaxoSmithKline PLC Enterprise Value (USD)||
adr_usa_0212|GSK|Unit|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric||
adr_usa_0212|GSK||||||||||||||||||||||||||||||||||||||0.3906|1976-08-23/price|0.3906|1976-08-31/price|0.3906|1976-08-23/total_return_price|0.0983|1976-08-31/total_return_price|0.0983
adr_usa_0212|GSK|197609||||||||||||||||||||||||||||||||||0.3906|0.0983||0.2968|1976-10-06/price|0.2968|1976-10-07/price|0.2968|1976-10-08/price|0.2968|1976-10-11/price|0.2968|1976-10-12/price|0.2968|1976-10-13/price|0.2968|1976-10-14/price|0.2968|1976-10-15/price|0.2968|1976-10-18/price|0.2968|1976-10-19/price|0.2968|1976-10-20/price|0.2968|1976-10-21/price|0.2968|1976-10-22/price|0.2968|1976-10-25/price|0.2968|1976-10-26/price|0.2968|1976-10-27/price|0.2968|1976-10-28/price|0.2968|1976-10-29/price|0.2968|1976-11-01/price|0.2968|1976-11-30/price|0.3593|1976-10-06/total_return_price|0.0747|1976-10-07/total_return_price|0.0747|1976-10-08/total_return_price|0.0747|1976-10-11/total_return_price|0.0747|1976-10-12/total_return_price|0.0747|1976-10-13/total_return_price|0.0747|1976-10-14/total_return_price|0.0747|1976-10-15/total_return_price|0.0747|1976-10-18/total_return_price|0.0747|1976-10-19/total_return_price|0.0747|1976-10-20/total_return_price|0.0747|1976-10-21/total_return_price|0.0747|1976-10-22/total_return_price|0.0747|1976-10-25/total_return_price|0.0747|1976-10-26/total_return_price|0.0747|1976-10-27/total_return_price|0.0747|1976-10-28/total_return_price|0.0747|1976-10-29/total_return_price|0.0747|1976-11-01/total_return_price|0.0747|1976-11-30/total_return_price|0.0904
adr_usa_0212|GSK|197612||||||||||||||||||||||||||||||||||0.4062|0.1022||0.4843|1977-01-31/price|0.4843|1977-02-28/price|0.4531|1977-01-31/total_return_price|0.1219|1977-02-28/total_return_price|0.114
adr_usa_0212|GSK|197703||||||||||||||||||||||||||||||||||0.4999|0.1258||0.4999|1977-04-29/price|0.4999|1977-05-31/price|0.5312|1977-04-29/total_return_price|0.1258|1977-05-31/total_return_price|0.1337
adr_usa_0212|GSK|197706||||||||||||||||||||||||||||||||||0.5624|0.1415||0.5781|1977-07-29/price|0.5781|1977-08-31/price|0.6406|1977-07-29/total_return_price|0.1455|1977-08-31/total_return_price|0.1612
adr_usa_0212|GSK|197709||||||||||||||||||||||||||||||||||0.7031|0.1769||0.7031|1977-10-31/price|0.7031|1977-11-30/price|0.6562|1977-10-31/total_return_price|0.1769|1977-11-30/total_return_price|0.1651
adr_usa_0212|GSK|197712||||||||||||||||||||||||||||||||||0.7031|0.1769||0.7031|1978-01-31/price|0.7031|1978-02-28/price|0.6406|1978-01-31/total_return_price|0.1769|1978-02-28/total_return_price|0.1612
adr_usa_0212|GSK|197803||||||||||||||||||||||||||||||||||0.6093|0.1533||0.5937|1978-04-28/price|0.5937|1978-05-31/price|0.6406|1978-04-28/total_return_price|0.1494|1978-05-31/total_return_price|0.1612
adr_usa_0212|GSK|197806||||||||||||||||||||||||||||||||||0.6249|0.1572||0.7031|1978-07-31/price|0.7031|1978-08-22/price|0.7031|1978-07-31/total_return_price|0.1769|1978-08-22/total_return_price|0.1769
adr_usa_0212|GSK||||||||||||||||||||||||||||||||||||||0.7031|1978-10-31/price|0.7031|1978-11-30/price|0.6406|1978-10-31/total_return_price|0.1769|1978-11-30/total_return_price|0.1612
adr_usa_0212|GSK|197812||||||||||||||||||||||||||||||||||0.6249|0.1572||0.5937|1979-01-31/price|0.5937|1979-02-28/price|0.5937|1979-01-31/total_return_price|0.1494|1979-02-28/total_return_price|0.1494
adr_usa_0212|GSK|197903||||||||||||||||||||||||||||||||||0.7499|0.1887||0.6874|1979-04-30/price|0.6874|1979-05-31/price|0.5937|1979-04-30/total_return_price|0.173|1979-05-31/total_return_price|0.1494
adr_usa_0212|GSK|197906||||||||||||||||||||||||||||||||||0.5781|0.1455||0.6249|1979-07-31/price|0.6249|1979-08-31/price|0.6093|1979-07-31/total_return_price|0.1572|1979-08-31/total_return_price|0.1533
adr_usa_0212|GSK|197909||||||||||||||||||||||||||||||||||0.6093|0.1533||0.5937|1979-10-31/price|0.5937|1979-11-30/price|0.5468|1979-10-31/total_return_price|0.1494|1979-11-30/total_return_price|0.1376
adr_usa_0212|GSK|197912||||||||||||||||||||||||||||||||||0.5937|0.1494||0.6718|1980-01-31/price|0.6718|1980-02-29/price|0.6718|1980-01-31/total_return_price|0.169|1980-02-29/total_return_price|0.169
adr_usa_0212|GSK|198003||||||||||||||||||||||||||||||||||0.625|0.1573||0.5468|1980-04-30/price|0.5468|1980-05-30/price|0.5156|1980-04-30/total_return_price|0.1376|1980-05-30/total_return_price|0.1297
adr_usa_0212|GSK|198006||||||||||||||||||||||||||||||||||0.6406|0.1612||0.6562|1980-07-31/price|0.6562|1980-08-29/price|0.6874|1980-07-31/total_return_price|0.1651|1980-08-29/total_return_price|0.173
adr_usa_0212|GSK|198009||||||||||||||||||||||||||||||||||0.75|0.1887||0.7343|1980-10-31/price|0.7343|1980-11-28/price|0.7343|1980-10-31/total_return_price|0.1848|1980-11-28/total_return_price|0.1848
adr_usa_0212|GSK|198012||||||||||||||||||||||||||||||||||0.7811|0.1965||0.7655|1981-01-30/price|0.7655|1981-02-27/price|0.7811|1981-01-30/total_return_price|0.1926|1981-02-27/total_return_price|0.1965
adr_usa_0212|GSK|198103||||||||||||||||||||||||||||||||||0.8436|0.2123||0.9842|1981-04-30/price|0.9842|1981-05-29/price|0.8748|1981-04-30/total_return_price|0.2476|1981-05-29/total_return_price|0.2201
adr_usa_0212|GSK|198106||||||||||||||||||||||||||||||||||0.8905|0.2241||0.8748|1981-07-31/price|0.8748|1981-08-31/price|0.953|1981-07-31/total_return_price|0.2201|1981-08-31/total_return_price|0.2398
adr_usa_0212|GSK|198109||||||||||||||||||||||||||||||||||0.7967|0.2005||0.9373|1981-10-30/price|0.9373|1981-11-30/price|1.0467|1981-10-30/total_return_price|0.2358|1981-11-30/total_return_price|0.2634
adr_usa_0212|GSK|198112||||||||||||||||||||||||||||||||||0.9998|0.2516||1.1248|1982-01-29/price|1.1248|1982-02-26/price|1.078|1982-01-29/total_return_price|0.283|1982-02-26/total_return_price|0.2712
adr_usa_0212|GSK|198203||||||||||||||||||||||||||||||||||1.1717|0.2948||1.4216|1982-04-30/price|1.4216|1982-05-28/price|1.531|1982-04-30/total_return_price|0.3577|1982-05-28/total_return_price|0.3852
adr_usa_0212|GSK|198206||||||||||||||||||||||||||||||||||1.531|0.3852||1.578|1982-07-30/price|1.578|1982-08-31/price|1.6717|1982-07-30/total_return_price|0.397|1982-08-31/total_return_price|0.4206
adr_usa_0212|GSK|198209||||||||||||||||||||||||||||||||||1.8279|0.4599||2.1404|1982-10-29/price|2.1404|1982-11-30/price|2.6403|1982-10-29/total_return_price|0.5385|1982-11-30/total_return_price|0.6643
adr_usa_0212|GSK|198212||||||||||||||||||||||||||||||||||2.5465|0.6407||2.7496|1983-01-31/price|2.7496|1983-02-28/price|2.6559|1983-01-31/total_return_price|0.6918|1983-02-28/total_return_price|0.6682
adr_usa_0212|GSK|198303||||||||||||||||||||||||||||||||||3.062|0.7704||3.4994|1983-04-29/price|3.4994|1983-05-31/price|3.3744|1983-04-29/total_return_price|0.8805|1983-05-31/total_return_price|0.849
adr_usa_0212|GSK|198306||||||||||||||||||||||||||||||||||3.4682|0.8726||3.4369|1983-07-29/price|3.4369|1983-08-31/price|3.0933|1983-07-29/total_return_price|0.8647|1983-08-31/total_return_price|0.7783
adr_usa_0212|GSK|198309||||||||||||||||||||||||||||||||||3.0308|0.7626||2.6871|1983-10-31/price|2.6871|1983-11-30/price|2.812|1983-10-31/total_return_price|0.6761|1983-11-30/total_return_price|0.7075
adr_usa_0212|GSK|198312||||||||||||||||||||||||||||||||||2.4996|0.6289||2.6871|1984-01-31/price|2.6871|1984-02-29/price|2.7496|1984-01-31/total_return_price|0.6761|1984-02-29/total_return_price|0.6918
adr_usa_0212|GSK|198403||||||||||||||||||||||||||||||||||2.9995|0.7547||3.0308|1984-04-30/price|3.0308|1984-05-31/price|2.7184|1984-04-30/total_return_price|0.7626|1984-05-31/total_return_price|0.684
adr_usa_0212|GSK|198406||||||||||||||||||||||||||||||||||2.8745|0.7232||2.7496|1984-07-31/price|2.7496|1984-08-31/price|3.1245|1984-07-31/total_return_price|0.6918|1984-08-31/total_return_price|0.7861
adr_usa_0212|GSK|198409||||||||||||||||||||||||||||||||||2.9683|0.7468||3.062|1984-10-31/price|3.062|1984-11-30/price|3.1245|1984-10-31/total_return_price|0.7704|1984-11-30/total_return_price|0.7936
adr_usa_0212|GSK|198412||||||||||||||||||||||||||||||||||3.1558|0.8016||3.3432|1985-01-31/price|3.3432|1985-02-28/price|3.187|1985-01-31/total_return_price|0.8492|1985-02-28/total_return_price|0.8095
adr_usa_0212|GSK|198503||||||||||||||||||||||||||||||||||3.3432|0.8492||3.6557|1985-04-30/price|3.6557|1985-05-31/price|4.0618|1985-04-30/total_return_price|0.9285|1985-05-31/total_return_price|1.0377
adr_usa_0212|GSK|198506||||||||||||||||||||||||||||||||||3.9681|1.0138||4.3742|1985-07-31/price|4.3742|1985-08-30/price|4.6867|1985-07-31/total_return_price|1.1175|1985-08-30/total_return_price|1.1973
adr_usa_0212|GSK|||||||||||||||||||||||||||0.1081|0|540.4401||||151.394||4.4992|1.1494||5.2804|1985-11-22/dividend_yield|1.4022|1985-10-31/price|5.2804|1985-11-29/price|5.7803|1985-10-31/total_return_price|1.349|1985-11-29/total_return_price|1.4923
adr_usa_0212|GSK|198512||||||||||||||||||||||1.4586||||0.1097|0.0569|548.4521||||153.5387||5.5304|1.4277||6.124|1986-01-03/dividend_yield|1.4258|1986-01-17/dividend_yield|1.4339|1986-01-31/dividend_yield|1.2949|1986-02-14/dividend_yield|1.2321|1986-02-28/dividend_yield|1.1035|1986-01-31/price|6.124|1986-02-28/price|7.1863|1986-01-31/total_return_price|1.581|1986-02-28/total_return_price|1.8552
adr_usa_0212|GSK|198603||||||||||||||||||||||0.9992|||740|0.0985|0|542.0394||||151.842||7.9361|2.0488||7.5612|1986-04-14/dividend_yield|0.9687|1986-04-28/dividend_yield|1.0234|1986-05-12/dividend_yield|1.1876|1986-05-27/dividend_yield|1.2076|1986-04-30/price|7.5612|1986-05-30/price|7.4362|1986-04-30/total_return_price|1.952|1986-05-30/total_return_price|1.9281
adr_usa_0212|GSK|198606|1868.7637|906.0672|422.4232|820.3582||1075.9549|855.5601|220.3947||1668.2657|||2.4516|8.6913||1.8529|||3.4925||0.1064|1.1054|||740||0.0315|454.7139||||131.5453||7.8736|2.0416|5113.2421|7.1238|1986-07-14/ev_revenues|2.1413|1986-07-28/ev_revenues|2.1634|1986-08-11/ev_revenues|2.2078|1986-08-25/ev_revenues|2.1191|1986-07-14/price_to_book_value|3.1045|1986-07-28/price_to_book_value|3.1322|1986-08-11/price_to_book_value|3.1877|1986-08-25/price_to_book_value|3.0768|1986-07-08/dividend_yield|1.1779|1986-07-22/dividend_yield|1.2496|1986-08-05/dividend_yield|1.2717|1986-08-19/dividend_yield|1.2831|1986-07-31/price|7.1238|1986-08-29/price|7.2488|1986-07-31/total_return_price|1.8471|1986-08-29/total_return_price|1.8795|1986-07-14/enterprise_value|4465.8901|1986-07-28/enterprise_value|4512.1401|1986-08-11/enterprise_value|4604.6401|1986-08-25/enterprise_value|4419.6401
adr_usa_0212|GSK|198609|||||||||||||2.1634|6.8986|||2.2517||3.1322|||1.3306|||740|0.1233|0|672.7611||||183.6298||6.7489|1.7499|4512.1401|6.6239|1986-10-06/ev_revenues|1.9301|1986-10-20/ev_revenues|1.9093|1986-11-03/ev_revenues|1.9093|1986-11-17/ev_revenues|1.8259|1986-10-14/ps_ratio|2.21|1986-10-28/ps_ratio|2.1474|1986-11-11/ps_ratio|2.21|1986-11-25/ps_ratio|2.1266|1986-10-06/price_to_book_value|2.9936|1986-10-20/price_to_book_value|2.9659|1986-11-03/price_to_book_value|2.9659|1986-11-17/price_to_book_value|2.855|1986-10-14/dividend_yield|1.3557|1986-10-28/dividend_yield|1.3952|1986-11-11/dividend_yield|1.3557|1986-11-25/dividend_yield|1.8042|1986-10-31/price|6.6239|1986-11-28/price|6.5614|1986-10-31/total_return_price|1.7175|1986-11-28/total_return_price|1.724|1986-10-06/enterprise_value|4280.9641|1986-10-20/enterprise_value|4234.7141|1986-10-27/enterprise_value|3957.2141|1986-11-10/enterprise_value|4188.4641|1986-11-18/enterprise_value|3957.2141
adr_usa_0212|GSK|198612|||||||||||||2.222|7.7769|||2.5227||3.3817|||1.5209||||0.1159|0.0835|632.5946||||172.64||7.6862|2.0196|4928.3161|9.8108|1987-01-12/ev_revenues|2.4019|1987-01-26/ev_revenues|2.6831|1987-02-09/ev_revenues|2.884|1987-02-23/ev_revenues|3.4063|1987-01-06/ps_ratio|2.6113|1987-01-20/ps_ratio|2.772|1987-02-03/ps_ratio|3.3143|1987-02-17/ps_ratio|3.4349|1987-01-12/price_to_book_value|3.742|1987-01-26/price_to_book_value|4.1301|1987-02-09/price_to_book_value|4.4073|1987-02-23/price_to_book_value|5.128|1987-01-06/dividend_yield|1.4156|1987-01-20/dividend_yield|1.3336|1987-02-03/dividend_yield|1.1153|1987-02-17/dividend_yield|1.0762|1987-01-30/price|9.8108|1987-02-27/price|12.3729|1987-01-30/total_return_price|2.5778|1987-02-27/total_return_price|3.251|1987-01-13/enterprise_value|5436.9921|1987-01-27/enterprise_value|6315.5934|1987-02-10/enterprise_value|6500.5934|1987-02-24/enterprise_value|8488.9741
adr_usa_0212|GSK|198703|||||||||||||3.7076|11.3147|||3.4948||5.5437|||0.9841|||740|0.1439|0|714.3033||||213.4082||11.6856|3.0704|8535.2241|11.8105|1987-04-06/ev_revenues|3.3373|1987-04-20/ev_revenues|3.2439|1987-05-04/ev_revenues|3.2626|1987-05-18/ev_revenues|3.6363|1987-04-14/ps_ratio|3.3826|1987-04-28/ps_ratio|3.4948|1987-05-12/ps_ratio|3.7938|1987-05-26/ps_ratio|3.8872|1987-04-06/price_to_book_value|5.3775|1987-04-20/price_to_book_value|5.2388|1987-05-04/price_to_book_value|5.2666|1987-05-18/price_to_book_value|5.8209|1987-04-14/dividend_yield|1.0167|1987-04-28/dividend_yield|0.9841|1987-05-12/dividend_yield|0.9066|1987-05-14/dividend_yield|0.86|1987-05-28/dividend_yield|1.0176|1987-04-30/price|11.8105|1987-05-29/price|12.9978|1987-04-30/total_return_price|3.1033|1987-05-29/total_return_price|3.4273|1987-04-07/enterprise_value|8257.7981|1987-04-21/enterprise_value|8072.7981|1987-05-05/enterprise_value|8119.0481|1987-05-19/enterprise_value|9136.3254
adr_usa_0212|GSK|198706|2667.6441|1505.2789|463.6581|1046.4506||1439.2721|1144.656|294.6161||2334.3898|||3.7298|10.8878||2.2931|4.018||5.9595||0.1448|0.9359|||740||0.0475|758.6745||||229.8284||13.3102|3.5096|8704.8913|14.1851|1987-07-13/ev_revenues|3.3828|1987-07-27/ev_revenues|3.3662|1987-08-10/ev_revenues|3.2663|1987-08-24/ev_revenues|3.4827|1987-07-07/ps_ratio|3.7948|1987-07-21/ps_ratio|3.8447|1987-08-04/ps_ratio|3.645|1987-08-18/ps_ratio|3.8281|1987-07-13/price_to_book_value|4.5165|1987-07-27/price_to_book_value|4.4967|1987-08-10/price_to_book_value|4.3778|1987-08-24/price_to_book_value|4.6354|1987-07-09/dividend_yield|0.9115|1987-07-23/dividend_yield|0.9154|1987-08-06/dividend_yield|0.9359|1987-08-20/dividend_yield|0.9154|1987-07-31/price|14.1851|1987-08-31/price|14.0601|1987-07-31/total_return_price|3.7403|1987-08-31/total_return_price|3.7074|1987-07-14/enterprise_value|9814.744|1987-07-28/enterprise_value|9629.8173|1987-08-11/enterprise_value|9306.0673|1987-08-25/enterprise_value|9629.8173
adr_usa_0212|GSK|198709|||||||||||||3.5825|11.147|||3.9113||4.7542|||0.8845|||740|0.1787|0|862.2267||||252.1653||14.6226|3.8557|9953.494|9.9983|1987-10-06/ev_revenues|3.1513|1987-10-20/ev_revenues|1.9827|1987-11-03/ev_revenues|1.8892|1987-11-17/ev_revenues|1.8892|1987-10-13/ps_ratio|3.0228|1987-10-27/ps_ratio|2.3216|1987-11-10/ps_ratio|2.2749|1987-11-24/ps_ratio|2.306|1987-10-06/price_to_book_value|4.4967|1987-10-20/price_to_book_value|3.011|1987-11-03/price_to_book_value|2.8921|1987-11-17/price_to_book_value|2.8921|1987-10-01/dividend_yield|0.9036|1987-10-15/dividend_yield|1.121|1987-10-29/dividend_yield|1.3353|1987-11-12/dividend_yield|1.3353|1987-11-27/dividend_yield|2.1158|1987-10-30/price|9.9983|1987-11-30/price|8.936|1987-10-30/total_return_price|2.6364|1987-11-30/total_return_price|2.3962|1987-10-06/enterprise_value|9352.3173|1987-10-20/enterprise_value|5884.1593|1987-11-03/enterprise_value|5606.734|1987-11-17/enterprise_value|5606.734
adr_usa_0212|GSK|198712|||||||||||||1.9048|6.0056|||2.306||2.912|||2.1446||||0.1688|0.1441|814.4215||||238.1843||9.1235|2.4465|5652.984|9.3734|1988-01-12/ev_revenues|1.7361|1988-01-26/ev_revenues|1.7214|1988-02-09/ev_revenues|1.692|1988-02-23/ev_revenues|1.7801|1988-01-05/ps_ratio|2.1729|1988-01-19/ps_ratio|2.1142|1988-02-02/ps_ratio|2.1362|1988-02-16/ps_ratio|2.0995|1988-01-12/price_to_book_value|2.8327|1988-01-26/price_to_book_value|2.8129|1988-02-09/price_to_book_value|2.7733|1988-02-23/price_to_book_value|2.8921|1988-01-11/dividend_yield|2.2358|1988-01-25/dividend_yield|2.2046|1988-02-08/dividend_yield|2.3352|1988-02-22/dividend_yield|2.1446|1988-01-29/price|9.3734|1988-02-29/price|9.2485|1988-01-29/total_return_price|2.5135|1988-02-29/total_return_price|2.48|1988-01-12/enterprise_value|5467.984|1988-01-26/enterprise_value|5421.734|1988-02-09/enterprise_value|5329.308|1988-02-23/enterprise_value|5606.734
adr_usa_0212|GSK|198803|||||||||||||1.8829|5.9692|||2.2023||3.0308|||2.0471|||740|0.1546|0|863.7197||||226.8472||9.186|2.4632|5930.4093|8.6861|1988-04-05/ev_revenues|1.7415|1988-04-19/ev_revenues|1.7135|1988-05-03/ev_revenues|1.6574|1988-05-17/ev_revenues|1.5874|1988-05-31/ev_revenues|1.5593|1988-04-12/ps_ratio|2.1306|1988-04-26/ps_ratio|1.9904|1988-05-10/ps_ratio|1.9764|1988-05-24/ps_ratio|1.9203|1988-04-05/price_to_book_value|2.9515|1988-04-19/price_to_book_value|2.912|1988-05-03/price_to_book_value|2.8327|1988-05-17/price_to_book_value|2.7337|1988-05-31/price_to_book_value|2.694|1988-04-04/dividend_yield|2.1893|1988-04-18/dividend_yield|2.9436|1988-05-02/dividend_yield|3.113|1988-05-16/dividend_yield|3.0908|1988-05-31/dividend_yield|3.1817|1988-04-29/price|8.6861|1988-05-31/price|8.4986|1988-04-29/total_return_price|2.3478|1988-05-31/total_return_price|2.2971|1988-04-05/enterprise_value|5745.4093|1988-04-19/enterprise_value|5652.984|1988-05-03/enterprise_value|5467.984|1988-05-17/enterprise_value|5236.808|1988-05-31/enterprise_value|5144.308
adr_usa_0212|GSK|198806|3392.0811|2002.7804|529.7457|1416.6425||1818.2238|1484.9967|333.2271||3048.6009|||1.5313|4.6167||0.983|1.9764||2.6544||0.148|3.2292|||740||0.0722|1189.3331||||325.9891||8.5611|2.314|5051.808|8.4361|1988-07-12/ev_revenues|1.2913|1988-07-26/ev_revenues|1.2417|1988-08-09/ev_revenues|1.2169|1988-08-23/ev_revenues|1.1921|1988-08-25/ev_revenues|1.1797|1988-08-31/ev_revenues|1.1797|1988-07-05/ps_ratio|1.6986|1988-07-19/ps_ratio|1.6738|1988-08-02/ps_ratio|1.6738|1988-08-16/ps_ratio|1.6242|1988-08-25/ps_ratio|1.587|1988-08-31/ps_ratio|1.587|1988-07-12/price_to_book_value|2.0781|1988-07-26/price_to_book_value|2.0174|1988-08-09/price_to_book_value|1.9871|1988-08-23/price_to_book_value|1.9567|1988-08-25/price_to_book_value|1.9415|1988-08-31/price_to_book_value|1.9415|1988-07-12/dividend_yield|3.1585|1988-07-26/dividend_yield|3.2535|1988-08-09/dividend_yield|3.3031|1988-08-23/dividend_yield|3.3543|1988-07-29/price|8.4361|1988-08-31/price|7.9986|1988-07-29/total_return_price|2.2802|1988-08-31/total_return_price|2.162|1988-07-12/enterprise_value|4816.0401|1988-07-26/enterprise_value|4631.0401|1988-08-09/enterprise_value|4538.6141|1988-08-23/enterprise_value|4446.1141
adr_usa_0212|GSK|198809|||||||||||||1.3656|4.934|||1.773||2.1691|||3.0908|||740|0.2011|0|1018.3788||||288.1787||9.2485|2.4998|4954.7901|10.0608|1988-10-12/ev_revenues|1.3941|1988-10-26/ev_revenues|1.525|1988-11-09/ev_revenues|1.4655|1988-11-23/ev_revenues|1.525|1988-10-12/ps_ratio|1.785|1988-10-26/ps_ratio|1.9159|1988-11-09/ps_ratio|1.8564|1988-11-23/ps_ratio|1.9159|1988-10-12/price_to_book_value|2.2752|1988-10-26/price_to_book_value|2.4421|1988-11-09/price_to_book_value|2.3663|1988-11-23/price_to_book_value|2.4421|1988-10-04/dividend_yield|2.9436|1988-10-18/dividend_yield|2.7561|1988-11-01/dividend_yield|2.7215|1988-11-15/dividend_yield|2.7917|1988-11-29/dividend_yield|2.6222|1988-10-31/price|10.0608|1988-11-30/price|9.9358|1988-10-31/total_return_price|2.7194|1988-11-30/total_return_price|2.7374|1988-10-04/enterprise_value|5278.4661|1988-10-18/enterprise_value|5740.8174|1988-11-01/enterprise_value|5833.3174|1988-11-15/enterprise_value|5648.3914|1988-11-29/enterprise_value|5787.0674
adr_usa_0212|GSK|198812|||||||||||||1.406|4.9755|||1.7969||2.2904|||2.7079||||0.1988|0.18|1006.9192||||284.9359||9.6234|2.6513|5555.8914|10.6232|1989-01-04/ev_revenues|1.385|1989-01-18/ev_revenues|1.3509|1989-02-01/ev_revenues|1.555|1989-02-15/ev_revenues|1.6457|1989-01-04/ps_ratio|1.7575|1989-01-18/ps_ratio|1.7234|1989-02-01/ps_ratio|1.9275|1989-02-15/ps_ratio|2.0182|1989-01-04/price_to_book_value|2.3511|1989-01-18/price_to_book_value|2.3056|1989-02-01/price_to_book_value|2.5786|1989-02-15/price_to_book_value|2.7|1989-01-10/dividend_yield|2.6903|1989-01-24/dividend_yield|2.5894|1989-02-07/dividend_yield|2.3276|1989-02-21/dividend_yield|2.3675|1989-01-31/price|10.6232|1989-02-28/price|10.6857|1989-01-31/total_return_price|2.9267|1989-02-28/total_return_price|2.944|1989-01-10/enterprise_value|5602.1414|1989-01-24/enterprise_value|5879.5674|1989-02-07/enterprise_value|6711.9201|1989-02-21/enterprise_value|6573.1701
adr_usa_0212|GSK|198903|||||||||||||1.6231|5.808|||1.9956||2.6696|||2.3017|||744.864|0.1658|0.0979|1018.2747||||256.5373||11.1231|3.0645|6804.4201|11.6231|1989-04-12/ev_revenues|1.6731|1989-04-26/ev_revenues|1.684|1989-05-10/ev_revenues|1.6075|1989-05-24/ev_revenues|1.5857|1989-04-12/ps_ratio|2.0364|1989-04-26/ps_ratio|2.0474|1989-05-10/ps_ratio|1.9707|1989-05-24/ps_ratio|1.9488|1989-04-12/price_to_book_value|2.8213|1989-04-26/price_to_book_value|2.8365|1989-05-10/price_to_book_value|2.7303|1989-05-24/price_to_book_value|2.7|1989-04-04/dividend_yield|2.2517|1989-04-18/dividend_yield|2.3459|1989-05-02/dividend_yield|2.3961|1989-05-16/dividend_yield|2.4352|1989-05-30/dividend_yield|2.5604|1989-04-28/price|11.6231|1989-05-31/price|10.8106|1989-04-28/total_return_price|3.229|1989-05-31/total_return_price|3.0033|1989-04-04/enterprise_value|6989.4201|1989-04-18/enterprise_value|7313.0961|1989-05-02/enterprise_value|7128.1701|1989-05-16/enterprise_value|6989.4201|1989-05-30/enterprise_value|6573.1701
adr_usa_0212|GSK|198906|3536.6619|2005.4516|543.9826|1741.9842||1791.578|1337.4843|454.0937||3550.6101|||1.5529|5.4256||1.1726|1.916||2.6544||0.0759|2.4756|||744.864||0|1285.1517||||332.2912||10.7482|2.986|6850.6701|12.248|1989-07-05/ev_revenues|1.5424|1989-07-19/ev_revenues|1.6177|1989-08-02/ev_revenues|1.7897|1989-08-16/ev_revenues|1.6929|1989-08-30/ev_revenues|1.7575|1989-07-05/ps_ratio|1.9313|1989-07-19/ps_ratio|2.0064|1989-08-02/ps_ratio|2.1781|1989-08-16/ps_ratio|2.0815|1989-08-30/ps_ratio|2.1459|1989-07-05/price_to_book_value|2.3597|1989-07-19/price_to_book_value|2.4515|1989-08-02/price_to_book_value|2.6612|1989-08-16/price_to_book_value|2.5432|1989-08-30/price_to_book_value|2.6219|1989-07-11/dividend_yield|2.462|1989-07-25/dividend_yield|2.409|1989-08-08/dividend_yield|2.2182|1989-08-22/dividend_yield|2.3216|1989-07-31/price|12.248|1989-08-31/price|12.5604|1989-07-31/total_return_price|3.4027|1989-08-31/total_return_price|3.4894|1989-07-11/enterprise_value|6769.7236|1989-07-25/enterprise_value|6955.9396|1989-08-08/enterprise_value|7700.6546|1989-08-22/enterprise_value|7281.7431
adr_usa_0212|GSK|198909|||||||||||||1.7252|6.1783|||2.1137||2.5825|||2.3337|||744.864|0.2163|0.2197|1187.2993||||327.4461||12.248|3.4027|7235.1891|11.0606|1989-10-11/ev_revenues|1.4948|1989-10-25/ev_revenues|1.4431|1989-11-08/ev_revenues|1.5569|1989-11-22/ev_revenues|1.5155|1989-10-11/ps_ratio|1.8732|1989-10-25/ps_ratio|1.8214|1989-11-08/ps_ratio|1.9353|1989-11-22/ps_ratio|1.8939|1989-10-11/price_to_book_value|2.3728|1989-10-25/price_to_book_value|2.3072|1989-11-08/price_to_book_value|2.4515|1989-11-22/price_to_book_value|2.399|1989-10-03/dividend_yield|2.2745|1989-10-17/dividend_yield|4.5781|1989-10-31/dividend_yield|4.5522|1989-11-14/dividend_yield|4.3087|1989-11-28/dividend_yield|4.2858|1989-10-31/price|11.0606|1989-11-30/price|11.998|1989-10-31/total_return_price|3.1296|1989-11-30/total_return_price|3.3948|1989-10-03/enterprise_value|7467.8846|1989-10-17/enterprise_value|6490.3996|1989-10-31/enterprise_value|6536.9536|1989-11-14/enterprise_value|7002.4936|1989-11-28/enterprise_value|7049.0476
adr_usa_0212|GSK|198912|||||||||||||1.7432|6.4085|||2.1215||2.6874|||3.9497||||0.2271|0|1192.7135||||328.9393||12.9978|3.6777|7793.7626|12.123|1990-01-03/ev_revenues|1.7436|1990-01-17/ev_revenues|1.6542|1990-01-31/ev_revenues|1.5647|1990-02-14/ev_revenues|1.5747|1990-02-28/ev_revenues|1.5349|1990-01-03/ps_ratio|2.107|1990-01-17/ps_ratio|2.0175|1990-01-31/ps_ratio|1.9281|1990-02-14/ps_ratio|1.938|1990-02-28/ps_ratio|1.8982|1990-01-03/price_to_book_value|2.7792|1990-01-17/price_to_book_value|2.6612|1990-01-31/price_to_book_value|2.5432|1990-02-14/price_to_book_value|2.5563|1990-02-28/price_to_book_value|2.5039|1990-01-09/dividend_yield|3.6792|1990-01-23/dividend_yield|4.1748|1990-02-06/dividend_yield|4.1533|1990-02-20/dividend_yield|4.0489|1990-01-31/price|12.123|1990-02-28/price|11.9355|1990-01-31/total_return_price|3.4302|1990-02-28/total_return_price|3.3771|1990-01-09/enterprise_value|8491.9229|1990-01-23/enterprise_value|7281.7431|1990-02-06/enterprise_value|7328.2971|1990-02-20/enterprise_value|7560.9926
adr_usa_0212|GSK|199003|||||||||||||1.6939|5.8339|||2.0573||2.7136|||3.8186|||1494.249|0.2419|0.134|1298.0575||||363.2142||12.8728|3.68|8119.5661|12.5604|1990-04-11/ev_revenues|1.6172|1990-04-25/ev_revenues|1.5515|1990-05-09/ev_revenues|1.6547|1990-05-23/ev_revenues|1.7672|1990-04-11/ps_ratio|2.6174|1990-04-25/ps_ratio|2.5297|1990-05-09/ps_ratio|2.6674|1990-05-23/ps_ratio|2.8177|1990-04-11/price_to_book_value|2.7399|1990-04-25/price_to_book_value|2.6481|1990-05-09/price_to_book_value|2.7923|1990-05-23/price_to_book_value|2.9496|1990-04-03/dividend_yield|2.6784|1990-04-17/dividend_yield|2.6535|1990-05-01/dividend_yield|2.7965|1990-05-15/dividend_yield|2.5932|1990-05-29/dividend_yield|2.5814|1990-05-08/percent_of_shares_outstanding|0.3754|1990-04-30/price|12.5604|1990-05-31/price|13.3727|1990-04-30/total_return_price|3.5907|1990-05-31/total_return_price|3.8229|1990-04-03/enterprise_value|8212.5989|1990-04-17/enterprise_value|8305.7069|1990-05-01/enterprise_value|7793.7626|1990-05-15/enterprise_value|8538.4769|1990-05-29/enterprise_value|8584.9564
adr_usa_0212|GSK|199006|4991.9491|2774.8544|726.8306|2807.9714||2940.4393|2450.6566|489.7827||4761.8733|||1.7954|14.6411||2.5331|2.8553||2.9889||0.1717|2.5355||0.5001|1494.249||0|1548.0167||||334.9885||14.4975|4.1445|8771.1724|15.4974|1990-07-05/ev_revenues|3.8128|1990-07-19/ev_revenues|4.1523|1990-08-02/ev_revenues|3.92|1990-08-16/ev_revenues|3.7592|1990-08-30/ev_revenues|3.6878|1990-07-05/ps_ratio|3.4671|1990-07-19/ps_ratio|3.7498|1990-08-02/ps_ratio|3.5564|1990-08-16/ps_ratio|3.4224|1990-08-30/ps_ratio|3.3629|1990-07-05/price_to_book_value|4.5689|1990-07-19/price_to_book_value|4.9414|1990-08-02/price_to_book_value|4.6865|1990-08-16/price_to_book_value|4.51|1990-08-30/price_to_book_value|4.4316|1990-07-10/dividend_yield|2.3097|1990-07-24/dividend_yield|2.3477|1990-08-07/dividend_yield|2.4485|1990-08-21/dividend_yield|2.6412|1990-07-06/percent_of_shares_outstanding|0.1585|1990-08-08/percent_of_shares_outstanding|0.1314|1990-07-31/price|15.4974|1990-08-31/price|14.0601|1990-07-31/total_return_price|4.4303|1990-08-31/total_return_price|4.0194|1990-07-10/enterprise_value|21233.4349|1990-07-24/enterprise_value|20860.0221|1990-08-07/enterprise_value|19926.2644|1990-08-21/enterprise_value|18338.7743
adr_usa_0212|GSK|199009|||||||||||||3.652|13.7483|||3.3332||4.3924|||2.5355||0.0227|1494.249|0.2484|0.3318|1370.1917||||367.8814||14.0601|4.1195|19179.1399|15.06|1990-10-11/ev_revenues|3.7875|1990-10-25/ev_revenues|3.8048|1990-11-08/ev_revenues|3.8566|1990-11-23/ev_revenues|4.0464|1990-10-11/ps_ratio|4.1258|1990-10-25/ps_ratio|4.1431|1990-11-08/ps_ratio|4.1949|1990-11-23/ps_ratio|4.3848|1990-10-11/price_to_book_value|4.6865|1990-10-25/price_to_book_value|4.7061|1990-11-08/price_to_book_value|4.765|1990-11-23/price_to_book_value|4.9806|1990-10-02/dividend_yield|3.1533|1990-10-16/dividend_yield|3.1666|1990-10-30/dividend_yield|3.0628|1990-11-13/dividend_yield|2.9774|1990-11-27/dividend_yield|2.9422|1990-10-08/percent_of_shares_outstanding|0.0947|1990-11-08/percent_of_shares_outstanding|0.0982|1990-10-31/price|15.06|1990-11-30/price|16.4972|1990-10-31/total_return_price|4.4125|1990-11-30/total_return_price|4.8336|1990-10-02/enterprise_value|20299.6787|1990-10-16/enterprise_value|20206.4361|1990-10-30/enterprise_value|20953.4127|1990-11-13/enterprise_value|21606.9972|1990-11-27/enterprise_value|21887.0195
adr_usa_0212|GSK|199012|||||||||||||4.1673|15.7222|||4.5056||5.1179|||2.8415||0.3013||0.2522|0|1391.263||||373.5388||16.3722|4.7969|22727.3851|17.8095|1991-01-04/ev_revenues|3.9698|1991-01-18/ev_revenues|4.0697|1991-02-01/ev_revenues|4.4527|1991-02-15/ev_revenues|4.8024|1991-01-04/ps_ratio|4.2961|1991-01-18/ps_ratio|4.396|1991-02-01/ps_ratio|4.779|1991-02-15/ps_ratio|5.1287|1991-01-04/price_to_book_value|5.0591|1991-01-18/price_to_book_value|5.1767|1991-02-01/price_to_book_value|5.6277|1991-02-15/price_to_book_value|6.0395|1991-01-09/dividend_yield|2.9893|1991-01-23/dividend_yield|2.7679|1991-02-06/dividend_yield|2.5247|1991-02-20/dividend_yield|2.5247|1991-01-08/percent_of_shares_outstanding|0.1384|1991-02-08/percent_of_shares_outstanding|0.2036|1991-01-31/price|17.8095|1991-02-28/price|18.9343|1991-01-31/total_return_price|5.2181|1991-02-28/total_return_price|5.5476|1991-01-09/enterprise_value|21513.6066|1991-01-23/enterprise_value|23380.9711|1991-02-06/enterprise_value|25808.8254|1991-02-20/enterprise_value|25808.8254
adr_usa_0212|GSK|199103|||||||||||||4.7694|18.7301|||5.0898|||||2.7053||0.1579|1499.602|0.2742|0.1825|1512.9361||||406.2067||19.8091|5.8551|25808.8254|19.0593|1991-04-15/ev_revenues|4.8015|1991-04-29/ev_revenues|4.5128|1991-05-13/ev_revenues|4.6893|1991-05-28/ev_revenues|5.1543|1991-04-15/ps_ratio|5.1219|1991-04-29/ps_ratio|4.8329|1991-05-13/ps_ratio|5.0096|1991-05-28/ps_ratio|5.4752|1991-04-15/price_to_book_value|6.2552|1991-04-29/price_to_book_value|5.9023|1991-05-13/price_to_book_value|6.118|1991-05-28/price_to_book_value|6.6866|1991-04-03/dividend_yield|2.434|1991-04-17/dividend_yield|2.5182|1991-05-01/dividend_yield|2.6084|1991-05-15/dividend_yield|2.6604|1991-05-29/dividend_yield|2.3692|1991-04-08/percent_of_shares_outstanding|0.134|1991-05-08/percent_of_shares_outstanding|0.1475|1991-04-30/price|19.0593|1991-05-31/price|20.3715|1991-04-30/total_return_price|5.6334|1991-05-31/total_return_price|6.0213|1991-04-03/enterprise_value|28890.1162|1991-04-17/enterprise_value|27862.968|1991-05-01/enterprise_value|26835.9721|1991-05-15/enterprise_value|26275.6288|1991-05-29/enterprise_value|29730.6313
adr_usa_0212|GSK|199106|5896.7224|3453.6787|801.3703|3375.8128||3993.8736|3288.2136|705.66||5204.0401|||5.0421|17.5375||3.0767|5.3628||6.5493||0.3152|2.3904||0.0414|1499.602||0|1737.7982||||487.0577||20.2466|5.9844|29450.3117|21.9963|1991-07-09/ev_revenues|4.8775|1991-07-23/ev_revenues|5.0957|1991-08-06/ev_revenues|5.2515|1991-08-20/ev_revenues|5.158|1991-07-09/ps_ratio|5.153|1991-07-23/ps_ratio|5.371|1991-08-06/ps_ratio|5.5267|1991-08-20/ps_ratio|5.4332|1991-07-09/price_to_book_value|5.9603|1991-07-23/price_to_book_value|6.2124|1991-08-06/price_to_book_value|6.3925|1991-08-20/price_to_book_value|6.2844|1991-07-10/dividend_yield|2.4266|1991-07-24/dividend_yield|2.3011|1991-08-07/dividend_yield|2.2306|1991-08-21/dividend_yield|2.182|1991-07-08/percent_of_shares_outstanding|0.063|1991-08-08/percent_of_shares_outstanding|0.1137|1991-07-31/price|21.9963|1991-08-30/price|23.1211|1991-07-31/total_return_price|6.5015|1991-08-30/total_return_price|6.834|1991-07-10/enterprise_value|29230.4585|1991-07-24/enterprise_value|30917.3623|1991-08-07/enterprise_value|31948.0388|1991-08-21/enterprise_value|32697.6868
adr_usa_0212|GSK|199109|||||||||||||5.5633|20.1463|||5.838||6.7526|||4.1004||0.1525|1489.697|0.3172|0.7611|1873.4531||||472.4962||24.4959|7.4868|33353.6157|27.7454|1991-10-01/ev_revenues|5.3781|1991-10-15/ev_revenues|5.3062|1991-10-29/ev_revenues|6.1116|1991-11-12/ev_revenues|6.5862|1991-11-26/ev_revenues|6.0972|1991-10-01/ps_ratio|5.6256|1991-10-15/ps_ratio|5.5538|1991-10-29/ps_ratio|6.3575|1991-11-12/ps_ratio|6.8311|1991-11-26/ps_ratio|6.3431|1991-10-01/price_to_book_value|7.0588|1991-10-15/price_to_book_value|6.9687|1991-10-29/price_to_book_value|7.9771|1991-11-12/price_to_book_value|8.5714|1991-11-26/price_to_book_value|7.9591|1991-10-02/dividend_yield|3.8628|1991-10-16/dividend_yield|3.9626|1991-10-30/dividend_yield|3.4154|1991-11-13/dividend_yield|3.1554|1991-11-27/dividend_yield|3.4695|1991-10-08/percent_of_shares_outstanding|0.0806|1991-11-08/percent_of_shares_outstanding|0.2879|1991-10-31/price|27.7454|1991-11-29/price|27.2454|1991-10-31/total_return_price|8.4799|1991-11-29/total_return_price|8.3271|1991-10-02/enterprise_value|35508.9922|1991-10-16/enterprise_value|34572.0424|1991-10-30/enterprise_value|40381.9489|1991-11-13/enterprise_value|43849.0302|1991-11-27/enterprise_value|39726.0215
adr_usa_0212|GSK|199112|||||||||||||6.73|25.0587|||6.9746||8.7514|||3.1043||0.1838|1489.697|0.3131|0|1849.159||||466.369||31.7447|9.7023|44598.8312|30.7449|1992-01-07/ev_revenues|7.0675|1992-01-21/ev_revenues|6.3419|1992-02-04/ev_revenues|6.3956|1992-02-18/ev_revenues|6.1537|1992-01-07/ps_ratio|7.2863|1992-01-21/ps_ratio|6.563|1992-02-04/ps_ratio|6.6166|1992-02-18/ps_ratio|6.3755|1992-01-07/price_to_book_value|9.7958|1992-01-21/price_to_book_value|8.8234|1992-02-04/price_to_book_value|8.8955|1992-02-18/price_to_book_value|8.5714|1992-01-09/dividend_yield|2.7582|1992-01-23/dividend_yield|3.1297|1992-02-06/dividend_yield|3.1425|1992-02-20/dividend_yield|3.2768|1992-01-08/percent_of_shares_outstanding|0.1825|1992-02-07/percent_of_shares_outstanding|0.1986|1992-01-31/price|30.7449|1992-02-28/price|27.9953|1992-01-31/total_return_price|9.3967|1992-02-28/total_return_price|8.63|1992-01-09/enterprise_value|50408.8907|1992-01-23/enterprise_value|44223.9307|1992-02-06/enterprise_value|44036.4805|1992-02-20/enterprise_value|42162.4263
adr_usa_0212|GSK|199203|||||||||||||5.2372|20.2395|||5.4377||7.815|||3.9355||0.1759|1489.697|0.3355|0.2427|1981.8075||||499.8238||27.1204|8.3603|37664.3701|26.6205|1992-04-14/ev_revenues|5.5646|1992-04-28/ev_revenues|5.0105|1992-05-12/ev_revenues|5.3379|1992-05-26/ev_revenues|5.2372|1992-04-14/ps_ratio|5.7634|1992-04-28/ps_ratio|5.2121|1992-05-12/ps_ratio|5.5379|1992-05-26/ps_ratio|5.4377|1992-04-14/price_to_book_value|8.2832|1992-04-28/price_to_book_value|7.4909|1992-05-12/price_to_book_value|7.9591|1992-05-26/price_to_book_value|7.815|1992-04-02/dividend_yield|3.8086|1992-04-16/dividend_yield|3.7911|1992-04-30/dividend_yield|3.8801|1992-05-14/dividend_yield|3.8801|1992-05-28/dividend_yield|3.7228|1992-04-08/percent_of_shares_outstanding|0.1539|1992-05-08/percent_of_shares_outstanding|0.1936|1992-04-30/price|26.6205|1992-05-29/price|28.2453|1992-04-30/total_return_price|8.2062|1992-05-29/total_return_price|8.707|1992-04-02/enterprise_value|38976.2205|1992-04-16/enterprise_value|39163.6707|1992-04-30/enterprise_value|38226.5724|1992-05-14/enterprise_value|38226.5724|1992-05-28/enterprise_value|39913.4717
adr_usa_0212|GSK|199206|6287.1199|3323.1105|902.5028|4447.914||3881.7123|2979.2094|902.5028||6786.8214|||5.0105|20.2599||3.3296|5.2121|21.5448|7.4909||0.1408|3.9544||0.1837|1551.4031|0.2118|0|1330.7135||||335.5491||25.3707|7.8209|37476.9199|27.4954|1992-07-07/ev_revenues|5.1897|1992-07-21/ev_revenues|5.4571|1992-08-04/ev_revenues|5.5908|1992-08-18/ev_revenues|5.6175|1992-07-07/ps_ratio|5.5081|1992-07-21/ps_ratio|5.7755|1992-08-04/ps_ratio|5.9092|1992-08-18/ps_ratio|5.936|1992-07-14/pe_ratio|22.3938|1992-07-28/pe_ratio|23.2428|1992-08-11/pe_ratio|22.9245|1992-08-25/pe_ratio|23.1368|1992-07-07/price_to_book_value|5.7097|1992-07-21/price_to_book_value|5.9868|1992-08-04/price_to_book_value|6.1254|1992-08-18/price_to_book_value|6.1531|1992-07-09/dividend_yield|3.8262|1992-07-23/dividend_yield|3.862|1992-08-06/dividend_yield|3.7911|1992-08-20/dividend_yield|3.6895|1992-07-08/percent_of_shares_outstanding|0.1602|1992-08-07/percent_of_shares_outstanding|0.1934|1992-07-31/price|27.4954|1992-08-31/price|28.1203|1992-07-31/total_return_price|8.4759|1992-08-31/total_return_price|8.6685|1992-07-09/enterprise_value|38391.3024|1992-07-23/enterprise_value|38015.175|1992-08-06/enterprise_value|38767.5832|1992-08-20/enterprise_value|39896.2768
adr_usa_0212|GSK|199209|||||||||||||5.4838|21.81|||5.8022|23.3491|6.0145|||3.5623||0.2112|1532.7586|0.3104|0.4088|1860.9129||||475.7712||27.2454|8.5104|41401.0993|25.1208|1992-10-13/ev_revenues|5.44|1992-10-27/ev_revenues|5.0651|1992-11-10/ev_revenues|4.9579|1992-11-24/ev_revenues|4.8776|1992-10-13/ps_ratio|5.8002|1992-10-27/ps_ratio|5.4225|1992-11-10/ps_ratio|5.3146|1992-11-24/ps_ratio|5.2337|1992-10-06/pe_ratio|22.2032|1992-10-20/pe_ratio|21.7762|1992-11-03/pe_ratio|21.9897|1992-11-17/pe_ratio|20.8155|1992-10-13/price_to_book_value|5.9591|1992-10-27/price_to_book_value|5.5711|1992-11-10/price_to_book_value|5.4602|1992-11-24/price_to_book_value|5.3771|1992-10-01/dividend_yield|2.329|1992-10-15/dividend_yield|2.351|1992-10-29/dividend_yield|2.4432|1992-11-12/dividend_yield|2.5172|1992-11-27/dividend_yield|2.6232|1992-10-08/percent_of_shares_outstanding|0.1591|1992-11-06/percent_of_shares_outstanding|0.1854|1992-10-30/price|25.1208|1992-11-30/price|24.246|1992-10-30/total_return_price|7.8468|1992-11-30/total_return_price|7.5735|1992-10-01/enterprise_value|38015.175|1992-10-15/enterprise_value|37638.8941|1992-10-29/enterprise_value|36134.0716|1992-11-12/enterprise_value|35005.527|1992-11-27/enterprise_value|33500.5556
adr_usa_0212|GSK|199212|||||||||||||4.824|18.8913|||5.1797|19.9615|5.3216|||2.8||0.2423|1532.7586|0.3015|0|1807.7715||||462.1848||23.746|7.4173|31243.3218|20.7465|1993-01-05/ev_revenues|4.7448|1993-01-19/ev_revenues|4.3406|1993-02-02/ev_revenues|3.6939|1993-02-16/ev_revenues|3.7209|1993-01-05/ps_ratio|5.1381|1993-01-19/ps_ratio|4.7282|1993-02-02/ps_ratio|4.0722|1993-02-16/ps_ratio|4.0996|1993-01-12/pe_ratio|19.2975|1993-01-26/pe_ratio|18.1117|1993-02-09/pe_ratio|15.9555|1993-02-23/pe_ratio|16.3867|1993-01-05/price_to_book_value|5.2107|1993-01-19/price_to_book_value|4.795|1993-02-02/price_to_book_value|4.1298|1993-02-16/price_to_book_value|4.1575|1993-01-11/dividend_yield|2.6941|1993-01-25/dividend_yield|2.9491|1993-02-08/dividend_yield|3.279|1993-02-22/dividend_yield|3.3227|1993-01-08/percent_of_shares_outstanding|0.1416|1993-02-05/percent_of_shares_outstanding|0.1248|1993-01-29/price|20.7465|1993-02-26/price|18.8718|1993-01-29/total_return_price|6.4804|1993-02-26/total_return_price|5.8948|1993-01-11/enterprise_value|32560.0024|1993-01-25/enterprise_value|29550.3589|1993-02-08/enterprise_value|26352.4215|1993-02-22/enterprise_value|25976.2942
adr_usa_0212|GSK|199303|||||||||||||3.5592|14.0099|||3.9356|15.5243|3.9912|||3.4648||0.1342|1522.8571|0.346|0.2414|2229.2323||||526.9328||18.247|5.7695|24471.4717|18.3719|1993-04-13/ev_revenues|3.2292|1993-04-27/ev_revenues|3.5675|1993-05-11/ev_revenues|3.8017|1993-05-25/ev_revenues|3.6716|1993-04-13/ps_ratio|3.6092|1993-04-27/ps_ratio|3.9542|1993-05-11/ps_ratio|4.1931|1993-05-25/ps_ratio|4.0604|1993-04-06/pe_ratio|14.8507|1993-04-20/pe_ratio|15.4919|1993-05-04/pe_ratio|15.8123|1993-05-18/pe_ratio|16.9875|1993-04-13/price_to_book_value|3.7695|1993-04-27/price_to_book_value|4.1298|1993-05-11/price_to_book_value|4.3793|1993-05-25/price_to_book_value|4.2407|1993-04-05/dividend_yield|3.5396|1993-04-19/dividend_yield|3.5143|1993-05-03/dividend_yield|3.302|1993-05-17/dividend_yield|3.0371|1993-04-07/percent_of_shares_outstanding|0.0918|1993-05-07/percent_of_shares_outstanding|0.1155|1993-04-30/price|18.3719|1993-05-28/price|18.9968|1993-04-30/total_return_price|5.809|1993-05-28/total_return_price|6.0066|1993-04-05/enterprise_value|23906.8984|1993-04-19/enterprise_value|24095.0388|1993-05-03/enterprise_value|25788.1537|1993-05-17/enterprise_value|28233.5249
adr_usa_0212|GSK|199306|6695.6017|3767.2189|897.6753|4464.2374||4225.8631|3319.1356|906.7275||6858.5411|||3.2812|12.4885||2.0613|3.6623|14.4234|3.8249|3.2273|0.178|3.6445||0.0667|1457.1012|0.2698|0|1680.3677||||392.2574||16.8721|5.3348|23154.4886|15.8723|1993-07-06/ev_revenues|3.0355|1993-07-20/ev_revenues|2.8105|1993-08-03/ev_revenues|2.8605|1993-08-17/ev_revenues|3.0355|1993-08-31/ev_revenues|3.2604|1993-07-06/ps_ratio|3.34|1993-07-20/ps_ratio|3.1156|1993-08-03/ps_ratio|3.1655|1993-08-17/ps_ratio|3.34|1993-08-31/ps_ratio|3.5643|1993-07-13/pe_ratio|13.539|1993-07-27/pe_ratio|13.2337|1993-08-10/pe_ratio|12.4193|1993-08-24/pe_ratio|14.1498|1993-07-06/price_to_book_value|3.7009|1993-07-20/price_to_book_value|3.4523|1993-08-03/price_to_book_value|3.5076|1993-08-17/price_to_book_value|3.7009|1993-08-31/price_to_book_value|3.9495|1993-07-14/peg_ratio|3.1556|1993-07-28/peg_ratio|3.1556|1993-08-11/peg_ratio|2.9165|1993-08-25/peg_ratio|3.2512|1993-07-13/dividend_yield|3.6993|1993-07-27/dividend_yield|3.7846|1993-08-10/dividend_yield|4.0328|1993-08-24/dividend_yield|3.5396|1993-07-08/percent_of_shares_outstanding|0.0811|1993-08-06/percent_of_shares_outstanding|0.154|1993-07-30/price|15.8723|1993-08-31/price|17.872|1993-07-30/total_return_price|5.0186|1993-08-31/total_return_price|5.6509|1993-07-13/enterprise_value|22814.1708|1993-07-27/enterprise_value|22245.9532|1993-08-10/enterprise_value|20730.6109|1993-08-24/enterprise_value|23950.6029
adr_usa_0212|GSK|199309|||||||||||||3.4854|13.8097|||3.7886|15.9822|4.198|3.7532||3.1338||0.457|1524.2857|0.3486|0.467|2093.7867||||531.289||18.9968|6.1499|27360.354|20.2466|1993-10-12/ev_revenues|3.624|1993-10-26/ev_revenues|3.624|1993-11-09/ev_revenues|3.4057|1993-11-23/ev_revenues|3.3815|1993-10-12/ps_ratio|3.912|1993-10-26/ps_ratio|3.912|1993-11-09/ps_ratio|3.6947|1993-11-23/ps_ratio|3.6705|1993-10-05/pe_ratio|15.5993|1993-10-19/pe_ratio|16.0929|1993-11-02/pe_ratio|15.4018|1993-11-16/pe_ratio|15.2044|1993-11-30/pe_ratio|15.8954|1993-10-12/price_to_book_value|4.4742|1993-10-26/price_to_book_value|4.4742|1993-11-09/price_to_book_value|4.2257|1993-11-23/price_to_book_value|4.198|1993-10-06/peg_ratio|1.9333|1993-10-20/peg_ratio|2.0428|1993-11-03/peg_ratio|1.9576|1993-11-17/peg_ratio|1.8725|1993-10-05/dividend_yield|3.5545|1993-10-19/dividend_yield|3.4455|1993-11-02/dividend_yield|3.6001|1993-11-16/dividend_yield|3.6468|1993-11-30/dividend_yield|3.4883|1993-10-08/percent_of_shares_outstanding|0.2476|1993-11-08/percent_of_shares_outstanding|0.2329|1993-10-29/price|20.2466|1993-11-30/price|20.1216|1993-10-29/total_return_price|6.5545|1993-11-30/total_return_price|6.514|1993-10-05/enterprise_value|27549.8099|1993-10-19/enterprise_value|28496.7861|1993-11-02/enterprise_value|27170.8981|1993-11-16/enterprise_value|26792.1364|1993-11-30/enterprise_value|28118.0244
adr_usa_0212|GSK|199312|||||||||||||3.721|14.7121|||4.0086|17.0802|4.5847|2.1036||3.2463||0.3016|1524.2857|0.3529|0|2120.142||||537.9766||20.8714|6.7568|30391.1948|19.7467|1994-01-04/ev_revenues|3.6945|1994-01-18/ev_revenues|3.5079|1994-02-01/ev_revenues|3.3447|1994-02-15/ev_revenues|3.368|1994-01-04/ps_ratio|3.965|1994-01-18/ps_ratio|3.7795|1994-02-01/ps_ratio|3.6172|1994-02-15/ps_ratio|3.6404|1994-01-11/pe_ratio|15.1803|1994-01-25/pe_ratio|14.8957|1994-02-08/pe_ratio|14.7059|1994-02-22/pe_ratio|15.0854|1994-01-04/price_to_book_value|4.7228|1994-01-18/price_to_book_value|4.5018|1994-02-01/price_to_book_value|4.3085|1994-02-15/price_to_book_value|4.3361|1994-01-12/peg_ratio|1.1069|1994-01-26/peg_ratio|1.1139|1994-02-09/peg_ratio|1.0651|1994-02-23/peg_ratio|1.1139|1994-01-11/dividend_yield|3.5101|1994-01-25/dividend_yield|3.5772|1994-02-08/dividend_yield|3.6233|1994-02-22/dividend_yield|3.5322|1994-01-07/percent_of_shares_outstanding|0.4406|1994-02-08/percent_of_shares_outstanding|0.8537|1994-01-31/price|19.7467|1994-02-28/price|20.4965|1994-01-31/total_return_price|6.3927|1994-02-28/total_return_price|6.6354|1994-01-11/enterprise_value|27928.5685|1994-01-25/enterprise_value|27360.354|1994-02-08/enterprise_value|26981.4422|1994-02-22/enterprise_value|27739.1127
adr_usa_0212|GSK|199403|||||||||||||3.0882|12.7807|||3.3621|14.8008|4.0047|1.0303||3.8489||1.1158|1522.9032|0.3098|0.2813|2260.796||||471.7444||17.872|5.8673|27170.8981|17.2471|1994-04-12/ev_revenues|2.9137|1994-04-26/ev_revenues|2.7975|1994-05-10/ev_revenues|2.9369|1994-05-24/ev_revenues|2.7743|1994-04-12/ps_ratio|3.1874|1994-04-26/ps_ratio|3.072|1994-05-10/ps_ratio|3.2105|1994-05-24/ps_ratio|3.0488|1994-04-05/pe_ratio|13.9514|1994-04-19/pe_ratio|13.0733|1994-05-03/pe_ratio|13.7562|1994-05-17/pe_ratio|13.0733|1994-05-31/pe_ratio|12.6831|1994-04-12/price_to_book_value|3.8114|1994-04-26/price_to_book_value|3.6733|1994-05-10/price_to_book_value|3.839|1994-05-24/price_to_book_value|3.6457|1994-04-06/peg_ratio|1.4978|1994-04-20/peg_ratio|1.3542|1994-05-04/peg_ratio|1.4055|1994-05-18/peg_ratio|1.3696|1994-04-05/dividend_yield|4.1987|1994-04-19/dividend_yield|4.4807|1994-05-03/dividend_yield|4.2583|1994-05-17/dividend_yield|4.4807|1994-05-31/dividend_yield|4.6186|1994-04-08/percent_of_shares_outstanding|0.9728|1994-05-06/percent_of_shares_outstanding|0.9925|1994-04-29/price|17.2471|1994-05-31/price|16.2473|1994-04-29/total_return_price|5.6622|1994-05-31/total_return_price|5.3339|1994-04-05/enterprise_value|24708.4264|1994-04-19/enterprise_value|23003.6267|1994-05-03/enterprise_value|24329.5147|1994-05-17/enterprise_value|23003.6267|1994-05-31/enterprise_value|22245.9532
adr_usa_0212|GSK|199406|7160.244|4256.4015|885.7875|4904.952||4217.889|3281.265|936.624||7742.553|||2.8208|11.4996||1.8364|3.0951|13.0733|3.7009|1.3952|0.1337|4.4807||1.0373|1508.8678|0.2643|0|1974.5724||||399.2448||16.6222|5.457|23003.6267|17.622|1994-07-05/ev_revenues|2.7084|1994-07-19/ev_revenues|2.8888|1994-08-02/ev_revenues|2.9339|1994-08-16/ev_revenues|3.1594|1994-08-30/ev_revenues|3.2271|1994-07-05/ps_ratio|3.0579|1994-07-19/ps_ratio|3.2378|1994-08-02/ps_ratio|3.2828|1994-08-16/ps_ratio|3.5076|1994-08-30/ps_ratio|3.575|1994-07-12/pe_ratio|13.4228|1994-07-26/pe_ratio|13.6187|1994-08-09/pe_ratio|14.8925|1994-08-23/pe_ratio|15.6763|1994-07-05/price_to_book_value|3.3471|1994-07-19/price_to_book_value|3.5441|1994-08-02/price_to_book_value|3.5933|1994-08-16/price_to_book_value|3.8394|1994-08-30/price_to_book_value|3.9132|1994-07-13/peg_ratio|3.4424|1994-07-27/peg_ratio|3.4424|1994-08-10/peg_ratio|3.8947|1994-08-24/peg_ratio|4.0957|1994-07-12/dividend_yield|4.3826|1994-07-26/dividend_yield|4.3196|1994-08-09/dividend_yield|3.9501|1994-08-23/dividend_yield|3.7526|1994-07-08/percent_of_shares_outstanding|1.0281|1994-08-08/percent_of_shares_outstanding|1.1419|1994-07-29/price|17.622|1994-08-31/price|19.6217|1994-07-29/total_return_price|5.7853|1994-08-31/total_return_price|6.4418|1994-07-12/enterprise_value|23074.3377|1994-07-26/enterprise_value|23455.3583|1994-08-09/enterprise_value|25932.6869|1994-08-23/enterprise_value|27457.0805
adr_usa_0212|GSK|199409|||||||||||||2.9114|13.6589|||3.2603|14.4026|3.5687|3.7188||4.0845||1.1467|1591.5385|0.2551|0.5872|2530.842||||405.9314||18.247|6.1894|24979.9059|19.25|1994-10-11/ev_revenues|2.811|1994-10-25/ev_revenues|2.9183|1994-11-08/ev_revenues|2.9617|1994-11-22/ev_revenues|2.9403|1994-10-11/ps_ratio|3.1774|1994-10-25/ps_ratio|3.2855|1994-11-08/ps_ratio|3.3293|1994-11-22/ps_ratio|3.3077|1994-10-04/pe_ratio|15.2246|1994-10-18/pe_ratio|16.1761|1994-11-01/pe_ratio|16.496|1994-11-15/pe_ratio|16.496|1994-11-29/pe_ratio|16.3903|1994-10-11/price_to_book_value|3.6179|1994-10-25/price_to_book_value|3.7409|1994-11-08/price_to_book_value|3.7908|1994-11-22/price_to_book_value|3.7662|1994-10-05/peg_ratio||1994-10-19/peg_ratio||1994-11-02/peg_ratio||1994-11-16/peg_ratio||1994-11-30/peg_ratio||1994-10-04/dividend_yield|4.8903|1994-10-18/dividend_yield|4.6026|1994-11-01/dividend_yield|4.5133|1994-11-15/dividend_yield|4.5133|1994-11-29/dividend_yield|4.5425|1994-10-07/percent_of_shares_outstanding|0.9338|1994-11-08/percent_of_shares_outstanding|1.0893|1994-10-31/price|19.25|1994-11-30/price|19.25|1994-10-31/total_return_price|6.5296|1994-11-30/total_return_price|6.5296|1994-10-04/enterprise_value|24408.2949|1994-10-18/enterprise_value|26123.2743|1994-11-01/enterprise_value|26699.9168|1994-11-15/enterprise_value|26699.9168|1994-11-29/enterprise_value|26509.3294
adr_usa_0212|GSK|199412|||||||||||||3.2191|16.5267|||3.5887|17.4477|4.0862|||4.2672||0.9943|1591.5385|0.2635|0|2614.6259||||419.3698||20.375|6.9112|28415.2026|19.625|1995-01-03/ev_revenues|3.0697|1995-01-17/ev_revenues|3.09|1995-01-31/ev_revenues|2.8665|1995-02-14/ev_revenues|2.9681|1995-02-28/ev_revenues|2.9275|1995-01-03/ps_ratio|3.4574|1995-01-17/ps_ratio|3.4782|1995-01-31/ps_ratio|3.2504|1995-02-14/ps_ratio|3.3539|1995-02-28/ps_ratio|3.3125|1995-01-10/pe_ratio|19.4478|1995-01-24/pe_ratio|17.6175|1995-02-07/pe_ratio|18.4183|1995-02-21/pe_ratio|18.5327|1995-01-03/price_to_book_value|4.1108|1995-01-17/price_to_book_value|4.1354|1995-01-31/price_to_book_value|3.8646|1995-02-14/price_to_book_value|3.9877|1995-02-28/price_to_book_value|3.9385|1995-01-11/peg_ratio||1995-01-25/peg_ratio||1995-02-08/peg_ratio||1995-02-22/peg_ratio||1995-01-10/dividend_yield|4.1416|1995-01-24/dividend_yield|4.5719|1995-02-07/dividend_yield|4.3732|1995-02-21/dividend_yield|4.3462|1995-01-06/percent_of_shares_outstanding|1.0574|1995-02-08/percent_of_shares_outstanding|1.0583|1995-01-31/price|19.625|1995-02-28/price|20|1995-01-31/total_return_price|6.6568|1995-02-28/total_return_price|6.9178|1995-01-10/enterprise_value|29368.1391|1995-01-24/enterprise_value|26318.7421|1995-02-07/enterprise_value|27652.8533|1995-02-21/enterprise_value|27843.4406
adr_usa_0212|GSK|199503|||||||||||||3.3745|19.5354|||3.768|20.2486|4.48|||5.7812||1.1186|1591.5385|0.2549|0.3993|2528.8621||||405.6138||22.875|7.9123|30702.2503|23.625|1995-04-11/ev_revenues|3.3202|1995-04-25/ev_revenues|3.419|1995-05-09/ev_revenues|3.3202|1995-05-23/ev_revenues|3.2412|1995-04-11/ps_ratio|3.7445|1995-04-25/ps_ratio|3.8462|1995-05-09/ps_ratio|3.7445|1995-05-23/ps_ratio|3.6631|1995-04-04/pe_ratio|22.5246|1995-04-18/pe_ratio|21.8018|1995-05-02/pe_ratio|22.8859|1995-05-16/pe_ratio|21.6814|1995-05-30/pe_ratio|22.4041|1995-04-11/price_to_book_value|4.5293|1995-04-25/price_to_book_value|4.6523|1995-05-09/price_to_book_value|4.5293|1995-05-23/price_to_book_value|4.4308|1995-04-05/peg_ratio||1995-04-19/peg_ratio||1995-05-03/peg_ratio||1995-05-17/peg_ratio||1995-05-31/peg_ratio||1995-04-04/dividend_yield|5.4721|1995-04-18/dividend_yield|5.6535|1995-05-02/dividend_yield|5.3857|1995-05-16/dividend_yield|5.6849|1995-05-30/dividend_yield|5.5015|1995-04-06/percent_of_shares_outstanding|0.8839|1995-05-08/percent_of_shares_outstanding|0.8353|1995-04-28/price|23.625|1995-05-31/price|23.125|1995-04-28/total_return_price|8.1717|1995-05-31/total_return_price|7.9988|1995-04-04/enterprise_value|32608.1234|1995-04-18/enterprise_value|31464.5996|1995-05-02/enterprise_value|33179.8854|1995-05-16/enterprise_value|31274.0122|1995-05-30/enterprise_value|32417.5361
adr_usa_0212|GSK|199506|5958.4211|119.7874|1208.8911|6766.4852||12006.2822|5052.9046|6953.3776||654.7242|6536.5255||3.5572|26.4452||3.4027|3.9887|23.4882|4.8247||10.1813|5.2476||0.525|1530.9121|0.2814|0|2692.5568||||431.8681||24.375|8.4311|34132.8219|23.875|1995-07-05/ev_revenues|4.2049|1995-07-19/ev_revenues|4.1497|1995-08-02/ev_revenues|4.2784|1995-08-16/ev_revenues|4.1313|1995-08-30/ev_revenues|4.1681|1995-07-05/ps_ratio|3.6684|1995-07-19/ps_ratio|3.6114|1995-08-02/ps_ratio|3.7445|1995-08-16/ps_ratio|3.5924|1995-08-30/ps_ratio|3.6304|1995-07-11/pe_ratio|22.6347|1995-07-25/pe_ratio|22.3977|1995-08-08/pe_ratio|23.2273|1995-08-22/pe_ratio|22.8717|1995-07-05/price_to_book_value|56.1814|1995-07-19/price_to_book_value|55.3082|1995-08-02/price_to_book_value|57.3458|1995-08-16/price_to_book_value|55.0171|1995-08-30/price_to_book_value|55.5993|1995-07-12/peg_ratio||1995-07-26/peg_ratio||1995-08-09/peg_ratio||1995-08-23/peg_ratio||1995-07-11/dividend_yield|5.3575|1995-07-25/dividend_yield|5.4142|1995-08-08/dividend_yield|5.2208|1995-08-22/dividend_yield|5.302|1995-07-07/percent_of_shares_outstanding||1995-08-08/percent_of_shares_outstanding||1995-07-31/price|23.875|1995-08-31/price|23.75|1995-07-31/total_return_price|8.2582|1995-08-31/total_return_price|8.2149|1995-07-11/enterprise_value|43210.2269|1995-07-25/enterprise_value|42829.0523|1995-08-08/enterprise_value|44163.1635|1995-08-22/enterprise_value|43591.4016
adr_usa_0212|GSK|199509|||||||||||||4.2049|26.1315|||3.6684|22.5162|56.1814|||5.3857|||1591.5385|0.2584|0.7693|2564.3492||||411.3057||24.125|8.6198|43019.6396|27|1995-10-11/ev_revenues|4.1913|1995-10-25/ev_revenues|4.6128|1995-11-08/ev_revenues|4.7044|1995-11-22/ev_revenues|4.6494|1995-10-11/ps_ratio|3.6566|1995-10-25/ps_ratio|4.0924|1995-11-08/ps_ratio|4.1871|1995-11-22/ps_ratio|4.1303|1995-10-03/pe_ratio|22.7988|1995-10-17/pe_ratio|23.5075|1995-10-31/pe_ratio|25.5157|1995-11-14/pe_ratio|25.0432|1995-11-28/pe_ratio|25.6339|1995-10-11/price_to_book_value|56.1814|1995-10-25/price_to_book_value|62.8766|1995-11-08/price_to_book_value|64.3321|1995-11-22/price_to_book_value|63.4588|1995-10-04/peg_ratio||1995-10-18/peg_ratio||1995-11-01/peg_ratio||1995-11-15/peg_ratio||1995-11-29/peg_ratio||1995-10-03/dividend_yield|4.8622|1995-10-17/dividend_yield|4.7156|1995-10-31/dividend_yield|4.3444|1995-11-14/dividend_yield|4.4264|1995-11-28/dividend_yield|4.3244|1995-10-06/percent_of_shares_outstanding||1995-11-08/percent_of_shares_outstanding||1995-10-31/price|27|1995-11-30/price|26.625|1995-10-31/total_return_price|9.647|1995-11-30/total_return_price|9.513|1995-10-03/enterprise_value|43591.4016|1995-10-17/enterprise_value|44734.9254|1995-10-31/enterprise_value|47974.9097|1995-11-14/enterprise_value|47212.5605|1995-11-28/enterprise_value|48165.4971
adr_usa_0212|GSK|199512|||||||||||||4.5945||||4.0734|26.2245|62.5855|||4.227||||||||||||28.125|10.049|49118.4336|29.125|1996-01-03/ev_revenues|5.3508|1996-01-17/ev_revenues|5.2876|1996-01-31/ev_revenues|5.5614|1996-02-14/ev_revenues|5.4982|1996-02-28/ev_revenues|5.3508|1996-01-03/ps_ratio|4.225|1996-01-17/ps_ratio|4.1682|1996-01-31/ps_ratio|4.4145|1996-02-14/ps_ratio|4.3576|1996-02-28/ps_ratio|4.225|1996-01-09/pe_ratio|25.6339|1996-01-23/pe_ratio|25.752|1996-02-06/pe_ratio|27.642|1996-02-20/pe_ratio|27.2876|1996-01-03/price_to_book_value|74.6001|1996-01-17/price_to_book_value|73.5965|1996-01-31/price_to_book_value|77.9454|1996-02-14/price_to_book_value|76.9418|1996-02-28/price_to_book_value|74.6001|1996-01-10/peg_ratio||1996-01-24/peg_ratio||1996-02-07/peg_ratio||1996-02-21/peg_ratio||1996-01-09/dividend_yield|4.3244|1996-01-23/dividend_yield|4.3046|1996-02-06/dividend_yield|4.0103|1996-02-20/dividend_yield|4.0623|1996-01-08/percent_of_shares_outstanding|0.1918|1996-02-08/percent_of_shares_outstanding|0.109|1996-01-31/price|29.125|1996-02-29/price|27.375|1996-01-31/total_return_price|10.4063|1996-02-29/total_return_price|9.781|1996-01-09/enterprise_value|54336.3939|1996-01-23/enterprise_value|54555.4185|1996-02-06/enterprise_value|58059.8125|1996-02-20/enterprise_value|57402.7386
adr_usa_0212|GSK|199603|||||||||||||4.8875|24.5629|||3.8082|23.8619|67.2404|||4.6455||0.2577|1759.5652|0.4613|0.5684|3256.9719||||811.7608||25|9.1334|51051.0245|24.25|1996-04-10/ev_revenues|4.385|1996-04-24/ev_revenues|4.3454|1996-05-08/ev_revenues|4.385|1996-05-22/ev_revenues|4.7619|1996-04-10/ps_ratio|3.4807|1996-04-24/ps_ratio|3.4441|1996-05-08/ps_ratio|3.4807|1996-05-22/ps_ratio|3.8288|1996-04-02/pe_ratio|19.6057|1996-04-16/pe_ratio|19.1081|1996-04-30/pe_ratio|19.3071|1996-05-14/pe_ratio|18.9091|1996-05-28/pe_ratio|20.7004|1996-04-10/price_to_book_value|63.5606|1996-04-24/price_to_book_value|62.8916|1996-05-08/price_to_book_value|63.5606|1996-05-22/price_to_book_value|69.9167|1996-04-03/peg_ratio|1.3048|1996-04-17/peg_ratio|1.2649|1996-05-01/peg_ratio|1.3115|1996-05-15/peg_ratio|1.2649|1996-05-29/peg_ratio|1.398|1996-04-02/dividend_yield|5.4445|1996-04-16/dividend_yield|5.5862|1996-04-30/dividend_yield|5.5287|1996-05-14/dividend_yield|5.6451|1996-05-28/dividend_yield|5.1565|1996-04-08/percent_of_shares_outstanding|0.1166|1996-05-08/percent_of_shares_outstanding|0.1324|1996-04-30/price|24.25|1996-05-31/price|26.125|1996-04-30/total_return_price|8.8594|1996-05-31/total_return_price|9.5444|1996-04-02/enterprise_value|49955.9014|1996-04-16/enterprise_value|48860.7782|1996-04-30/enterprise_value|49298.8275|1996-05-14/enterprise_value|48422.729|1996-05-28/enterprise_value|52365.1722
adr_usa_0212|GSK|199606|||||||||||||4.8412|21.9139|||3.9021|20.7004|71.2548|1.398||5.1565||0.0916|1759.5652|0.4516|0|3188.2194||||794.625||26.75|9.7728|52365.1722|27.75|1996-07-03/ev_revenues|4.6246|1996-07-17/ev_revenues|4.6059|1996-07-31/ev_revenues|4.7369|1996-08-14/ev_revenues|4.8118|1996-08-28/ev_revenues|4.9053|1996-07-03/ps_ratio|3.831|1996-07-17/ps_ratio|3.8133|1996-07-31/ps_ratio|3.9374|1996-08-14/ps_ratio|4.0084|1996-08-28/ps_ratio|4.097|1996-07-09/pe_ratio|18.8435|1996-07-23/pe_ratio|19.0156|1996-08-06/pe_ratio|19.1016|1996-08-20/pe_ratio|19.4458|1996-07-03/price_to_book_value|72.2584|1996-07-17/price_to_book_value|71.9239|1996-07-31/price_to_book_value|74.2656|1996-08-14/price_to_book_value|75.6037|1996-08-28/price_to_book_value|77.2763|1996-07-10/peg_ratio|0.4734|1996-07-24/peg_ratio|0.4712|1996-08-07/peg_ratio|0.4734|1996-08-21/peg_ratio|0.4884|1996-07-09/dividend_yield|4.8975|1996-07-23/dividend_yield|4.8532|1996-08-06/dividend_yield|4.8314|1996-08-20/dividend_yield|6.8209|1996-07-08/percent_of_shares_outstanding|0.1177|1996-08-08/percent_of_shares_outstanding|1.7599|1996-07-31/price|27.75|1996-08-30/price|28.5|1996-07-31/total_return_price|10.1381|1996-08-30/total_return_price|10.6317|1996-07-09/enterprise_value|54774.4431|1996-07-23/enterprise_value|55212.4924|1996-08-06/enterprise_value|55431.517|1996-08-20/enterprise_value|56307.6155
adr_usa_0212|GSK|199609|||||||||||||5.0925|27.8974|||4.2744|20.3922|80.6216|0.5099||6.5043||0.2018|1825|0.0993|0.5849|3868.1703||||181.2662||31.125|11.611|58716.8864|31.5|1996-10-09/ev_revenues|4.6786|1996-10-23/ev_revenues|4.7807|1996-11-06/ev_revenues|4.9678|1996-11-20/ev_revenues|4.8827|1996-10-09/ps_ratio|4.1067|1996-10-23/ps_ratio|4.2077|1996-11-06/ps_ratio|4.3928|1996-11-20/ps_ratio|4.3086|1996-10-01/pe_ratio|24.9862|1996-10-15/pe_ratio|24.4944|1996-10-29/pe_ratio|24.4944|1996-11-12/pe_ratio|24.5927|1996-11-26/pe_ratio|26.7569|1996-10-09/price_to_book_value|81.6252|1996-10-23/price_to_book_value|83.6324|1996-11-06/price_to_book_value|87.3122|1996-11-20/price_to_book_value|85.6396|1996-10-02/peg_ratio|1.2447|1996-10-16/peg_ratio|1.2015|1996-10-30/peg_ratio|1.1918|1996-11-13/peg_ratio|1.2063|1996-11-27/peg_ratio|1.288|1996-10-01/dividend_yield|6.069|1996-10-15/dividend_yield|6.1908|1996-10-29/dividend_yield|6.1908|1996-11-12/dividend_yield|6.1661|1996-11-26/dividend_yield|5.6674|1996-10-08/percent_of_shares_outstanding|0.1542|1996-11-08/percent_of_shares_outstanding|0.1462|1996-10-31/price|31.5|1996-11-29/price|32.875|1996-10-31/total_return_price|11.7509|1996-11-29/total_return_price|12.2638|1996-10-01/enterprise_value|62440.305|1996-10-15/enterprise_value|61345.1819|1996-10-29/enterprise_value|61345.1819|1996-11-12/enterprise_value|61564.2065|1996-11-26/enterprise_value|66382.7482
adr_usa_0212|GSK|199612|7423.3854|2144.7602|1366.3924|6548.1465||11976.3272|7059.6939|4916.6332||2081.8789|||4.7637|18.8197||4.2271|4.1908|24.7895|83.2979|1.2063|2.649|6.1171||0.0992|1750.3529|0.79|0|5510.6778||||1386.0005||31.75|11.8441|62002.2557|31.875|1997-01-02/ev_revenues|3.7325|1997-01-16/ev_revenues|3.7044|1997-01-30/ev_revenues|3.7465|1997-02-13/ev_revenues|3.9565|1997-02-27/ev_revenues|4.0545|1997-01-02/ps_ratio|3.5166|1997-01-16/ps_ratio|3.4886|1997-01-30/ps_ratio|3.5306|1997-02-13/ps_ratio|3.7408|1997-02-27/ps_ratio|3.8389|1997-01-07/pe_ratio|17.0619|1997-01-21/pe_ratio|17.1313|1997-02-04/pe_ratio|17.8942|1997-02-18/pe_ratio|18.3797|1997-01-02/price_to_book_value|26.7167|1997-01-16/price_to_book_value|26.5038|1997-01-30/price_to_book_value|26.8232|1997-02-13/price_to_book_value|28.4198|1997-02-27/price_to_book_value|29.1649|1997-01-09/peg_ratio|0.2387|1997-01-23/peg_ratio|0.2417|1997-02-06/peg_ratio|0.2555|1997-02-20/peg_ratio|0.2624|1997-01-07/dividend_yield|6.2663|1997-01-21/dividend_yield|6.241|1997-02-04/dividend_yield|5.9749|1997-02-18/dividend_yield|5.8171|1997-01-08/percent_of_shares_outstanding|0.088|1997-02-07/percent_of_shares_outstanding|0.1379|1997-01-31/price|31.875|1997-02-28/price|33.875|1997-01-31/total_return_price|11.8908|1997-02-28/total_return_price|12.6368|1997-01-07/enterprise_value|57954.4583|1997-01-21/enterprise_value|58176.0558|1997-02-04/enterprise_value|60613.6283|1997-02-18/enterprise_value|62164.8108
adr_usa_0212|GSK|199703|||||||||||||4.1946|20.6035|||3.979|19.6975|30.2293|0.2693||5.4279||0.77|1773.9583|0.4785|0.7244|3338.7931||||848.9048||35.375|13.4722|66375.1633|39.375|1997-04-10/ev_revenues|4.173|1997-04-24/ev_revenues|4.368|1997-05-08/ev_revenues|4.5631|1997-05-22/ev_revenues|4.591|1997-04-10/ps_ratio|3.9665|1997-04-24/ps_ratio|4.1621|1997-05-08/ps_ratio|4.3576|1997-05-22/ps_ratio|4.3855|1997-04-01/pe_ratio|20.1297|1997-04-15/pe_ratio|19.8549|1997-04-29/pe_ratio|21.5037|1997-05-13/pe_ratio|22.3798|1997-05-27/pe_ratio|21.7098|1997-04-10/price_to_book_value|30.2293|1997-04-24/price_to_book_value|31.7194|1997-05-08/price_to_book_value|33.2096|1997-05-22/price_to_book_value|33.4225|1997-04-03/peg_ratio|0.4349|1997-04-17/peg_ratio|0.4487|1997-05-01/peg_ratio|0.4824|1997-05-15/peg_ratio|0.5176|1997-05-29/peg_ratio|0.4947|1997-04-01/dividend_yield|3.5844|1997-04-15/dividend_yield|3.634|1997-04-29/dividend_yield|3.3554|1997-05-13/dividend_yield|3.224|1997-05-27/dividend_yield|3.3235|1997-04-08/percent_of_shares_outstanding|0.391|1997-05-08/percent_of_shares_outstanding|0.1228|1997-04-30/price|39.375|1997-05-30/price|40.25|1997-04-30/total_return_price|14.9955|1997-05-30/total_return_price|15.3287|1997-04-01/enterprise_value|68369.5408|1997-04-15/enterprise_value|67483.1508|1997-04-29/enterprise_value|72801.4908|1997-05-13/enterprise_value|75627.3057|1997-05-27/enterprise_value|73466.2833
adr_usa_0212|GSK|199706|||||||||||||4.9253|23.8458|||4.7207|23.1526|35.9771|0.5123||3.1164||0.1654|1773.9583|0.4716|0|3290.6685||||836.6689||41.813|15.924|78119.8308|42.5|1997-07-03/ev_revenues|5.1638|1997-07-17/ev_revenues|5.2468|1997-07-31/ev_revenues|4.9215|1997-08-14/ev_revenues|4.6169|1997-08-28/ev_revenues|4.5686|1997-07-03/ps_ratio|4.9712|1997-07-17/ps_ratio|5.0547|1997-07-31/ps_ratio|4.7278|1997-08-14/ps_ratio|4.4219|1997-08-28/ps_ratio|4.3733|1997-07-08/pe_ratio|24.4296|1997-07-22/pe_ratio|24.1578|1997-08-05/pe_ratio|23.4783|1997-08-19/pe_ratio|21.6435|1997-07-03/price_to_book_value|38.0531|1997-07-17/price_to_book_value|38.6918|1997-07-31/price_to_book_value|36.19|1997-08-14/price_to_book_value|33.8483|1997-08-28/price_to_book_value|33.4762|1997-07-10/peg_ratio|0.9088|1997-07-24/peg_ratio|0.9203|1997-08-07/peg_ratio|0.8564|1997-08-21/peg_ratio|0.8105|1997-07-08/dividend_yield|2.9214|1997-07-22/dividend_yield|2.9542|1997-08-05/dividend_yield|3.0397|1997-08-19/dividend_yield|3.0583|1997-07-08/percent_of_shares_outstanding|0.1441|1997-08-08/percent_of_shares_outstanding|0.0932|1997-07-31/price|42.5|1997-08-29/price|39.938|1997-07-31/total_return_price|16.1856|1997-08-29/total_return_price|15.3992|1997-07-08/enterprise_value|83106.661|1997-07-22/enterprise_value|82220.271|1997-08-05/enterprise_value|80004.296|1997-08-19/enterprise_value|74021.1635
adr_usa_0212|GSK|199709|||||||||||||5.0807|22.159|||4.8878|21.181|37.4145|0.8858||2.7095||0.1092|1779.7368|0.3815|0.4949|3253.7353||||678.8946||44.938|17.3271|83106.661|42.578|1997-10-09/ev_revenues|5.3482|1997-10-23/ev_revenues|5.0315|1997-11-06/ev_revenues|5.2187|1997-11-20/ev_revenues|5.3843|1997-10-09/ps_ratio|5.1152|1997-10-23/ps_ratio|4.7991|1997-11-06/ps_ratio|4.9859|1997-11-20/ps_ratio|5.1512|1997-10-14/pe_ratio|20.7978|1997-10-28/pe_ratio|19.1189|1997-11-11/pe_ratio|19.9437|1997-11-25/pe_ratio|21.5934|1997-10-09/price_to_book_value|37.893|1997-10-23/price_to_book_value|35.5513|1997-11-06/price_to_book_value|36.9351|1997-11-20/price_to_book_value|38.1596|1997-10-02/peg_ratio|0.3119|1997-10-16/peg_ratio|0.3044|1997-10-30/peg_ratio|0.2917|1997-11-13/peg_ratio|0.2908|1997-11-28/peg_ratio|0.3216|1997-10-14/dividend_yield|2.7594|1997-10-28/dividend_yield|3.0018|1997-11-11/dividend_yield|2.8776|1997-11-25/dividend_yield|2.6578|1997-10-08/percent_of_shares_outstanding|0.114|1997-11-07/percent_of_shares_outstanding|0.1086|1997-10-31/price|42.578|1997-11-28/price|45.688|1997-10-31/total_return_price|16.4172|1997-11-28/total_return_price|17.6163|1997-10-14/enterprise_value|81665.3908|1997-10-28/enterprise_value|75350.7485|1997-11-11/enterprise_value|78453.1135|1997-11-25/enterprise_value|84657.8435
adr_usa_0212|GSK|199712|7952.573|2752.4316|1415.9621|5933.792||10842.4605|6435.5891|4406.8715||3052.1849|||5.6649|29.3451||6.2912|5.4313|22.3593|40.2347|0.3339|1.6397|2.5667||0.1303|1877.209|0.3257|0|3054.0466||||631.0228||47.875|18.4596|87538.611|53.813|1998-01-02/ev_revenues|6.8291|1998-01-16/ev_revenues|7.4163|1998-01-30/ev_revenues|7.615|1998-02-13/ev_revenues|8.9015|1998-02-27/ev_revenues|7.6841|1998-01-02/ps_ratio|6.7003|1998-01-16/ps_ratio|7.292|1998-01-30/ps_ratio|7.4922|1998-02-13/ps_ratio|8.7887|1998-02-27/ps_ratio|7.5618|1998-01-06/pe_ratio|29.7925|1998-01-20/pe_ratio|32.9229|1998-02-03/pe_ratio|37.8628|1998-02-17/pe_ratio|38.3154|1998-01-02/price_to_book_value|28.183|1998-01-16/price_to_book_value|30.6719|1998-01-30/price_to_book_value|31.514|1998-02-13/price_to_book_value|36.9673|1998-02-27/price_to_book_value|31.8068|1998-01-09/peg_ratio||1998-01-23/peg_ratio||1998-02-06/peg_ratio||1998-02-20/peg_ratio||1998-01-06/dividend_yield|2.466|1998-01-20/dividend_yield|2.2315|1998-02-03/dividend_yield|1.9404|1998-02-17/dividend_yield|1.9175|1998-01-08/percent_of_shares_outstanding|0.1557|1998-02-06/percent_of_shares_outstanding|0.1353|1998-01-30/price|53.813|1998-02-27/price|54.313|1998-01-30/total_return_price|20.7491|1998-02-27/total_return_price|20.9419|1998-01-06/enterprise_value|90584.1624|1998-01-20/enterprise_value|99857.3155|1998-02-03/enterprise_value|114490.9517|1998-02-17/enterprise_value|115831.5193
adr_usa_0212|GSK|199803|||||||||||||7.3214|35.0477|||7.1964|34.8576|30.2696|||2.1125||0.102|1818.9474|0.374|0.6538|3179.4684||||680.2602||54.125|21.1168|99074.424|56.563|1998-04-13/ev_revenues|8.3219|1998-04-27/ev_revenues|7.3689|1998-05-11/ev_revenues|8.0247|1998-05-26/ev_revenues|8.0683|1998-04-13/ps_ratio|8.2536|1998-04-27/ps_ratio|7.2872|1998-05-11/ps_ratio|7.9522|1998-05-26/ps_ratio|7.9964|1998-04-14/pe_ratio|37.9166|1998-04-28/pe_ratio|34.2541|1998-05-12/pe_ratio|36.1057|1998-05-26/pe_ratio|36.3066|1998-04-13/price_to_book_value|34.0761|1998-04-27/price_to_book_value|30.0863|1998-05-11/price_to_book_value|32.8317|1998-05-26/price_to_book_value|33.0144|1998-04-03/peg_ratio||1998-04-17/peg_ratio||1998-05-01/peg_ratio||1998-05-15/peg_ratio||1998-05-29/peg_ratio||1998-04-14/dividend_yield|1.9421|1998-04-28/dividend_yield|2.1497|1998-05-12/dividend_yield|2.0395|1998-05-26/dividend_yield|2.0282|1998-04-07/percent_of_shares_outstanding|0.14|1998-05-08/percent_of_shares_outstanding|0.1259|1998-04-30/price|56.563|1998-05-29/price|53.938|1998-04-30/total_return_price|22.068|1998-05-29/total_return_price|21.0439|1998-04-14/enterprise_value|107564.6856|1998-04-28/enterprise_value|97399.6082|1998-05-12/enterprise_value|102538.4508|1998-05-26/enterprise_value|103096.1269
adr_usa_0212|GSK|199806|7910.0073|356.768|1580.3011|5882.921|196.7375|10330.5686|5887.922|4442.6466||3747.4141|658.4255||8.5054|41.7926||7.883|8.4397|38.3192|34.8444||1.3576|1.9217||0.114|1813.6842|0.3768|0|3194.1264|2708.9928|1097.5006|986.7291|683.471||59.813|23.336|108681.8253|60.813|1998-07-07/ev_revenues|8.679|1998-07-21/ev_revenues|8.9081|1998-08-04/ev_revenues|8.8817|1998-08-18/ev_revenues|9.3309|1998-07-07/ps_ratio|8.4607|1998-07-21/ps_ratio|8.6942|1998-08-04/ps_ratio|8.6674|1998-08-18/ps_ratio|9.1254|1998-07-07/pe_ratio|40.382|1998-07-21/pe_ratio|41.4966|1998-08-04/pe_ratio|41.3684|1998-08-18/pe_ratio|43.5543|1998-07-07/price_to_book_value|28.0819|1998-07-21/price_to_book_value|28.857|1998-08-04/price_to_book_value|28.7678|1998-08-18/price_to_book_value|30.2879|1998-07-10/peg_ratio||1998-07-24/peg_ratio||1998-08-07/peg_ratio||1998-08-21/peg_ratio||1998-07-07/dividend_yield|1.9421|1998-07-21/dividend_yield|1.8899|1998-08-04/dividend_yield|1.8958|1998-08-18/dividend_yield|1.809|1998-07-08/percent_of_shares_outstanding|0.0971|1998-08-07/percent_of_shares_outstanding|0.1105|1998-07-31/price|60.813|1998-08-31/price|55.375|1998-07-31/total_return_price|23.7261|1998-08-31/total_return_price|21.7943|1998-07-07/enterprise_value|110062.1785|1998-07-21/enterprise_value|112966.7417|1998-08-04/enterprise_value|112632.4935|1998-08-18/enterprise_value|118329.0122
adr_usa_0212|GSK|199809|||||||||||||8.6351|37.8136|||8.4159|40.168|27.9331|||1.9615||0.1433|1785.625|0.4666|0.4882|3400.3574||||833.175||57.125|22.483|109504.5024|62.25|1998-10-13/ev_revenues|8.2489|1998-10-27/ev_revenues|8.9021|1998-11-10/ev_revenues|8.8934|1998-11-24/ev_revenues|9.355|1998-10-13/ps_ratio|8.0331|1998-10-27/ps_ratio|8.6996|1998-11-10/ps_ratio|8.6907|1998-11-24/ps_ratio|9.1617|1998-10-13/pe_ratio|36.6147|1998-10-27/pe_ratio|39.6528|1998-11-10/pe_ratio|39.612|1998-11-24/pe_ratio|41.759|1998-10-13/price_to_book_value|26.9491|1998-10-27/price_to_book_value|29.1852|1998-11-10/price_to_book_value|29.1551|1998-11-24/price_to_book_value|30.7353|1998-10-02/peg_ratio||1998-10-16/peg_ratio||1998-10-30/peg_ratio||1998-11-13/peg_ratio||1998-11-27/peg_ratio||1998-10-13/dividend_yield|2.0331|1998-10-27/dividend_yield|1.8773|1998-11-10/dividend_yield|1.8793|1998-11-24/dividend_yield|1.7826|1998-10-08/percent_of_shares_outstanding|0.1428|1998-11-06/percent_of_shares_outstanding|0.1308|1998-10-30/price|62.25|1998-11-30/price|63.5|1998-10-30/total_return_price|24.5001|1998-11-30/total_return_price|24.9921|1998-10-13/enterprise_value|105817.0477|1998-10-27/enterprise_value|114196.4891|1998-11-10/enterprise_value|114083.8814|1998-11-24/enterprise_value|120005.6226
adr_usa_0212|GSK|199812|9111.3186|3117.5958|1908.5971|6008.6078|175.3131|10879.3345|6855.4031|4023.9314||4468.8297|||9.773|42.0947||8.2903|9.5882|43.7031|32.1663||1.1551|1.7033||0.1096|1886.0476|0.4507|0|3458.9122||||847.3325||69.5|27.3535|125367.8931|75.563|1999-01-05/ev_revenues|10.1977|1999-01-06/ev_revenues|10.5146|1999-01-20/ev_revenues|10.0607|1999-02-03/ev_revenues|9.2302|1999-02-17/ev_revenues|8.999|1999-01-05/ps_ratio|10.1082|1999-01-06/ps_ratio|10.4274|1999-01-20/ps_ratio|9.9702|1999-02-03/ps_ratio|9.1336|1999-02-17/ps_ratio|8.9007|1999-01-05/pe_ratio|43.9102|1999-01-19/pe_ratio|43.5733|1999-02-02/pe_ratio|39.7889|1999-02-16/pe_ratio|39.3393|1999-01-05/price_to_book_value|29.715|1999-01-19/price_to_book_value|29.487|1999-02-02/price_to_book_value|26.926|1999-02-16/price_to_book_value|26.6218|1999-01-06/peg_ratio|68.9983|1999-01-20/peg_ratio|65.9731|1999-02-03/peg_ratio|60.4378|1999-02-17/peg_ratio|58.8964|1999-01-05/dividend_yield|1.5682|1999-01-19/dividend_yield|1.5803|1999-02-02/dividend_yield|1.7306|1999-02-16/dividend_yield|1.7504|1999-01-08/percent_of_shares_outstanding|0.1396|1999-02-09/percent_of_shares_outstanding|0.0863|1999-01-06/price|75.563|1999-01-29/price|67.875|1999-02-26/price|64.063|1999-01-29/total_return_price|26.714|1999-02-26/total_return_price|25.2137|1999-01-05/enterprise_value|134944.5631|1999-01-19/enterprise_value|133925.7493|1999-02-02/enterprise_value|122481.2263|1999-02-16/enterprise_value|121121.5895
adr_usa_0212|GSK|199903|||||||||||||9.258|39.7111|||9.1881|38.5528|26.0896|4.1562||1.9486||0.0933|1839|0.4057|0.7736|3286.6637||||746.0332||66.938|26.6695|118743.1389|58|1999-04-14/ev_revenues|8.6719|1999-04-28/ev_revenues|8.434|1999-05-12/ev_revenues|8.2472|1999-05-26/ev_revenues|7.6102|1999-04-14/ps_ratio|8.5961|1999-04-28/ps_ratio|8.3559|1999-05-12/ps_ratio|8.1671|1999-05-26/ps_ratio|7.5238|1999-04-13/pe_ratio|38.2754|1999-04-27/pe_ratio|37.1353|1999-05-11/pe_ratio|34.8928|1999-05-25/pe_ratio|32.0984|1999-04-13/price_to_book_value|26.3938|1999-04-27/price_to_book_value|25.6076|1999-05-11/price_to_book_value|24.0612|1999-05-25/price_to_book_value|22.1343|1999-04-14/peg_ratio|3.8884|1999-04-28/peg_ratio|3.7797|1999-05-12/peg_ratio|3.6944|1999-05-26/peg_ratio|3.4034|1999-04-13/dividend_yield|1.9261|1999-04-27/dividend_yield|1.9853|1999-05-11/dividend_yield|2.1129|1999-05-25/dividend_yield|2.2968|1999-04-12/percent_of_shares_outstanding|0.0992|1999-05-11/percent_of_shares_outstanding|0.1133|1999-04-30/price|58|1999-05-28/price|56.25|1999-04-30/total_return_price|23.1084|1999-05-28/total_return_price|22.4112|1999-04-13/enterprise_value|120102.7756|1999-04-27/enterprise_value|116589.467|1999-05-11/enterprise_value|109678.8866|1999-05-25/enterprise_value|101067.8539
adr_usa_0212|GSK|199906|9535.8879|412.6518|2208.0263|5890.0655|247.2319|10743.9121|7145.2812|3598.6309||4949.826|609.4995||7.6866|33.7841||6.8424|7.6009|32.9809|22.7428|3.4382|1.1394|2.2353||0.1372|1163.6863|0.4279|0|3388.4834|2857.6957|1154.2849|1086.0262|769.1837||56.625|22.5606|103787.1274|52.188|1999-07-07/ev_revenues|7.9855|1999-07-21/ev_revenues|7.3827|1999-08-04/ev_revenues|7.2738|1999-08-18/ev_revenues|7.3576|1999-07-07/ps_ratio|6.9888|1999-07-21/ps_ratio|6.434|1999-08-04/ps_ratio|6.3338|1999-08-18/ps_ratio|6.4108|1999-07-06/pe_ratio|32.5544|1999-07-20/pe_ratio|30.1631|1999-08-03/pe_ratio|29.592|1999-08-17/pe_ratio|29.4846|1999-08-31/pe_ratio|30.2345|1999-07-06/price_to_book_value|20.876|1999-07-20/price_to_book_value|19.3425|1999-08-03/price_to_book_value|18.9763|1999-08-17/price_to_book_value|18.9074|1999-08-31/price_to_book_value|19.3883|1999-07-07/peg_ratio|1.6112|1999-07-21/peg_ratio|1.4833|1999-08-04/peg_ratio|1.4602|1999-08-18/peg_ratio|1.478|1999-07-06/dividend_yield|2.1986|1999-07-20/dividend_yield|2.3729|1999-08-03/dividend_yield|2.4187|1999-08-17/dividend_yield|2.5102|1999-08-31/dividend_yield|2.448|1999-07-12/percent_of_shares_outstanding|0.0987|1999-08-10/percent_of_shares_outstanding|0.0879|1999-07-30/price|52.188|1999-08-31/price|52.938|1999-07-30/total_return_price|20.7928|1999-08-31/total_return_price|21.3259|1999-07-06/enterprise_value|108644.3868|1999-07-20/enterprise_value|101053.9881|1999-08-03/enterprise_value|99241.1391|1999-08-17/enterprise_value|98900.3234|1999-08-31/enterprise_value|101280.5942
adr_usa_0212|GSK|199909|||||||||||||7.2823|32.1524|||6.3415|29.6988|19.0447|1.462||2.4921||0.0832|1798.0952|0.4085|0.5381|3645.9801||||734.5848||52|20.948|99580.1418|59.875|1999-10-13/ev_revenues|8.0651|1999-10-27/ev_revenues|8.2543|1999-11-10/ev_revenues|8.2049|1999-11-24/ev_revenues|8.2624|1999-10-13/ps_ratio|7.0817|1999-10-27/ps_ratio|7.2561|1999-11-10/ps_ratio|7.2106|1999-11-24/ps_ratio|7.2637|1999-10-12/pe_ratio|34.4467|1999-10-26/pe_ratio|35.1851|1999-11-09/pe_ratio|36.145|1999-11-23/pe_ratio|35.3694|1999-10-12/price_to_book_value|21.3568|1999-10-26/price_to_book_value|21.8147|1999-11-09/price_to_book_value|22.4098|1999-11-23/price_to_book_value|21.9289|1999-10-13/peg_ratio|3.5533|1999-10-27/peg_ratio|3.6408|1999-11-10/peg_ratio|3.618|1999-11-24/peg_ratio|3.6446|1999-10-12/dividend_yield|2.2223|1999-10-26/dividend_yield|2.1757|1999-11-09/dividend_yield|2.1179|1999-11-23/dividend_yield|2.1643|1999-10-12/percent_of_shares_outstanding|0.1213|1999-11-10/percent_of_shares_outstanding|0.0838|1999-10-29/price|59.875|1999-11-30/price|59.438|1999-10-29/total_return_price|24.1204|1999-11-30/total_return_price|23.9444|1999-10-12/enterprise_value|111024.6576|1999-10-26/enterprise_value|113290.7188|1999-11-09/enterprise_value|116236.5984|1999-11-23/enterprise_value|113856.3277
adr_usa_0212|GSK|199912|9824.6234|3176.8437|2483.626|6011.1182|232.6884|11689.3627|8504.4396|3184.9231||5077.1327|||7.3662|34.7825||6.1899|6.4373|30.7913|19.0905|3.2299|1.1171|2.4861||0.0707|1813.7561|0.4128|0|3715.1849||||748.6091||55.875|22.509|99806.7479|52.75|2000-01-05/ev_revenues|7.4384|2000-01-19/ev_revenues|7.5761|2000-02-02/ev_revenues|6.9114|2000-02-16/ev_revenues|6.3116|2000-01-05/ps_ratio|6.5901|2000-01-19/ps_ratio|6.7152|2000-02-02/ps_ratio|6.1115|2000-02-16/ps_ratio|5.5666|2000-01-04/pe_ratio|32.707|2000-01-18/pe_ratio|32.6695|2000-02-01/pe_ratio|30.7811|2000-02-15/pe_ratio|29.4215|2000-02-29/pe_ratio|29.4589|2000-01-04/price_to_book_value|19.4065|2000-01-18/price_to_book_value|19.3842|2000-02-01/price_to_book_value|18.2638|2000-02-15/price_to_book_value|17.457|2000-02-29/price_to_book_value|17.4793|2000-01-05/peg_ratio||2000-01-19/peg_ratio||2000-02-02/peg_ratio||2000-02-16/peg_ratio||2000-01-04/dividend_yield|2.3943|2000-01-18/dividend_yield|2.397|2000-02-01/dividend_yield|2.5441|2000-02-15/dividend_yield|2.6616|2000-02-29/dividend_yield|2.6583|2000-01-11/percent_of_shares_outstanding|0.0851|2000-02-10/percent_of_shares_outstanding|0.0634|2000-01-31/price|52.75|2000-02-29/price|48.75|2000-01-31/total_return_price|21.2501|2000-02-29/total_return_price|19.6387|2000-01-04/enterprise_value|101106.606|2000-01-18/enterprise_value|100993.7411|2000-02-01/enterprise_value|95304.9848|2000-02-15/enterprise_value|91209.0803|2000-02-29/enterprise_value|91321.9452
adr_usa_0212|GSK|200003|14673.4713|3479.6223|3680.738|10204.2317|1797.2728|19362.9806|13295.9878|6066.9928||9685.4807|||7.4464|31.3319||3.5832|6.5974|33.6514|19.9669||0.8085|2.3774|1.7983|0.1569|3036.5|0.411|0.7979|6568.3683|5177.9486|2504.6821|1815.8945|1273.2134|-69.0393|57.313|23.4661|103951.8943|62.813|2000-04-12/ev_revenues|6.8384|2000-04-26/ev_revenues|6.799|2000-05-10/ev_revenues|6.4574|2000-05-24/ev_revenues|6.5033|2000-04-12/ps_ratio|6.9568|2000-04-26/ps_ratio|6.9145|2000-05-10/ps_ratio|6.548|2000-05-24/ps_ratio|6.5972|2000-04-11/pe_ratio|37.4955|2000-04-25/pe_ratio|38.399|2000-05-09/pe_ratio|35.9144|2000-05-23/pe_ratio|35.35|2000-04-11/price_to_book_value|11.7|2000-04-25/price_to_book_value|11.9819|2000-05-09/price_to_book_value|11.2066|2000-05-23/price_to_book_value|11.0305|2000-04-12/peg_ratio||2000-04-26/peg_ratio||2000-05-10/peg_ratio||2000-05-24/peg_ratio||2000-04-11/dividend_yield|2.1267|2000-04-25/dividend_yield|2.0767|2000-05-09/dividend_yield|2.2204|2000-05-23/dividend_yield|2.2558|2000-04-11/percent_of_shares_outstanding|0|2000-05-10/percent_of_shares_outstanding|0.1474|2000-04-28/price|62.813|2000-05-31/price|56.313|2000-04-28/total_return_price|25.718|2000-05-31/total_return_price|23.0567|2000-04-11/enterprise_value|119450.8635|2000-04-25/enterprise_value|122181.4665|2000-05-09/enterprise_value|114672.3083|2000-05-23/enterprise_value|112966.5916
adr_usa_0212|GSK|200006|15001.2432|846.3325|3544.0173|9970.0989|1756.1399|18986.5624|13137.8004|5848.762||9619.4754|||6.3982|27.7481||3.7431|6.4845|34.1453|10.6546||0.7939|2.3354|0.8387|0.1676|3026.5|0.435|0|6938.0036|5381.9304|2769.0752|1949.6862|1346.2484|-55.1365|57.813|23.6709|109325.7876|57.125|2000-07-05/ev_revenues|5.5671|2000-07-19/ev_revenues|5.1719|2000-08-02/ev_revenues|5.5972|2000-08-16/ev_revenues|5.5426|2000-08-30/ev_revenues|5.3954|2000-07-05/ps_ratio|6.8495|2000-07-19/ps_ratio|6.3243|2000-08-02/ps_ratio|6.8893|2000-08-16/ps_ratio|6.8169|2000-08-30/ps_ratio|6.6212|2000-07-05/pe_ratio|35.4435|2000-07-19/pe_ratio|32.7259|2000-08-02/pe_ratio|35.6498|2000-08-16/pe_ratio|35.2749|2000-08-30/pe_ratio|34.2625|2000-07-05/price_to_book_value|11.183|2000-07-19/price_to_book_value|10.3256|2000-08-02/price_to_book_value|11.2481|2000-08-16/price_to_book_value|11.1298|2000-08-30/price_to_book_value|10.8104|2000-07-05/peg_ratio||2000-07-19/peg_ratio||2000-08-02/peg_ratio||2000-08-16/peg_ratio||2000-08-30/peg_ratio||2000-07-05/dividend_yield|2.2403|2000-07-19/dividend_yield|2.4264|2000-08-02/dividend_yield|2.2274|2000-08-16/dividend_yield|2.1024|2000-08-30/dividend_yield|2.1646|2000-07-11/percent_of_shares_outstanding|0.1206|2000-08-10/percent_of_shares_outstanding|0.1346|2000-07-31/price|57.125|2000-08-31/price|57.563|2000-07-31/total_return_price|23.3892|2000-08-31/total_return_price|23.7528|2000-07-05/enterprise_value|116172.6706|2000-07-19/enterprise_value|107924.4255|2000-08-02/enterprise_value|116798.8853|2000-08-16/enterprise_value|115661.134|2000-08-30/enterprise_value|112588.2955
adr_usa_0212|GSK|200009|15376.5708|807.9016|3426.9717|9735.9487|1705.4068|18446.5969|12833.8841|5612.7128||10117.8659|||5.4826|26.4675||3.8979|6.7371|34.8623|10.9996||0.73|2.1273|1.7285|0.1178|3033|0.3578|0.4613|6547.8747|5153.7348|2556.1697|1573.0275|1105.8501|-87.2261|60.438|24.9392|114408.6975|58.188|2000-10-11/ev_revenues|4.8477|2000-10-25/ev_revenues|4.8573|2000-11-08/ev_revenues|4.9243|2000-11-22/ev_revenues|4.795|2000-10-11/ps_ratio|6.7342|2000-10-25/ps_ratio|6.7485|2000-11-08/ps_ratio|6.8489|2000-11-22/ps_ratio|6.6552|2000-10-11/pe_ratio|36.3053|2000-10-25/pe_ratio|36.3826|2000-11-08/pe_ratio|36.9239|2000-11-22/pe_ratio|35.8797|2000-10-11/price_to_book_value|10.5591|2000-10-25/price_to_book_value|10.5816|2000-11-08/price_to_book_value|10.739|2000-11-22/price_to_book_value|10.4353|2000-10-11/peg_ratio||2000-10-25/peg_ratio||2000-11-08/peg_ratio||2000-11-22/peg_ratio||2000-10-11/dividend_yield|2.1069|2000-10-25/dividend_yield|2.1024|2000-11-08/dividend_yield|2.0716|2000-11-22/dividend_yield|2.1319|2000-10-10/percent_of_shares_outstanding|0.1086|2000-11-10/percent_of_shares_outstanding|0.1328|2000-10-31/price|58.188|2000-11-30/price|57.313|2000-10-31/total_return_price|24.0107|2000-11-30/total_return_price|23.6497|2000-10-11/enterprise_value|115227.6468|2000-10-25/enterprise_value|115455.1971|2000-11-08/enterprise_value|117048.0488|2000-11-22/enterprise_value|113975.2103
adr_usa_0212|GSK|200012|16799.9908|5355.4816|3394.8863|9902.87|1693.7158|18838.1153|13543.7625|5294.3528||11496.6923|6375.2894||4.594|28.6019|157.385|5.5507|6.354|34.2558|9.963||0.5229|2.233|2.5594|0.1671|3172|0.8048|0.6475|7279.6074|5633.7705||3707.1136|2521.59|-30.398|56|23.3901|109196.655|52.55|2001-01-03/ev_revenues|6.4001|2001-01-17/ev_revenues|6.0764|2001-01-31/ev_revenues|6.1397|2001-02-14/ev_revenues|6.4573|2001-02-28/ev_revenues|6.4573|2001-01-16/ev_free_cash_flow|150.1112|2001-01-30/ev_free_cash_flow|146.7168|2001-02-13/ev_free_cash_flow|154.0598|2001-02-27/ev_free_cash_flow|153.7827|2001-01-03/ps_ratio|6.1503|2001-01-17/ps_ratio|5.8347|2001-01-31/ps_ratio|5.8964|2001-02-14/ps_ratio|6.2061|2001-02-28/ps_ratio|6.2061|2001-01-03/pe_ratio|27.2893|2001-01-17/pe_ratio|25.8888|2001-01-31/pe_ratio|26.1626|2001-02-14/pe_ratio|27.5367|2001-02-28/pe_ratio|27.5367|2001-01-03/price_to_book_value|14.9981|2001-01-17/price_to_book_value|14.2284|2001-01-31/price_to_book_value|14.3789|2001-02-14/price_to_book_value|15.1341|2001-02-28/price_to_book_value|15.1341|2001-01-03/peg_ratio|1.2766|2001-01-17/peg_ratio|1.2111|2001-01-31/peg_ratio|1.2239|2001-02-14/peg_ratio|1.2882|2001-02-28/peg_ratio|1.2882|2001-01-03/dividend_yield|3.4747|2001-01-17/dividend_yield|3.6627|2001-01-31/dividend_yield|3.6244|2001-02-14/dividend_yield|3.4435|2001-02-28/dividend_yield|3.4435|2001-01-09/percent_of_shares_outstanding|0.1441|2001-02-12/percent_of_shares_outstanding|0.154|2001-01-31/price|52.55|2001-02-28/price|55.31|2001-01-31/total_return_price|21.9491|2001-02-28/total_return_price|23.1019|2001-01-03/enterprise_value|174939.5443|2001-01-17/enterprise_value|166090.5087|2001-01-31/enterprise_value|167820.6792|2001-02-14/enterprise_value|176502.9892|2001-02-28/enterprise_value|176502.9892
adr_usa_0212|GSK|200103|15911.0123|3650.0476|3423.2568|9769.1191|2593.117|19745.06|13718.7016|6026.3583||11202.6079|6238.8855||6.0741|27.9701|149.4877|5.2266|5.8324|25.8789|14.2229|1.2106|0.5079|3.6641|3.8679|0.1258|3033.5|0.33|0|6945.4938|5419.7337|3055.9005|1521.38|1022.0403|-29.2012|52.3|21.8447|166027.5935|53.57|2001-04-11/ev_revenues|6.0291|2001-04-25/ev_revenues|6.188|2001-05-09/ev_revenues|6.2561|2001-05-23/ev_revenues|6.2448|2001-04-10/ev_free_cash_flow|218.2664|2001-04-24/ev_free_cash_flow|213.4395|2001-05-08/ev_free_cash_flow|224.878|2001-05-22/ev_free_cash_flow|226.2977|2001-04-11/ps_ratio|5.7649|2001-04-25/ps_ratio|5.9198|2001-05-09/ps_ratio|5.9862|2001-05-23/ps_ratio|5.9752|2001-04-11/pe_ratio|27.0293|2001-04-25/pe_ratio|27.7556|2001-05-09/pe_ratio|28.0669|2001-05-23/pe_ratio|28.015|2001-04-11/price_to_book_value|14.63|2001-04-25/price_to_book_value|15.0231|2001-05-09/price_to_book_value|15.1916|2001-05-23/price_to_book_value|15.1635|2001-04-11/peg_ratio|1.6786|2001-04-25/peg_ratio|1.7237|2001-05-09/peg_ratio|1.743|2001-05-23/peg_ratio|1.7398|2001-04-11/dividend_yield|3.6557|2001-04-25/dividend_yield|3.56|2001-05-09/dividend_yield|2.5477|2001-05-23/dividend_yield|2.5524|2001-04-09/percent_of_shares_outstanding|0.1296|2001-05-10/percent_of_shares_outstanding|0.1452|2001-04-30/price|53.57|2001-05-31/price|54.69|2001-04-30/total_return_price|22.3751|2001-05-31/total_return_price|22.9542|2001-04-11/enterprise_value|167072.2538|2001-04-25/enterprise_value|171476.3241|2001-05-09/enterprise_value|173363.7828|2001-05-23/enterprise_value|173049.2064
adr_usa_0212|GSK|200106|15236.1637|1531.2091|3267.7044|9645.6333|2504.2089|18120.0112|12391.6861|5728.3251||11744.8944|6788.5011||6.4151|29.6931|234.8969|5.8511|6.1411|28.7932|15.5848|1.7881|0.4251|2.4834|2.948|0.1213|3036.5|0.4774|0.2568|7278.241|5698.1153|2934.3162|2058.9948|1459.3427|-32.6825|56.2|23.588|177767.8531|57.76|2001-07-05/ev_revenues|6.4159|2001-07-19/ev_revenues|6.5875|2001-08-02/ev_revenues|6.5763|2001-08-16/ev_revenues|6.2264|2001-08-30/ev_revenues|6.103|2001-07-05/ev_free_cash_flow|63.602|2001-07-19/ev_free_cash_flow|65.3029|2001-08-02/ev_free_cash_flow|65.1918|2001-08-16/ev_free_cash_flow|61.7233|2001-08-30/ev_free_cash_flow|60.5004|2001-07-05/ps_ratio|6.0989|2001-07-19/ps_ratio|6.2663|2001-08-02/ps_ratio|6.2554|2001-08-16/ps_ratio|5.9141|2001-08-30/ps_ratio|5.7937|2001-07-05/pe_ratio|28.2992|2001-07-19/pe_ratio|29.0758|2001-08-02/pe_ratio|29.0251|2001-08-16/pe_ratio|27.4413|2001-08-30/pe_ratio|26.883|2001-07-05/price_to_book_value|14.9321|2001-07-19/price_to_book_value|15.3419|2001-08-02/price_to_book_value|15.3152|2001-08-16/price_to_book_value|14.4795|2001-08-30/price_to_book_value|14.1849|2001-07-05/peg_ratio|1.5585|2001-07-19/peg_ratio|1.6013|2001-08-02/peg_ratio|1.5985|2001-08-16/peg_ratio|1.5112|2001-08-30/peg_ratio|1.4805|2001-07-05/dividend_yield|2.4723|2001-07-19/dividend_yield|2.4062|2001-08-02/dividend_yield|2.0659|2001-08-16/dividend_yield|2.1852|2001-08-30/dividend_yield|2.2306|2001-07-10/percent_of_shares_outstanding|0.1338|2001-08-10/percent_of_shares_outstanding|0.1099|2001-07-31/price|57.76|2001-08-31/price|52.95|2001-07-31/total_return_price|24.2427|2001-08-31/total_return_price|22.3223|2001-07-05/enterprise_value|179974.2165|2001-07-19/enterprise_value|184787.2362|2001-07-31/enterprise_value|186297.2032|2001-08-14/enterprise_value|178369.8766|2001-08-28/enterprise_value|172424.3817
adr_usa_0212|GSK|200109|15848.5928|1956.852|3319.1616|9900.2325|2569.0105|19245.5587|13317.7504|5927.8082||12342.9944|7128.6371||5.8946|32.3176|58.434|5.468|5.6395|26.1672|13.687|1.4411|0.406|2.2916|2.5241|0.1032|3041|0.1754|0.2571|7181.8493|5528.0394|3061.7055|992.2859|543.6001|-38.8286|56.12|23.6587|165350.18|53.4|2001-10-01/ev_revenues|6.2348|2001-10-15/ev_revenues|6.2185|2001-10-29/ev_revenues|5.8674|2001-11-12/ev_revenues|6.0736|2001-11-26/ev_revenues|5.8055|2001-10-01/ev_free_cash_flow|145.891|2001-10-15/ev_free_cash_flow|145.5095|2001-10-29/ev_free_cash_flow|137.2931|2001-11-12/ev_free_cash_flow|142.1183|2001-11-26/ev_free_cash_flow|135.8447|2001-10-01/ps_ratio|5.9937|2001-10-15/ps_ratio|5.9777|2001-10-29/ps_ratio|5.6319|2001-11-12/ps_ratio|5.8439|2001-11-26/ps_ratio|5.5794|2001-10-01/pe_ratio|31.3197|2001-10-15/pe_ratio|31.2358|2001-10-29/pe_ratio|29.429|2001-11-12/pe_ratio|30.5366|2001-11-26/pe_ratio|29.1549|2001-10-01/price_to_book_value|14.1455|2001-10-15/price_to_book_value|14.1076|2001-10-29/price_to_book_value|13.2916|2001-11-12/price_to_book_value|13.7708|2001-11-26/price_to_book_value|13.1477|2001-10-01/peg_ratio|2.9577|2001-10-15/peg_ratio|2.9497|2001-10-29/peg_ratio|2.7791|2001-11-12/peg_ratio|2.8837|2001-11-26/peg_ratio|2.7532|2001-10-01/dividend_yield|2.1098|2001-10-15/dividend_yield|2.1155|2001-10-29/dividend_yield|2.2454|2001-11-12/dividend_yield|2.6325|2001-11-26/dividend_yield|2.7573|2001-10-10/percent_of_shares_outstanding|0.1294|2001-11-12/percent_of_shares_outstanding|0.1162|2001-10-31/price|53.4|2001-11-30/price|50.81|2001-10-31/total_return_price|22.6199|2001-11-30/total_return_price|21.5228|2001-10-01/enterprise_value|178846.3376|2001-10-15/enterprise_value|178378.581|2001-10-29/enterprise_value|168306.2233|2001-11-12/enterprise_value|174221.3073|2001-11-26/enterprise_value|166530.6486
adr_usa_0212|GSK|200112|14511.0435|3362.1205|3033.1849|9935.8484|2681.3235|19651.4097|13687.7077|5963.702||10910.6939|5716.5019||5.5049|35.3828|128.8122|4.9602|5.3354|27.8795|12.4493|2.6328|0.563|2.8834|4.536|0.0981|3130.3755|0.4582|0.2536|8165.117|6531.2777|1702.3846|4189.024|1434.8201||49.82|21.1035|157909.59|48.22|2002-01-07/ev_revenues|5.2685|2002-01-22/ev_revenues|5.2988|2002-02-05/ev_revenues|5.1141|2002-02-19/ev_revenues|5.3656|2002-01-07/ev_free_cash_flow|30.9797|2002-01-22/ev_free_cash_flow|31.1577|2002-02-05/ev_free_cash_flow|30.0714|2002-02-19/ev_free_cash_flow|31.5505|2002-01-07/ps_ratio|5.0887|2002-01-22/ps_ratio|5.1187|2002-02-05/ps_ratio|4.9356|2002-02-19/ps_ratio|5.185|2002-01-07/pe_ratio|34.1217|2002-01-22/pe_ratio|34.3229|2002-02-05/pe_ratio|33.0946|2002-02-19/pe_ratio|34.7671|2002-01-07/price_to_book_value|13.9095|2002-01-22/price_to_book_value|13.9915|2002-02-05/price_to_book_value|13.4908|2002-02-19/price_to_book_value|14.1726|2002-01-07/peg_ratio||2002-01-22/peg_ratio||2002-02-05/peg_ratio||2002-02-19/peg_ratio||2002-01-07/dividend_yield|2.9227|2002-01-22/dividend_yield|2.9056|2002-02-05/dividend_yield|3.0134|2002-02-19/dividend_yield|2.8685|2002-01-10/percent_of_shares_outstanding|0.1077|2002-02-12/percent_of_shares_outstanding|0.1105|2002-01-31/price|48.22|2002-02-28/price|48.95|2002-01-31/total_return_price|20.4257|2002-02-28/total_return_price|20.8776|2002-01-07/enterprise_value|155794.322|2002-01-22/enterprise_value|156689.4021|2002-02-05/enterprise_value|151226.3272|2002-02-19/enterprise_value|158664.7512
adr_usa_0212|GSK|200203|15476.9194|3533.7187|3051.2658|9771.4509|2610.0846|20775.3627|13539.9918|7235.3709||10443.1848|5324.0603||5.1389|30.291|30.2174|4.5814|4.9635|33.282|13.5581||0.616|2.3171|3.9564|0.1141|2990.5|0.4878|0.3447|7288.5453|5695.3349|2691.4843|2039.6516|1463.4144|-48.4952|47|20.0459|151960.5203|48.05|2002-04-02/ev_revenues|4.9702|2002-04-16/ev_revenues|4.9455|2002-04-30/ev_revenues|5.0221|2002-05-14/ev_revenues|5.011|2002-05-28/ev_revenues|4.53|2002-04-02/ev_free_cash_flow|26.3694|2002-04-16/ev_free_cash_flow|26.2386|2002-04-30/ev_free_cash_flow|26.6451|2002-05-14/ev_free_cash_flow|26.5857|2002-05-28/ev_free_cash_flow|24.0341|2002-04-02/ps_ratio|4.7986|2002-04-16/ps_ratio|4.7741|2002-04-30/ps_ratio|4.8985|2002-05-14/ps_ratio|4.8873|2002-05-28/ps_ratio|4.4051|2002-04-02/pe_ratio|29.4399|2002-04-16/pe_ratio|29.2898|2002-04-30/pe_ratio|30.0528|2002-05-14/pe_ratio|29.984|2002-05-28/pe_ratio|27.0257|2002-04-02/price_to_book_value|13.8455|2002-04-16/price_to_book_value|13.7749|2002-04-30/price_to_book_value|13.9943|2002-05-14/price_to_book_value|13.9623|2002-05-28/price_to_book_value|12.5847|2002-04-02/peg_ratio||2002-04-16/peg_ratio||2002-04-30/peg_ratio||2002-05-14/peg_ratio||2002-05-28/peg_ratio||2002-04-02/dividend_yield|2.361|2002-04-16/dividend_yield|2.3731|2002-04-30/dividend_yield|2.3128|2002-05-14/dividend_yield|2.3202|2002-05-28/dividend_yield|2.5742|2002-04-10/percent_of_shares_outstanding|0.1206|2002-05-10/percent_of_shares_outstanding|0.1638|2002-04-30/price|48.05|2002-05-31/price|40.75|2002-04-30/total_return_price|20.4937|2002-05-31/total_return_price|17.4746|2002-04-02/enterprise_value|148676.7095|2002-04-16/enterprise_value|147939.4715|2002-04-30/enterprise_value|150231.183|2002-05-14/enterprise_value|149896.6152|2002-05-28/enterprise_value|135510.202
adr_usa_0212|GSK|200206|16569.7399|1955.7021|3363.3778|10380.2651|2760.0882|22944.9603|15146.7133|7798.247||10361.844|4812.5009||4.2697|26.3791|22.6531|3.9463|4.1594|25.5183|11.8391||0.7304|2.7262|5.4086|0.1435|2971.5|0.5762|0.2604|7918.8718|6295.6128|3008.1476|2388.0919|1724.1643|-42.4095|43.14|18.4995|127723.6971|39.5|2002-07-09/ev_revenues|4.2067|2002-07-23/ev_revenues|3.4506|2002-08-06/ev_revenues|3.9799|2002-08-20/ev_revenues|4.2097|2002-07-09/ev_free_cash_flow|21.6554|2002-07-23/ev_free_cash_flow|17.763|2002-08-06/ev_free_cash_flow|20.4877|2002-08-20/ev_free_cash_flow|21.6706|2002-07-09/ps_ratio|4.0267|2002-07-23/ps_ratio|3.2622|2002-08-06/ps_ratio|3.7973|2002-08-20/ps_ratio|4.0296|2002-07-09/pe_ratio|23.8927|2002-07-23/pe_ratio|19.3569|2002-08-06/pe_ratio|22.532|2002-08-20/pe_ratio|23.9104|2002-07-09/price_to_book_value|11.7446|2002-07-23/price_to_book_value|9.515|2002-08-06/price_to_book_value|11.0758|2002-08-20/price_to_book_value|11.7533|2002-07-09/peg_ratio||2002-07-23/peg_ratio||2002-08-06/peg_ratio||2002-08-20/peg_ratio||2002-07-09/dividend_yield|2.7424|2002-07-23/dividend_yield|3.385|2002-08-06/dividend_yield|2.9752|2002-08-20/dividend_yield|2.8036|2002-07-10/percent_of_shares_outstanding|0.196|2002-08-12/percent_of_shares_outstanding|0.2312|2002-07-31/price|39.5|2002-08-30/price|37.89|2002-07-31/total_return_price|17.0595|2002-08-30/total_return_price|16.3642|2002-07-09/enterprise_value|128533.4248|2002-07-23/enterprise_value|105430.3602|2002-08-06/enterprise_value|121602.5055|2002-08-20/enterprise_value|128623.4368
adr_usa_0212|GSK|200209|16043.8362|1528.7303|3391.0871|10342.4242|2780.2216|22631.7866|14031.1125|8600.6741||10182.6593|4501.6094||3.8986|20.757|20.0693|3.5623|3.7199|22.0725|10.8361||0.6825|3.0371|6.7487|0.19|2937.5|0.4152|0.2776|7776.2238|6026.9996|2963.9203|1719.7865|1223.9922|-65.073|38.43|16.5974|119119.247|37.69|2002-10-01/ev_revenues|4.0933|2002-10-15/ev_revenues|4.3299|2002-10-29/ev_revenues|3.9026|2002-11-12/ev_revenues|3.9777|2002-11-26/ev_revenues|3.8609|2002-10-01/ev_free_cash_flow|18.107|2002-10-15/ev_free_cash_flow|19.1538|2002-10-29/ev_free_cash_flow|17.2636|2002-11-12/ev_free_cash_flow|17.5958|2002-11-26/ev_free_cash_flow|17.079|2002-10-01/ps_ratio|3.9094|2002-10-15/ps_ratio|4.1479|2002-10-29/ps_ratio|3.7172|2002-11-12/ps_ratio|3.7945|2002-11-26/ps_ratio|3.6767|2002-10-01/pe_ratio|20.8995|2002-10-15/pe_ratio|22.1744|2002-10-29/pe_ratio|19.8723|2002-11-12/pe_ratio|20.2853|2002-11-26/pe_ratio|19.6555|2002-10-01/price_to_book_value|11.8661|2002-10-15/price_to_book_value|12.5899|2002-10-29/price_to_book_value|11.2829|2002-11-12/price_to_book_value|11.5126|2002-11-26/price_to_book_value|11.1552|2002-10-01/peg_ratio|2.4962|2002-10-15/peg_ratio|2.6485|2002-10-29/peg_ratio|2.3735|2002-11-12/peg_ratio|2.4229|2002-11-26/peg_ratio|2.3476|2002-10-01/dividend_yield|2.8106|2002-10-15/dividend_yield|2.649|2002-10-29/dividend_yield|2.9558|2002-11-12/dividend_yield|2.9501|2002-11-26/dividend_yield|3.0446|2002-10-10/percent_of_shares_outstanding|0.2263|2002-11-12/percent_of_shares_outstanding|0.166|2002-10-31/price|37.69|2002-11-29/price|38|2002-10-31/total_return_price|16.3958|2002-11-29/total_return_price|16.5307|2002-10-01/enterprise_value|127500.6842|2002-10-15/enterprise_value|134871.5298|2002-10-29/enterprise_value|121562.2297|2002-11-12/enterprise_value|123901.4056|2002-11-26/enterprise_value|120262.2396
adr_usa_0212|GSK|200212|17328.9466|3980.386|3353.2616|10719.1521|2914.7582|24083.8342|14199.7732|9884.061||10609.5262|4749.3792||3.7413|19.9749|16.5498|3.2683|3.5618|19.0413|10.7893|2.2743|0.7055|3.1429|5.5389|0.168|2968.5|0.4968|0.2786|8910.9581|6941.0515||2095.6787|1477.823|-44.0203|37.46|16.2958|116535.9503|38.76|2003-01-07/ev_revenues|3.7876|2003-01-21/ev_revenues|3.7167|2003-02-04/ev_revenues|3.6935|2003-02-18/ev_revenues|3.6997|2003-01-07/ev_free_cash_flow|43.8289|2003-01-21/ev_free_cash_flow|43.0092|2003-02-04/ev_free_cash_flow|42.7408|2003-02-18/ev_free_cash_flow|42.8125|2003-01-07/ps_ratio|3.5824|2003-01-21/ps_ratio|3.5126|2003-02-04/ps_ratio|3.4898|2003-02-18/ps_ratio|3.4959|2003-01-07/pe_ratio|19.4887|2003-01-21/pe_ratio|19.1091|2003-02-04/pe_ratio|18.9849|2003-02-18/pe_ratio|19.0181|2003-01-07/price_to_book_value|10.9333|2003-01-21/price_to_book_value|10.7204|2003-02-04/price_to_book_value|10.6507|2003-02-18/price_to_book_value|10.6693|2003-01-07/peg_ratio|0.5249|2003-01-21/peg_ratio|0.5147|2003-02-04/peg_ratio|0.5114|2003-02-18/peg_ratio|0.5123|2003-01-07/dividend_yield|3.0106|2003-01-21/dividend_yield|3.0704|2003-02-04/dividend_yield|3.0905|2003-02-18/dividend_yield|3.0852|2003-01-10/percent_of_shares_outstanding|0.2091|2003-02-11/percent_of_shares_outstanding|0.1895|2003-01-31/price|38.76|2003-02-28/price|35.05|2003-01-31/total_return_price|16.8613|2003-02-28/total_return_price|15.4192|2003-01-07/enterprise_value|120803.0461|2003-01-21/enterprise_value|118543.9463|2003-02-04/enterprise_value|117804.1665|2003-02-18/enterprise_value|118001.7624
adr_usa_0212|GSK|200303|17285.7499|3754.9083|3413.6437|10555.2538|2937.6694|23152.1081|13368.1921|9783.916||11324.5959|5582.9689||3.582|17.2499|41.4503|3.0757|3.3852|18.4158|10.3154|0.496|0.596|3.396|6.1749|0.2201|2919|0.6683|0.4267|8460.2262|6661.8586|2877.7933|2703.6271|1941.1435||35.19|15.4808|114247.2009|40.52|2003-04-01/ev_revenues|3.3815|2003-04-15/ev_revenues|3.6438|2003-04-29/ev_revenues|3.7182|2003-05-13/ev_revenues|3.9451|2003-05-27/ev_revenues|3.857|2003-04-01/ev_free_cash_flow|45.4618|2003-04-15/ev_free_cash_flow|48.9881|2003-04-29/ev_free_cash_flow|49.9886|2003-05-13/ev_free_cash_flow|53.039|2003-05-27/ev_free_cash_flow|51.8555|2003-04-01/ps_ratio|3.1974|2003-04-15/ps_ratio|3.4552|2003-04-29/ps_ratio|3.5283|2003-05-13/ps_ratio|3.7513|2003-05-27/ps_ratio|3.6647|2003-04-01/pe_ratio|16.624|2003-04-15/pe_ratio|17.9641|2003-04-29/pe_ratio|18.3443|2003-05-13/pe_ratio|19.5036|2003-05-27/pe_ratio|19.0538|2003-04-01/price_to_book_value|9.5001|2003-04-15/price_to_book_value|10.266|2003-04-29/price_to_book_value|10.4833|2003-05-13/price_to_book_value|11.1458|2003-05-27/price_to_book_value|10.8887|2003-04-01/peg_ratio|0.4766|2003-04-15/peg_ratio|0.515|2003-04-29/peg_ratio|0.5259|2003-05-13/peg_ratio|0.5592|2003-05-27/peg_ratio|0.5463|2003-04-01/dividend_yield|3.4471|2003-04-15/dividend_yield|3.19|2003-04-29/dividend_yield|3.1239|2003-05-13/dividend_yield|2.9988|2003-05-27/dividend_yield|3.0696|2003-04-10/percent_of_shares_outstanding|0.2153|2003-05-12/percent_of_shares_outstanding|0.1731|2003-04-30/price|40.52|2003-05-30/price|40.01|2003-04-30/total_return_price|17.8255|2003-05-30/total_return_price|17.718|2003-04-01/enterprise_value|111812.9862|2003-04-15/enterprise_value|120485.8155|2003-04-29/enterprise_value|122946.6183|2003-05-13/enterprise_value|130449.0658|2003-05-27/enterprise_value|127538.1162
adr_usa_0212|GSK|200306|20025.2734|2925.9846|3662.8381|10869.8265|3031.4848|25062.9122|13255.1221|11807.79||12737.5113|6715.7527||3.8981|18.8981|52.408|3.2826|3.712|19.2996|11.0087|0.5533|0.6739|3.0305|4.2466|0.1494|2942.1111|0.7243|0.289|8618.0483|6911.7992|2974.1964|3020.5801|2140.2983||40.54|17.9527|128897.0197|38.31|2003-07-08/ev_revenues|3.7797|2003-07-22/ev_revenues|3.5688|2003-08-05/ev_revenues|3.5529|2003-08-19/ev_revenues|3.7264|2003-07-08/ev_free_cash_flow|41.2661|2003-07-22/ev_free_cash_flow|38.9638|2003-08-05/ev_free_cash_flow|38.79|2003-08-19/ev_free_cash_flow|40.684|2003-07-08/ps_ratio|3.5154|2003-07-22/ps_ratio|3.3081|2003-08-05/ps_ratio|3.2959|2003-08-19/ps_ratio|3.4667|2003-07-08/pe_ratio|17.5078|2003-07-22/pe_ratio|16.4751|2003-08-05/pe_ratio|16.4144|2003-08-19/pe_ratio|17.2648|2003-07-08/price_to_book_value|9.477|2003-07-22/price_to_book_value|8.918|2003-08-05/price_to_book_value|8.8758|2003-08-19/price_to_book_value|9.3357|2003-07-08/peg_ratio|0.4896|2003-07-22/peg_ratio|0.4607|2003-08-05/peg_ratio|0.459|2003-08-19/peg_ratio|0.4828|2003-07-08/dividend_yield|3.1259|2003-07-22/dividend_yield|3.3218|2003-08-05/dividend_yield|3.3503|2003-08-19/dividend_yield|3.1852|2003-07-10/percent_of_shares_outstanding|0.1559|2003-08-12/percent_of_shares_outstanding|0.1645|2003-07-31/price|38.31|2003-08-29/price|38.83|2003-07-31/total_return_price|17.0893|2003-08-29/total_return_price|17.3212|2003-07-08/enterprise_value|127621.9804|2003-07-22/enterprise_value|120501.8367|2003-08-05/enterprise_value|119964.4077|2003-08-19/enterprise_value|125821.9108
adr_usa_0212|GSK|200309|21618.9347|3039.9809|3741.3871|10846.8646|3093.1681|25845.655|13946.6811|11898.9739||8923.8149|7427.9249||3.8343|17.9453|41.1296|3.6977|3.5773|16.7363|14.1548|0.544|0.9873|2.9892|3.012|0.1936|2911.0408|0.644|0.2863|8799.7588|12295.9886|3142.541|2646.6892|1873.9333|-74.0558|42.4|18.9137|133390.6717|43.29|2003-10-14/ev_revenues|3.961|2003-10-28/ev_revenues|3.9644|2003-11-11/ev_revenues|3.9654|2003-11-25/ev_revenues|4.1827|2003-10-14/ev_free_cash_flow|42.4891|2003-10-28/ev_free_cash_flow|42.5258|2003-11-11/ev_free_cash_flow|42.5357|2003-11-25/ev_free_cash_flow|44.8674|2003-10-14/ps_ratio|3.7022|2003-10-28/ps_ratio|3.7056|2003-11-11/ps_ratio|3.7089|2003-11-25/ps_ratio|3.9232|2003-10-14/pe_ratio|17.3205|2003-10-28/pe_ratio|17.3362|2003-11-11/pe_ratio|17.352|2003-11-25/pe_ratio|18.3546|2003-10-14/price_to_book_value|14.6489|2003-10-28/price_to_book_value|14.6623|2003-11-11/price_to_book_value|14.6659|2003-11-25/price_to_book_value|15.5133|2003-10-14/peg_ratio|0.563|2003-10-28/peg_ratio|0.5635|2003-11-11/peg_ratio|0.564|2003-11-25/peg_ratio|0.5966|2003-10-14/dividend_yield|2.8883|2003-10-28/dividend_yield|2.8857|2003-11-11/dividend_yield|2.9354|2003-11-25/dividend_yield|2.7751|2003-10-10/percent_of_shares_outstanding|0.2185|2003-11-11/percent_of_shares_outstanding|0.2092|2003-10-31/price|43.29|2003-11-28/price|45.88|2003-10-31/total_return_price|19.4437|2003-11-28/total_return_price|20.607|2003-10-14/enterprise_value|137799.7841|2003-10-28/enterprise_value|137918.9493|2003-11-11/enterprise_value|137951.0737|2003-11-25/enterprise_value|145513.0347
adr_usa_0212|GSK|200312|22546.3409|6170.5775|3766.2353|11503.9913|3285.5672|27698.5027|15352.3408|12346.162||13787.1651|7222.0391||4.0485|18.6452|43.4276|3.1755|3.7933|17.7468|14.99|0.5768|0.661|2.8701|3.6043|0.3175|2821.5694|0.4781|0.3024|9141.6026|1393.1159|3397.081|1923.4292|1336.6887||46.62|20.9393|140843.4741|44|2004-01-06/ev_revenues|3.8905|2004-01-20/ev_revenues|3.7986|2004-02-03/ev_revenues|3.7106|2004-02-17/ev_revenues|3.5784|2004-01-06/ev_free_cash_flow|20.9122|2004-01-20/ev_free_cash_flow|20.4179|2004-02-03/ev_free_cash_flow|19.9453|2004-02-17/ev_free_cash_flow|19.2343|2004-01-06/ps_ratio|3.8668|2004-01-20/ps_ratio|3.7725|2004-02-03/ps_ratio|3.6823|2004-02-17/ps_ratio|3.5465|2004-01-06/pe_ratio|18.5784|2004-01-20/pe_ratio|18.1251|2004-02-03/pe_ratio|17.6916|2004-02-17/pe_ratio|17.0395|2004-01-06/price_to_book_value|9.5721|2004-01-20/price_to_book_value|9.3385|2004-02-03/price_to_book_value|9.1152|2004-02-17/price_to_book_value|8.7792|2004-01-06/peg_ratio|0.6814|2004-01-20/peg_ratio|0.6648|2004-02-03/peg_ratio|0.6489|2004-02-17/peg_ratio|0.625|2004-01-06/dividend_yield|2.762|2004-01-20/dividend_yield|2.8311|2004-02-03/dividend_yield|2.9004|2004-02-17/dividend_yield|3.0114|2004-01-12/percent_of_shares_outstanding|0.2741|2004-02-10/percent_of_shares_outstanding|0.2991|2004-01-30/price|44|2004-02-27/price|42.62|2004-01-30/total_return_price|19.7626|2004-02-27/total_return_price|19.3778|2004-01-06/enterprise_value|136244.4187|2004-01-20/enterprise_value|133024.2242|2004-02-03/enterprise_value|129945.2663|2004-02-17/enterprise_value|125312.7059
adr_usa_0212|GSK|200403|17956.4544|5503.7952|3889.152|15267.2256|4254.1056|29893.0176|16035.84|13857.1776||7990.272|6113.8944||3.5022|16.8857|18.8247|3.1944|3.3048|15.8783|8.5856|0.5824|1.1509|3.4851|4.1738|0.3551|2884|0.6613|0.5095|8918.8724|7017.5268|3168.9093|2693.1137|1905.0197|-75.319|39.95|18.1639|122644.2467|42|2004-04-13/ev_revenues|3.5019|2004-04-27/ev_revenues|3.5879|2004-05-11/ev_revenues|3.6115|2004-05-25/ev_revenues|3.6632|2004-04-13/ev_free_cash_flow|17.1979|2004-04-27/ev_free_cash_flow|17.6203|2004-05-11/ev_free_cash_flow|17.7363|2004-05-25/ev_free_cash_flow|17.9901|2004-04-13/ps_ratio|3.3011|2004-04-27/ps_ratio|3.385|2004-05-11/ps_ratio|3.4087|2004-05-25/ps_ratio|3.4591|2004-04-13/pe_ratio|16.1617|2004-04-27/pe_ratio|16.5725|2004-05-11/pe_ratio|16.6881|2004-05-25/pe_ratio|16.9349|2004-04-13/price_to_book_value|15.0278|2004-04-27/price_to_book_value|15.4097|2004-05-11/price_to_book_value|15.5146|2004-05-25/price_to_book_value|15.7441|2004-04-13/peg_ratio|0.9923|2004-04-27/peg_ratio|1.0175|2004-05-11/peg_ratio|1.0246|2004-05-25/peg_ratio|1.0397|2004-04-13/dividend_yield|3.4335|2004-04-27/dividend_yield|3.3484|2004-05-11/dividend_yield|3.3252|2004-05-25/dividend_yield|3.4362|2004-04-12/percent_of_shares_outstanding|0.3217|2004-05-11/percent_of_shares_outstanding|0.2886|2004-04-30/price|42|2004-05-28/price|42.5984|2004-04-30/total_return_price|19.0959|2004-05-28/total_return_price|19.5327|2004-04-13/enterprise_value|124240.0136|2004-04-27/enterprise_value|127291.5436|2004-05-11/enterprise_value|128129.578|2004-05-25/enterprise_value|129963.152
adr_usa_0212|GSK|200406|19636.721|7245.0219|3881.8467|15525.5669|4229.4476|24656.0052|14224.3384|10431.6668||9423.4422|7528.9263||3.678|17.9418|18.0629|3.1482|3.4774|17.0248|15.8099|1.0453|1.1595|3.418|4.8259|0.3494|2885|0.6829|0.3478|8981.1169|7094.9197|3221.3501|2782.3215|1967.4987|-83.1083|41.46|19.0107|130489.0712|40.9982|2004-07-06/ev_revenues|3.4911|2004-07-20/ev_revenues|3.4166|2004-08-03/ev_revenues|3.4847|2004-08-17/ev_revenues|3.3323|2004-08-31/ev_revenues|3.4965|2004-07-06/ev_free_cash_flow|18.8081|2004-07-20/ev_free_cash_flow|18.4067|2004-08-03/ev_free_cash_flow|18.7735|2004-08-17/ev_free_cash_flow|17.9523|2004-08-31/ev_free_cash_flow|18.8373|2004-07-06/ps_ratio|3.2732|2004-07-20/ps_ratio|3.201|2004-08-03/ps_ratio|3.282|2004-08-17/ps_ratio|3.1336|2004-08-31/ps_ratio|3.3005|2004-07-06/pe_ratio|16.5426|2004-07-20/pe_ratio|16.1777|2004-08-03/pe_ratio|16.5872|2004-08-17/pe_ratio|15.8371|2004-08-31/pe_ratio|16.6804|2004-07-06/price_to_book_value|12.8456|2004-07-20/price_to_book_value|12.5622|2004-08-03/price_to_book_value|12.8212|2004-08-17/price_to_book_value|12.2414|2004-08-31/price_to_book_value|12.8662|2004-07-06/peg_ratio|2.3582|2004-07-20/peg_ratio|2.3061|2004-08-03/peg_ratio|2.3645|2004-08-17/peg_ratio|2.2576|2004-08-31/peg_ratio|2.3778|2004-07-06/dividend_yield|3.5767|2004-07-20/dividend_yield|3.6574|2004-08-03/dividend_yield|3.5671|2004-08-17/dividend_yield|3.9396|2004-08-31/dividend_yield|3.7404|2004-07-12/percent_of_shares_outstanding|0.3221|2004-08-10/percent_of_shares_outstanding|0.4145|2004-07-30/price|40.9982|2004-08-31/price|41.14|2004-07-30/total_return_price|18.7989|2004-08-31/total_return_price|19.0342|2004-07-06/enterprise_value|125126.1776|2004-07-20/enterprise_value|122455.9658|2004-08-03/enterprise_value|124896.4472|2004-08-17/enterprise_value|119432.8255|2004-08-31/enterprise_value|125320.4346
adr_usa_0212|GSK|200409|18836.5392|6773.6862|4103.7264|16014.321|4799.7648|25157.0754|12709.9512|12447.1242||8985.0582|7045.5762||3.6758|18.9525|19.803|3.2861|3.4754|17.5643|13.548|2.5038|1.2362|3.5522|6.0216|0.387|2867|0.6407|0.3654|8963.1249|6951.3433|3000.0957|2641.5305|1835.01||43.73|20.2325|131745.1213|42.4|2004-10-12/ev_revenues|3.5649|2004-10-26/ev_revenues|3.5625|2004-11-09/ev_revenues|3.7669|2004-11-23/ev_revenues|3.6115|2004-10-12/ev_free_cash_flow|26.9706|2004-10-26/ev_free_cash_flow|26.952|2004-11-09/ev_free_cash_flow|28.4982|2004-11-23/ev_free_cash_flow|27.3231|2004-10-12/ps_ratio|3.3398|2004-10-26/ps_ratio|3.3374|2004-11-09/ps_ratio|3.5363|2004-11-23/ps_ratio|3.3851|2004-10-12/pe_ratio|17.0436|2004-10-26/pe_ratio|17.0314|2004-11-09/pe_ratio|18.0464|2004-11-23/pe_ratio|17.275|2004-10-12/price_to_book_value|13.752|2004-10-26/price_to_book_value|13.7421|2004-11-09/price_to_book_value|14.5611|2004-11-23/price_to_book_value|13.9387|2004-10-12/peg_ratio||2004-10-26/peg_ratio||2004-11-09/peg_ratio||2004-11-23/peg_ratio||2004-10-12/dividend_yield|3.6656|2004-10-26/dividend_yield|3.6682|2004-11-09/dividend_yield|3.6081|2004-11-23/dividend_yield|3.7692|2004-10-12/percent_of_shares_outstanding|0.541|2004-11-10/percent_of_shares_outstanding|0.1906|2004-10-29/price|42.4|2004-11-30/price|42.54|2004-10-29/total_return_price|19.6172|2004-11-30/total_return_price|19.8512|2004-10-12/enterprise_value|128354.7672|2004-10-26/enterprise_value|128266.4664|2004-11-09/enterprise_value|135624.8664|2004-11-23/enterprise_value|130032.4824
adr_usa_0212|GSK|200412|20382.1021|7633.5325|4206.4976|11888.0586|5137.0502|31650.793|16131.5783|15519.2147||11277.6962|9010.35||3.9003|20.2873|29.5078|3.3376|3.6715|18.7366|15.0958||1.0143|3.4752|4.2278|0.1852|2968.8445|0.4854|0.3706|9760.3063|7567.6575|3813.2132|2463.1874|1440.7871||47.39|22.1144|140429.4412|44.57|2005-01-04/ev_revenues|3.8957|2005-01-18/ev_revenues|3.7993|2005-02-01/ev_revenues|3.7295|2005-02-15/ev_revenues|4.0441|2005-01-04/ev_free_cash_flow|19.9635|2005-01-18/ev_free_cash_flow|19.4692|2005-02-01/ev_free_cash_flow|19.1119|2005-02-15/ev_free_cash_flow|20.7237|2005-01-04/ps_ratio|3.6915|2005-01-18/ps_ratio|3.5973|2005-02-01/ps_ratio|3.5291|2005-02-15/ps_ratio|3.8365|2005-01-04/pe_ratio|18.8637|2005-01-18/pe_ratio|18.382|2005-02-01/pe_ratio|18.0339|2005-02-15/pe_ratio|19.6045|2005-01-04/price_to_book_value|12.2674|2005-01-18/price_to_book_value|11.9541|2005-02-01/price_to_book_value|11.7278|2005-02-15/price_to_book_value|12.7492|2005-01-04/peg_ratio||2005-01-18/peg_ratio||2005-02-01/peg_ratio||2005-02-15/peg_ratio||2005-01-04/dividend_yield|3.4416|2005-01-18/dividend_yield|3.5318|2005-02-01/dividend_yield|3.6|2005-02-15/dividend_yield|3.3116|2005-01-11/percent_of_shares_outstanding|0.2456|2005-02-10/percent_of_shares_outstanding|0.2442|2005-01-31/price|44.57|2005-02-28/price|48.22|2005-01-31/total_return_price|20.7985|2005-02-28/total_return_price|22.7101|2005-01-04/enterprise_value|142674.7226|2005-01-18/enterprise_value|139141.7977|2005-02-01/enterprise_value|136588.5914|2005-02-15/enterprise_value|148107.7081
adr_usa_0212|GSK|200503|22299.645|8054.696|4023.57|11579.57|5309.979|32636.253|17265.46|15370.793||11483.231|8987.862||3.7577|18.3052|19.2561|3.0951|3.6012|18.4023|11.8191||0.949|3.3619|4.5364|0.1796|2864.5|0.7942|0.4374|9522.6507|7391.5889|3110.5561|3235.3565|2272.8805|-92.6549|45.92|21.6269|137618.6303|50.55|2005-04-12/ev_revenues|3.7414|2005-04-26/ev_revenues|3.7634|2005-05-10/ev_revenues|4.0331|2005-05-24/ev_revenues|3.9962|2005-04-12/ev_free_cash_flow|20.2561|2005-04-26/ev_free_cash_flow|20.3753|2005-05-10/ev_free_cash_flow|21.8354|2005-05-24/ev_free_cash_flow|21.6354|2005-04-12/ps_ratio|3.6178|2005-04-26/ps_ratio|3.6396|2005-05-10/ps_ratio|3.9064|2005-05-24/ps_ratio|3.8699|2005-04-12/pe_ratio|17.8627|2005-04-26/pe_ratio|17.9702|2005-05-10/pe_ratio|19.2878|2005-05-24/pe_ratio|19.1073|2005-04-12/price_to_book_value|11.8527|2005-04-26/price_to_book_value|11.9241|2005-05-10/price_to_book_value|12.7984|2005-05-24/price_to_book_value|12.6786|2005-04-12/peg_ratio|4.6945|2005-04-26/peg_ratio|4.7227|2005-05-10/peg_ratio|5.069|2005-05-24/peg_ratio|5.0216|2005-04-12/dividend_yield|3.2867|2005-04-26/dividend_yield|3.267|2005-05-10/dividend_yield|3.0438|2005-05-24/dividend_yield|3.1275|2005-04-12/percent_of_shares_outstanding|0.1821|2005-05-10/percent_of_shares_outstanding|0.1672|2005-04-29/price|50.55|2005-05-31/price|49.7|2005-04-29/total_return_price|23.8075|2005-05-31/total_return_price|23.5857|2005-04-12/enterprise_value|139282.6295|2005-04-26/enterprise_value|140102.1999|2005-05-10/enterprise_value|150141.9368|2005-05-24/enterprise_value|148766.2294
adr_usa_0212|GSK|200506|23486.112|10130.1759|3880.9368|11143.3725|5184.1296|33752.3355|16365.0942|17387.2413||11451.2697|8997.0426||4.0138|18.93|21.7308|3.2224|3.8901|19.2072|12.7357|5.0478|1.0818|3.1112|3.1653|0.1577|2861|0.7486|0.3882|9721.2457|7580.997|3115.0667|3079.8448|2203.4409||48.51|23.021|149422.409|47.44|2005-07-05/ev_revenues|3.8291|2005-07-19/ev_revenues|3.7461|2005-08-02/ev_revenues|3.8134|2005-08-16/ev_revenues|3.8072|2005-08-30/ev_revenues|3.8291|2005-07-05/ev_free_cash_flow|22.1626|2005-07-19/ev_free_cash_flow|21.6824|2005-08-02/ev_free_cash_flow|22.072|2005-08-16/ev_free_cash_flow|22.0357|2005-08-30/ev_free_cash_flow|22.1626|2005-07-05/ps_ratio|3.6579|2005-07-19/ps_ratio|3.5772|2005-08-02/ps_ratio|3.6427|2005-08-16/ps_ratio|3.6366|2005-08-30/ps_ratio|3.6579|2005-07-05/pe_ratio|18.0041|2005-07-19/pe_ratio|17.607|2005-08-02/pe_ratio|17.9292|2005-08-16/pe_ratio|17.8992|2005-08-30/pe_ratio|18.0041|2005-07-05/price_to_book_value|12.4691|2005-07-19/price_to_book_value|12.194|2005-08-02/price_to_book_value|12.4172|2005-08-16/price_to_book_value|12.3964|2005-08-30/price_to_book_value|12.4691|2005-07-05/peg_ratio|2.1931|2005-07-19/peg_ratio|2.1448|2005-08-02/peg_ratio|2.184|2005-08-16/peg_ratio|2.1804|2005-08-30/peg_ratio|2.1931|2005-07-05/dividend_yield|3.2375|2005-07-19/dividend_yield|3.3105|2005-08-02/dividend_yield|3.251|2005-08-16/dividend_yield|3.2185|2005-08-30/dividend_yield|3.1998|2005-07-12/percent_of_shares_outstanding|0.1439|2005-08-10/percent_of_shares_outstanding|0.182|2005-07-29/price|47.44|2005-08-31/price|48.72|2005-07-29/total_return_price|22.5132|2005-08-31/total_return_price|23.2899|2005-07-05/enterprise_value|145380.4362|2005-07-19/enterprise_value|142230.5136|2005-08-02/enterprise_value|144786.1112|2005-08-16/enterprise_value|144548.3812|2005-08-30/enterprise_value|145380.4362
adr_usa_0212|GSK|200509|24513.559|11342.0418|3881.24|11170.9144|5248.495|34047.2958|16638.1702|17409.1256||12252.369|9678.4012||3.9737|18.8551|22.9993|3.2233|3.868|19.0383|12.9484|2.3191|0.9832|3.026|3.1776|0.1911|2857|0.7553|0.3538|9791.8269|7672.8656|3371.4329|3137.8241|2068.0753||51.28|24.5137|150869.0196|51.99|2005-10-11/ev_revenues|3.7945|2005-10-25/ev_revenues|3.7689|2005-11-08/ev_revenues|4.0162|2005-11-22/ev_revenues|3.8014|2005-10-11/ev_free_cash_flow|20.4682|2005-10-25/ev_free_cash_flow|20.3304|2005-11-08/ev_free_cash_flow|21.6643|2005-11-22/ev_free_cash_flow|20.5056|2005-10-11/ps_ratio|3.7315|2005-10-25/ps_ratio|3.7062|2005-11-08/ps_ratio|3.9518|2005-11-22/ps_ratio|3.7389|2005-10-11/pe_ratio|18.01|2005-10-25/pe_ratio|17.8878|2005-11-08/pe_ratio|19.0734|2005-11-22/pe_ratio|18.0459|2005-10-11/price_to_book_value|11.9238|2005-10-25/price_to_book_value|11.8429|2005-11-08/price_to_book_value|12.6259|2005-11-22/price_to_book_value|11.9457|2005-10-11/peg_ratio|1.3847|2005-10-25/peg_ratio|1.3753|2005-11-08/peg_ratio|1.4665|2005-11-22/peg_ratio|1.3875|2005-10-11/dividend_yield|3.067|2005-10-25/dividend_yield|3.088|2005-11-08/dividend_yield|2.8772|2005-11-22/dividend_yield|3.041|2005-10-11/percent_of_shares_outstanding|0.1945|2005-11-10/percent_of_shares_outstanding|0.1653|2005-10-31/price|51.99|2005-11-30/price|49.57|2005-10-31/total_return_price|24.8531|2005-11-30/total_return_price|23.8596|2005-10-11/enterprise_value|147209.6856|2005-10-25/enterprise_value|146218.8178|2005-11-08/enterprise_value|155812.0142|2005-11-22/enterprise_value|147478.3631
adr_usa_0212|GSK|200512|22656.1892|8999.3086|3743.0487|11437.0378|7013.3439|33748.4068|16353.4749|17394.932||12570.447|9592.9991||3.9204|17.815|21.1478|3.2392|3.8588|18.6243|12.3227|1.4319|1.0076|2.9466|3.6533|0.1318|2876.6246|0.682|0.3507|10314.8861|8047.8711|3562.0857|2803.9362|1958.468||50.48|24.2976|152097.4451|51.24|2006-01-03/ev_revenues|3.8851|2006-01-17/ev_revenues|3.8955|2006-01-31/ev_revenues|3.9058|2006-02-14/ev_revenues|3.9392|2006-02-28/ev_revenues|3.8633|2006-01-03/ev_free_cash_flow|17.5936|2006-01-17/ev_free_cash_flow|17.6406|2006-01-31/ev_free_cash_flow|17.6876|2006-02-14/ev_free_cash_flow|17.8388|2006-02-28/ev_free_cash_flow|17.495|2006-01-03/ps_ratio|3.71|2006-01-17/ps_ratio|3.7202|2006-01-31/ps_ratio|3.7303|2006-02-14/ps_ratio|3.7631|2006-02-28/ps_ratio|3.6998|2006-01-03/pe_ratio|17.1004|2006-01-17/pe_ratio|17.1474|2006-01-31/pe_ratio|17.1943|2006-02-14/pe_ratio|17.3453|2006-02-28/pe_ratio|17.0534|2006-01-03/price_to_book_value|11.8347|2006-01-17/price_to_book_value|11.8672|2006-01-31/price_to_book_value|11.8998|2006-02-14/price_to_book_value|12.0043|2006-02-28/price_to_book_value|11.7666|2006-01-03/peg_ratio|0.8288|2006-01-17/peg_ratio|0.8311|2006-01-31/peg_ratio|0.8334|2006-02-14/peg_ratio|0.8407|2006-02-28/peg_ratio|0.8265|2006-01-03/dividend_yield|2.9974|2006-01-17/dividend_yield|2.9892|2006-01-31/dividend_yield|2.9811|2006-02-14/dividend_yield|2.9551|2006-02-28/dividend_yield|3.0905|2006-01-10/percent_of_shares_outstanding|0.1599|2006-02-10/percent_of_shares_outstanding|0.1453|2006-01-31/price|51.24|2006-02-28/price|50.82|2006-01-31/total_return_price|24.6634|2006-02-28/total_return_price|24.6942|2006-01-03/enterprise_value|152879.6648|2006-01-17/enterprise_value|153288.3675|2006-01-31/enterprise_value|153697.0703|2006-02-14/enterprise_value|155010.7578|2006-02-28/enterprise_value|152023.0345
adr_usa_0212|GSK|200603|24224.9112|10039.8567|4077.4431|11756.3091|7029.1158|32874.9279|16236.8058|16638.1221||15319.5114|11916.1407||3.9986|17.2912|18.1079|3.1519|3.833|17.6675|12.1903|0.8563|0.6976|2.9831|3.7579|0.1549|2859.5|0.921|0.4873|10178.1181|8192.316|3192.0079|3799.145|2630.2549||52.31|25.4182|157349.234|56.88|2006-04-11/ev_revenues|3.7961|2006-04-25/ev_revenues|3.8775|2006-05-09/ev_revenues|4.2345|2006-05-23/ev_revenues|4.0884|2006-04-11/ev_free_cash_flow|15.9964|2006-04-25/ev_free_cash_flow|16.3395|2006-05-09/ev_free_cash_flow|17.8438|2006-05-23/ev_free_cash_flow|17.228|2006-04-11/ps_ratio|3.7113|2006-04-25/ps_ratio|3.7915|2006-05-09/ps_ratio|4.1429|2006-05-23/ps_ratio|3.999|2006-04-11/pe_ratio|16.6889|2006-04-25/pe_ratio|17.0494|2006-05-09/pe_ratio|18.6298|2006-05-23/pe_ratio|17.9828|2006-04-11/price_to_book_value|9.8442|2006-04-25/price_to_book_value|10.0568|2006-05-09/price_to_book_value|10.9891|2006-05-23/price_to_book_value|10.6075|2006-04-11/peg_ratio|0.8626|2006-04-25/peg_ratio|0.8812|2006-05-09/peg_ratio|0.9629|2006-05-23/peg_ratio|0.9294|2006-04-11/dividend_yield|3.0291|2006-04-25/dividend_yield|2.9651|2006-05-09/dividend_yield|2.7135|2006-05-23/dividend_yield|2.8346|2006-04-10/percent_of_shares_outstanding|0.1299|2006-05-10/percent_of_shares_outstanding|0.1235|2006-04-28/price|56.88|2006-05-31/price|55.3|2006-04-28/total_return_price|27.6388|2006-05-31/total_return_price|27.0548|2006-04-11/enterprise_value|151866.1776|2006-04-25/enterprise_value|155123.7503|2006-05-09/enterprise_value|169405.1791|2006-05-23/enterprise_value|163558.9836
adr_usa_0212|GSK|200606|23383.4264|8832.5478|4441.2246|12440.2342|7230.1584|32258.4828|15243.9536|17014.5292||16291.883|12397.7256||3.986|18.0563|16.7967|3.3427|3.9003|17.5386|10.3402|0.9065|0.6164|2.9064|3.538|0.1062|2864|0.8416|0.3838|10632.117|8419.9795|3445.3919|3471.1259|2406.1326||55.8|27.2995|159464.2872|55.33|2006-07-05/ev_revenues|3.9824|2006-07-19/ev_revenues|3.9526|2006-08-02/ev_revenues|3.8545|2006-08-16/ev_revenues|3.9843|2006-08-30/ev_revenues|4.0821|2006-07-05/ev_free_cash_flow|19.082|2006-07-19/ev_free_cash_flow|18.9392|2006-08-02/ev_free_cash_flow|18.4693|2006-08-16/ev_free_cash_flow|19.0911|2006-08-30/ev_free_cash_flow|19.56|2006-07-05/ps_ratio|3.8893|2006-07-19/ps_ratio|3.8599|2006-08-02/ps_ratio|3.7661|2006-08-16/ps_ratio|3.8942|2006-08-30/ps_ratio|3.9908|2006-07-05/pe_ratio|17.3631|2006-07-19/pe_ratio|17.2318|2006-08-02/pe_ratio|16.8131|2006-08-16/pe_ratio|17.385|2006-08-30/pe_ratio|17.8162|2006-07-05/price_to_book_value|9.9025|2006-07-19/price_to_book_value|9.8277|2006-08-02/price_to_book_value|9.5814|2006-08-16/price_to_book_value|9.9073|2006-08-30/price_to_book_value|10.153|2006-07-05/peg_ratio|0.8726|2006-07-19/peg_ratio|0.866|2006-08-02/peg_ratio|0.8449|2006-08-16/peg_ratio|0.8737|2006-08-30/peg_ratio|0.8954|2006-07-05/dividend_yield|2.8504|2006-07-19/dividend_yield|2.8721|2006-08-02/dividend_yield|3.0524|2006-08-16/dividend_yield|2.952|2006-08-30/dividend_yield|2.8805|2006-07-11/percent_of_shares_outstanding|0.0954|2006-08-10/percent_of_shares_outstanding|0.0946|2006-07-31/price|55.33|2006-08-31/price|56.78|2006-07-31/total_return_price|27.0695|2006-08-31/total_return_price|27.9865|2006-07-05/enterprise_value|162946.0933|2006-07-19/enterprise_value|161726.5303|2006-08-02/enterprise_value|157713.9286|2006-08-16/enterprise_value|163023.6022|2006-08-30/enterprise_value|167027.6184
adr_usa_0212|GSK|200609|22266.7574|6340.8027|4667.1453|12720.9195|7250.6433|30792.3008|13653.2253|17139.0755||17152.1802|12992.374||3.8479|16.5042|18.4377|3.2743|3.7654|16.81|9.5648|0.8448|0.6009|3.053|4.0813|0.0938|2855|0.9198|0.4078|10572.8588|8282.7192|3029.4704|3789.0679|2606.9434||53.23|26.2367|157444.4996|53.25|2006-10-11/ev_revenues|3.8795|2006-10-25/ev_revenues|4.0003|2006-11-08/ev_revenues|3.7975|2006-11-22/ev_revenues|3.6783|2006-10-11/ev_free_cash_flow|31.0371|2006-10-25/ev_free_cash_flow|32.0033|2006-11-08/ev_free_cash_flow|30.3805|2006-11-22/ev_free_cash_flow|29.4269|2006-10-11/ps_ratio|3.7341|2006-10-25/ps_ratio|3.8536|2006-11-08/ps_ratio|3.6585|2006-11-22/ps_ratio|3.5404|2006-10-11/pe_ratio|16.1605|2006-10-25/pe_ratio|16.6776|2006-11-08/pe_ratio|15.8335|2006-11-22/pe_ratio|15.3223|2006-10-11/price_to_book_value|9.1738|2006-10-25/price_to_book_value|9.4674|2006-11-08/price_to_book_value|8.9743|2006-11-22/price_to_book_value|8.6845|2006-10-11/peg_ratio|0.7743|2006-10-25/peg_ratio|0.7991|2006-11-08/peg_ratio|0.7586|2006-11-22/peg_ratio|0.7341|2006-10-11/dividend_yield|3.0204|2006-10-25/dividend_yield|2.9268|2006-11-08/dividend_yield|3.2616|2006-11-22/dividend_yield|3.3704|2006-10-10/percent_of_shares_outstanding|0.0959|2006-11-10/percent_of_shares_outstanding|0.1407|2006-10-31/price|53.25|2006-11-30/price|53.13|2006-10-31/total_return_price|26.2466|2006-11-30/total_return_price|26.4108|2006-10-11/enterprise_value|161769.34|2006-10-25/enterprise_value|166805.0409|2006-11-08/enterprise_value|158346.7218|2006-11-22/enterprise_value|153376.6236
adr_usa_0212|GSK|200612|21520.1073|5951.5407|4771.0285|13567.3936|7931.7224|31139.1325|14223.1226|16916.0099||18375.4068|13636.3651||3.719|15.8464|29.7525|3.1374|3.5912|15.5422|8.7835|0.7447|0.5746|3.3227|4.5582|0.1419|2830.9203|0.8015|0.4526|11412.6871|8644.3295|3704.7521|3274.3359|2261.5809||52.76|26.2269|155073.5941|54.13|2007-01-03/ev_revenues|3.7382|2007-01-17/ev_revenues|3.8337|2007-01-31/ev_revenues|3.7558|2007-02-14/ev_revenues|4.0406|2007-02-28/ev_revenues|3.8922|2007-01-03/ev_free_cash_flow|31.3667|2007-01-17/ev_free_cash_flow|32.168|2007-01-31/ev_free_cash_flow|31.5141|2007-02-14/ev_free_cash_flow|33.904|2007-02-28/ev_free_cash_flow|32.6587|2007-01-03/ps_ratio|3.5865|2007-01-17/ps_ratio|3.6811|2007-01-31/ps_ratio|3.6078|2007-02-14/ps_ratio|3.8904|2007-02-28/ps_ratio|3.7418|2007-01-03/pe_ratio|15.4452|2007-01-17/pe_ratio|15.8528|2007-01-31/pe_ratio|15.537|2007-02-14/pe_ratio|16.7541|2007-02-28/pe_ratio|16.114|2007-01-03/price_to_book_value|8.4276|2007-01-17/price_to_book_value|8.65|2007-01-31/price_to_book_value|8.4685|2007-02-14/price_to_book_value|9.1318|2007-02-28/price_to_book_value|8.7862|2007-01-03/peg_ratio|0.9135|2007-01-17/peg_ratio|0.9376|2007-01-31/peg_ratio|0.9189|2007-02-14/peg_ratio|0.9909|2007-02-28/peg_ratio|0.953|2007-01-03/dividend_yield|3.2289|2007-01-17/dividend_yield|3.1459|2007-01-31/dividend_yield|3.2098|2007-02-14/dividend_yield|3.0865|2007-02-28/dividend_yield|3.2091|2007-01-09/percent_of_shares_outstanding|0.1498|2007-02-12/percent_of_shares_outstanding|0.1918|2007-01-31/price|54.13|2007-02-28/price|56.14|2007-01-31/total_return_price|26.9079|2007-02-28/total_return_price|28.1759|2007-01-03/enterprise_value|159978.9259|2007-01-17/enterprise_value|164065.5503|2007-01-31/enterprise_value|160730.6991|2007-02-14/enterprise_value|172919.7642|2007-02-28/enterprise_value|166568.6266
adr_usa_0212|GSK|200703|21363.3189|5883.423|5025.5058|13874.2527|9145.8696|31904.2878|14643.6234|17260.6644||19549.0995|14171.3754||3.7511|16.088|31.4746|3.1723|3.6018|15.5112|8.4575|0.9174|0.603|3.3338|4.7719|0.1758|2831|1.0438|0.5498|10930.4786|8518.4238|3270.1521|4188.844|2959.3606|-74.2772|55.26|27.7343|160529.3594|57.78|2007-04-11/ev_revenues|3.8248|2007-04-25/ev_revenues|4.0129|2007-05-09/ev_revenues|3.9208|2007-05-23/ev_revenues|3.6531|2007-04-11/ev_free_cash_flow|41.7345|2007-04-25/ev_free_cash_flow|43.7872|2007-05-09/ev_free_cash_flow|42.7821|2007-05-23/ev_free_cash_flow|39.8609|2007-04-11/ps_ratio|3.6542|2007-04-25/ps_ratio|3.8411|2007-05-09/ps_ratio|3.7496|2007-05-23/ps_ratio|3.4837|2007-04-11/pe_ratio|15.5071|2007-04-25/pe_ratio|16.3001|2007-05-09/pe_ratio|15.9119|2007-05-23/pe_ratio|14.7835|2007-04-11/price_to_book_value|8.1954|2007-04-25/price_to_book_value|8.6144|2007-05-09/price_to_book_value|8.4092|2007-05-23/price_to_book_value|7.8129|2007-04-11/peg_ratio|0.9638|2007-04-25/peg_ratio|1.0131|2007-05-09/peg_ratio|0.989|2007-05-23/peg_ratio|0.9188|2007-04-11/dividend_yield|3.2211|2007-04-25/dividend_yield|3.0644|2007-05-09/dividend_yield|3.2916|2007-05-23/dividend_yield|3.5429|2007-04-10/percent_of_shares_outstanding|0.163|2007-05-10/percent_of_shares_outstanding|0.1451|2007-04-30/price|57.78|2007-05-31/price|52.18|2007-04-30/total_return_price|28.999|2007-05-31/total_return_price|26.4092|2007-04-11/enterprise_value|166563.7799|2007-04-25/enterprise_value|174756.2785|2007-05-09/enterprise_value|170744.5871|2007-05-23/enterprise_value|159086.1291
adr_usa_0212|GSK|200706|22034.6946|5855.0364|5537.7882|14486.9985|9324.6876|31702.7331|14470.9353|17231.7978||21677.2884|15701.778||3.5857|14.9131|39.1254|2.8997|3.4236|14.5284|7.6627|0.903|0.5741|3.6051|5.308|0.2708|2815|0.9413|0.4773|11267.4204|8860.6327|3655.8549|3765.0739|2647.0693|-45.6734|52.37|26.5053|156150.8644|51.08|2007-07-05/ev_revenues|3.5188|2007-07-19/ev_revenues|3.5742|2007-08-02/ev_revenues|3.5007|2007-08-16/ev_revenues|3.368|2007-08-30/ev_revenues|3.4595|2007-07-05/ev_free_cash_flow|37.0694|2007-07-19/ev_free_cash_flow|37.6533|2007-08-02/ev_free_cash_flow|36.8788|2007-08-16/ev_free_cash_flow|35.481|2007-08-30/ev_free_cash_flow|36.4446|2007-07-05/ps_ratio|3.3412|2007-07-19/ps_ratio|3.3964|2007-08-02/ps_ratio|3.3252|2007-08-16/ps_ratio|3.1931|2007-08-30/ps_ratio|3.2842|2007-07-05/pe_ratio|14.0595|2007-07-19/pe_ratio|14.2915|2007-08-02/pe_ratio|13.992|2007-08-16/pe_ratio|13.4362|2007-08-30/pe_ratio|13.8194|2007-07-05/price_to_book_value|6.8455|2007-07-19/price_to_book_value|6.9585|2007-08-02/price_to_book_value|6.8086|2007-08-16/price_to_book_value|6.5382|2007-08-30/price_to_book_value|6.7246|2007-07-05/peg_ratio|0.8882|2007-07-19/peg_ratio|0.9029|2007-08-02/peg_ratio|0.884|2007-08-16/peg_ratio|0.8488|2007-08-30/peg_ratio|0.873|2007-07-05/dividend_yield|3.6251|2007-07-19/dividend_yield|3.5663|2007-08-02/dividend_yield|3.8131|2007-08-16/dividend_yield|3.9708|2007-08-30/dividend_yield|3.8607|2007-07-10/percent_of_shares_outstanding|0.2732|2007-08-10/percent_of_shares_outstanding|0.3571|2007-07-31/price|51.08|2007-08-31/price|52.22|2007-07-31/total_return_price|25.8524|2007-08-31/total_return_price|26.6879|2007-07-05/enterprise_value|155473.6864|2007-07-19/enterprise_value|157922.6784|2007-08-02/enterprise_value|154674.4898|2007-08-16/enterprise_value|148811.7669|2007-08-30/enterprise_value|152853.0613
adr_usa_0212|GSK|200709|23270.8445|6408.1211|6062.5652|15261.7154|9622.4053|35796.738|18461.6866|17335.0514||20199.6901|13940.8328||3.5577|14.9696|37.479|2.7826|3.4098|14.3482|6.9247|0.9065|0.6963|3.7184|6.2392|0.2772|2798.7744|0.9462|0.4914|11068.3532|8578.196|3267.8372|3803.4186|2648.2623||53.2|27.1887|157191.5603|51.25|2007-10-11/ev_revenues|3.4645|2007-10-25/ev_revenues|3.3697|2007-11-08/ev_revenues|3.3479|2007-11-23/ev_revenues|3.3411|2007-10-11/ev_free_cash_flow|17.7551|2007-10-25/ev_free_cash_flow|17.2694|2007-11-08/ev_free_cash_flow|17.1579|2007-11-23/ev_free_cash_flow|17.1228|2007-10-11/ps_ratio|3.2972|2007-10-25/ps_ratio|3.202|2007-11-08/ps_ratio|3.2114|2007-11-23/ps_ratio|3.2045|2007-10-11/pe_ratio|14.0002|2007-10-25/pe_ratio|13.5957|2007-11-08/pe_ratio|13.6359|2007-11-23/pe_ratio|13.6064|2007-10-11/price_to_book_value|7.2552|2007-10-25/price_to_book_value|7.0455|2007-11-08/price_to_book_value|6.9974|2007-11-23/price_to_book_value|6.9823|2007-10-11/peg_ratio|1.2785|2007-10-25/peg_ratio|1.2416|2007-11-08/peg_ratio|1.2452|2007-11-23/peg_ratio|1.2425|2007-10-11/dividend_yield|3.7839|2007-10-25/dividend_yield|3.8965|2007-11-08/dividend_yield|4.0464|2007-11-23/dividend_yield|4.0552|2007-10-10/percent_of_shares_outstanding|0.278|2007-10-26/percent_of_shares_outstanding|0.3504|2007-11-09/percent_of_shares_outstanding|0.3087|2007-11-27/percent_of_shares_outstanding|0.2635|2007-10-31/price|51.25|2007-11-30/price|52.68|2007-10-31/total_return_price|26.4675|2007-11-30/total_return_price|27.206|2007-10-11/enterprise_value|154788.4441|2007-10-25/enterprise_value|150553.9616|2007-11-08/enterprise_value|149581.6762|2007-11-23/enterprise_value|149276.2142
adr_usa_0212|GSK|200712|27090.3295|9010.4139|6088.0633|15548.1466|11583.244|41936.431|20567.6191|21368.8119||19090.42|12873.1643||3.3299|14.5041|17.0657|2.4536|3.2121|13.6385|6.9576|1.2455|1.0922|4.0456|7.2125|0.3534|2667.4235|0.8322|0.5236|12259.7251|9126.0519|3460.2977|3303.1494|2172.3593||50.39|26.0233|148778.3397|47.38|2008-01-04/ev_revenues|3.3159|2008-01-18/ev_revenues|3.3244|2008-02-01/ev_revenues|3.1187|2008-02-15/ev_revenues|2.9481|2008-02-29/ev_revenues|2.9156|2008-01-04/ev_free_cash_flow|18.7555|2008-01-18/ev_free_cash_flow|18.8034|2008-02-01/ev_free_cash_flow|17.6404|2008-02-15/ev_free_cash_flow|16.675|2008-02-29/ev_free_cash_flow|16.4912|2008-01-04/ps_ratio|3.0688|2008-01-18/ps_ratio|3.0773|2008-02-01/ps_ratio|2.8686|2008-02-15/ps_ratio|2.6965|2008-02-29/ps_ratio|2.6794|2008-01-04/pe_ratio|13.3628|2008-01-18/pe_ratio|13.4|2008-02-01/pe_ratio|12.4912|2008-02-15/pe_ratio|11.7419|2008-02-29/pe_ratio|11.6675|2008-01-04/price_to_book_value|7.2554|2008-01-18/price_to_book_value|7.2756|2008-02-01/price_to_book_value|6.7852|2008-02-15/price_to_book_value|6.3782|2008-02-29/price_to_book_value|6.3007|2008-01-04/peg_ratio|1.6656|2008-01-18/peg_ratio|1.6703|2008-02-01/peg_ratio|1.557|2008-02-15/peg_ratio|1.4636|2008-02-29/peg_ratio|1.4543|2008-01-04/dividend_yield|4.0955|2008-01-18/dividend_yield|4.0841|2008-02-01/dividend_yield|4.3812|2008-02-15/dividend_yield|4.832|2008-02-29/dividend_yield|4.8628|2008-01-15/percent_of_shares_outstanding|0.3679|2008-01-31/percent_of_shares_outstanding|0.2996|2008-02-15/percent_of_shares_outstanding|0.2644|2008-02-29/percent_of_shares_outstanding|0.25|2008-01-31/price|47.38|2008-02-29/price|43.91|2008-01-31/total_return_price|24.4689|2008-02-29/total_return_price|23.0042|2008-01-04/enterprise_value|150959.0772|2008-01-18/enterprise_value|151344.6647|2008-02-01/enterprise_value|141983.8072|2008-02-15/enterprise_value|134213.4641|2008-02-29/enterprise_value|132734.3223
adr_usa_0212|GSK|200803|24862.9654|6689.3736|6574.3132|15921.9788|11633.0032|41949.4348|18407.6802|23541.7546||17687.5608|11341.3846||2.8175|12.7877|15.9364|2.1346|2.58|11.2344|6.0668|1.4003|1.1118|5.0503|10.1459|0.2406|2700.4132|0.9571|0.6245|11244.0787|8556.6529|3450.7417|3705.8395|2584.5957|-174.0202|42.43|22.2288|128269.2215|44.11|2008-04-11/ev_revenues|2.8113|2008-04-25/ev_revenues|2.9633|2008-05-09/ev_revenues|2.8731|2008-05-23/ev_revenues|2.9078|2008-04-11/ev_free_cash_flow|13.7379|2008-04-25/ev_free_cash_flow|14.4804|2008-05-09/ev_free_cash_flow|14.0399|2008-05-23/ev_free_cash_flow|14.2091|2008-04-11/ps_ratio|2.5484|2008-04-25/ps_ratio|2.7023|2008-05-09/ps_ratio|2.6292|2008-05-23/ps_ratio|2.6646|2008-04-11/pe_ratio|11.5727|2008-04-25/pe_ratio|12.2717|2008-05-09/pe_ratio|11.9399|2008-05-23/pe_ratio|12.1003|2008-04-11/price_to_book_value|6.5193|2008-04-25/price_to_book_value|6.9131|2008-05-09/price_to_book_value|6.6795|2008-05-23/price_to_book_value|6.7692|2008-04-11/peg_ratio|5.9605|2008-04-25/peg_ratio|6.3205|2008-05-09/peg_ratio|6.1496|2008-05-23/peg_ratio|6.2323|2008-04-11/dividend_yield|5.0182|2008-04-25/dividend_yield|4.7324|2008-05-09/dividend_yield|4.9503|2008-05-23/dividend_yield|4.8846|2008-04-15/percent_of_shares_outstanding|0.2265|2008-04-30/percent_of_shares_outstanding|0.2763|2008-05-15/percent_of_shares_outstanding|0.3047|2008-05-30/percent_of_shares_outstanding|0.3279|2008-04-30/price|44.11|2008-05-30/price|44.53|2008-04-30/total_return_price|23.3819|2008-05-30/total_return_price|23.6046|2008-04-11/enterprise_value|128870.5814|2008-04-25/enterprise_value|135835.3303|2008-05-09/enterprise_value|131702.8784|2008-05-23/enterprise_value|133290.6854
adr_usa_0212|GSK|200806|29250.8433|10722.7187|7024.2675|16124.9284|12506.1852|49448.8505|16471.6582|32977.1923||14821.7026|8478.9385||2.8221|13.5055|13.7905|2.0717|2.5945|11.7821|6.5472|6.0684|1.845|5.0166|10.3376|0.3327|2636|0.9622|0.5156|11582.46|8599.0991|3541.3855|3620.2582|2535.7582|-232.6745|44.22|23.4402|129363.328|46.56|2008-07-07/ev_revenues|3.0012|2008-07-21/ev_revenues|3.1481|2008-08-04/ev_revenues|3.0662|2008-08-18/ev_revenues|3.0372|2008-07-07/ev_free_cash_flow|14.6198|2008-07-21/ev_free_cash_flow|15.3353|2008-08-04/ev_free_cash_flow|14.936|2008-08-18/ev_free_cash_flow|14.7949|2008-07-07/ps_ratio|2.6817|2008-07-21/ps_ratio|2.8315|2008-08-04/ps_ratio|2.777|2008-08-18/ps_ratio|2.7472|2008-07-07/pe_ratio|12.3941|2008-07-21/pe_ratio|13.0864|2008-08-04/pe_ratio|12.8349|2008-08-18/pe_ratio|12.697|2008-07-07/price_to_book_value|8.1881|2008-07-21/price_to_book_value|8.6455|2008-08-04/price_to_book_value|8.3903|2008-08-18/price_to_book_value|8.3001|2008-07-07/peg_ratio||2008-07-21/peg_ratio||2008-08-04/peg_ratio||2008-08-18/peg_ratio||2008-07-07/dividend_yield|4.7418|2008-07-21/dividend_yield|4.491|2008-08-04/dividend_yield|4.6304|2008-08-18/dividend_yield|4.6807|2008-07-15/percent_of_shares_outstanding|0.3529|2008-07-31/percent_of_shares_outstanding|0.4147|2008-08-15/percent_of_shares_outstanding|0.3452|2008-08-29/percent_of_shares_outstanding|0.3283|2008-07-31/price|46.56|2008-08-29/price|46.97|2008-07-31/total_return_price|24.9571|2008-08-29/total_return_price|25.1769|2008-07-07/enterprise_value|138521.329|2008-07-21/enterprise_value|145300.4519|2008-08-04/enterprise_value|141517.1064|2008-08-18/enterprise_value|140180.7692
adr_usa_0212|GSK|200809|26642.0464|9886.0984|6262.324|14956.532|11920.6856|46433.8408|15674.5168|30759.324||13337.0576|7302.7784||2.7996|14.0084|14.9648|2.1443|2.4871|12.3899|8.5035||1.8953|5.0566|10.6249|0.2791|2573|0.7562|0.4949|11119.8099|8113.9449|3438.7851|2935.9172|1941.5241|-226.8577|43.46|23.2955|129356.4499|38.7|2008-10-14/ev_revenues|2.5194|2008-10-28/ev_revenues|2.4957|2008-11-11/ev_revenues|2.4899|2008-11-25/ev_revenues|2.2866|2008-10-14/ev_free_cash_flow|13.4674|2008-10-28/ev_free_cash_flow|13.3406|2008-11-11/ev_free_cash_flow|13.3094|2008-11-25/ev_free_cash_flow|12.223|2008-10-14/ps_ratio|2.2032|2008-10-28/ps_ratio|2.1792|2008-11-11/ps_ratio|2.174|2008-11-25/ps_ratio|1.968|2008-10-14/pe_ratio|10.9758|2008-10-28/pe_ratio|10.8561|2008-11-11/pe_ratio|10.8304|2008-11-25/pe_ratio|9.8041|2008-10-14/price_to_book_value|7.533|2008-10-28/price_to_book_value|7.4508|2008-11-11/price_to_book_value|7.4306|2008-11-25/price_to_book_value|6.7264|2008-10-14/peg_ratio||2008-10-28/peg_ratio||2008-11-11/peg_ratio||2008-11-25/peg_ratio||2008-10-14/dividend_yield|5.708|2008-10-28/dividend_yield|5.771|2008-11-11/dividend_yield|5.6325|2008-11-25/dividend_yield|6.2221|2008-10-15/percent_of_shares_outstanding|0.2002|2008-10-31/percent_of_shares_outstanding|0.2333|2008-11-14/percent_of_shares_outstanding|0.1892|2008-11-28/percent_of_shares_outstanding|0.1592|2008-10-31/price|38.7|2008-11-28/price|34.44|2008-10-31/total_return_price|21.0059|2008-11-28/total_return_price|18.6936|2008-10-14/enterprise_value|116413.072|2008-10-28/enterprise_value|115317.0602|2008-11-11/enterprise_value|115047.1243|2008-11-25/enterprise_value|105656.061
adr_usa_0212|GSK|200812|25293.9043|10062.489|5940.8232|14175.3666|11673.659|45515.5525|14671.8999|30843.6526||11616.5357|6769.8434||2.3626|12.8947|12.6291|1.9216|2.051|10.2175|6.9896||2.041|5.9704|10.7368|0.1449|2550|0.6071|0.4573|10812.8214|7756.7519|3592.7986|2184.4716|1536.6412|-319.2208|37.27|20.2297|109166.6294|35.26|2009-01-06/ev_revenues|2.5055|2009-01-20/ev_revenues|2.3839|2009-02-03/ev_revenues|2.4243|2009-02-17/ev_revenues|2.2545|2009-01-06/ev_free_cash_flow|11.8071|2009-01-20/ev_free_cash_flow|11.2337|2009-02-03/ev_free_cash_flow|11.4241|2009-02-17/ev_free_cash_flow|10.6239|2009-01-06/ps_ratio|2.206|2009-01-20/ps_ratio|2.0833|2009-02-03/ps_ratio|2.1236|2009-02-17/ps_ratio|1.9524|2009-01-06/pe_ratio|11.5027|2009-01-20/pe_ratio|10.863|2009-02-03/pe_ratio|11.0732|2009-02-17/pe_ratio|10.1807|2009-01-06/price_to_book_value|8.4305|2009-01-20/price_to_book_value|7.9616|2009-02-03/price_to_book_value|8.1173|2009-02-17/price_to_book_value|7.463|2009-01-06/peg_ratio||2009-01-20/peg_ratio||2009-02-03/peg_ratio||2009-02-17/peg_ratio||2009-01-06/dividend_yield|5.6668|2009-01-20/dividend_yield|6.0005|2009-02-03/dividend_yield|5.8866|2009-02-17/dividend_yield|6.0056|2009-01-15/percent_of_shares_outstanding|0.1828|2009-01-30/percent_of_shares_outstanding|0.132|2009-02-13/percent_of_shares_outstanding|0.1596|2009-02-27/percent_of_shares_outstanding|0.1564|2009-01-30/price|35.26|2009-02-27/price|30.13|2009-01-30/total_return_price|19.1387|2009-02-27/total_return_price|16.5796|2009-01-06/enterprise_value|112146.3122|2009-01-20/enterprise_value|106699.8341|2009-02-03/enterprise_value|108508.7075|2009-02-17/enterprise_value|100908.0168
adr_usa_0212|GSK|200903|24340.8582|9816.9678|5891.9022|13544.0586|11912.9184|44089.5618|13981.6116|30107.9502||11565.7452|6626.4174||2.1927|12.4119|9.63|1.6875|1.8524|10.4835|6.969||2.032|6.7397|11.9098|0.1496|2554|0.6381|0.4978|9728.4815|7160.1854|3161.8643|2394.3936|1625.4857|-251.5119|31.07|17.0969|94819.7355|30.76|2009-04-14/ev_revenues|2.1339|2009-04-28/ev_revenues|2.1633|2009-05-12/ev_revenues|2.2485|2009-05-26/ev_revenues|2.3547|2009-04-06/ev_free_cash_flow|10.9424|2009-04-20/ev_free_cash_flow|10.8478|2009-05-04/ev_free_cash_flow|11.1226|2009-05-18/ev_free_cash_flow|11.5653|2009-04-14/ps_ratio|1.794|2009-04-28/ps_ratio|1.8232|2009-05-12/ps_ratio|1.9079|2009-05-26/ps_ratio|2.0134|2009-04-14/pe_ratio|10.1528|2009-04-28/pe_ratio|10.3182|2009-05-12/pe_ratio|10.7973|2009-05-26/pe_ratio|11.3945|2009-04-14/price_to_book_value|6.7492|2009-04-28/price_to_book_value|6.8591|2009-05-12/price_to_book_value|7.1776|2009-05-26/price_to_book_value|7.5746|2009-04-14/peg_ratio||2009-04-28/peg_ratio||2009-05-12/peg_ratio||2009-05-26/peg_ratio||2009-04-06/dividend_yield|6.6109|2009-04-20/dividend_yield|6.6791|2009-05-04/dividend_yield|6.1318|2009-05-18/dividend_yield|5.8573|2009-04-15/percent_of_shares_outstanding|0.1472|2009-04-30/percent_of_shares_outstanding|0.2192|2009-05-15/percent_of_shares_outstanding|0.178|2009-05-29/percent_of_shares_outstanding|0.1874|2009-04-30/price|30.76|2009-05-29/price|33.71|2009-04-30/total_return_price|17.1559|2009-05-29/total_return_price|18.8012|2009-04-14/enterprise_value|92277.4315|2009-04-28/enterprise_value|93548.5835|2009-05-12/enterprise_value|97232.3974|2009-05-26/enterprise_value|101824.1135
adr_usa_0212|GSK|200906|25104.4287|9744.4497|6437.033|14610.9125|12844.4326|45981.159|14872.6742|31108.4848||12704.4971|7008.2991||2.5124|14.4435|12.5026|1.789|2.1702|12.2819|8.1645||1.8468|5.3504|6.9373|0.2059|2553.5|0.8731|0.4298|10481.9556|7853.3104|3560.7888|3203.4671|2229.3769|-233.0359|35.34|19.7103|108646.9494|38.29|2009-07-07/ev_revenues|2.4529|2009-07-21/ev_revenues|2.6856|2009-08-04/ev_revenues|2.7361|2009-08-18/ev_revenues|2.7287|2009-07-13/ev_free_cash_flow|12.1287|2009-07-27/ev_free_cash_flow|12.8724|2009-08-10/ev_free_cash_flow|12.9455|2009-08-24/ev_free_cash_flow|13.103|2009-07-07/ps_ratio|2.0853|2009-07-21/ps_ratio|2.3147|2009-08-04/ps_ratio|2.3644|2009-08-18/ps_ratio|2.3572|2009-07-07/pe_ratio|11.9531|2009-07-21/pe_ratio|13.2681|2009-08-04/pe_ratio|13.5533|2009-08-18/pe_ratio|13.5116|2009-07-07/price_to_book_value|7.0161|2009-07-21/price_to_book_value|7.788|2009-08-04/price_to_book_value|7.9555|2009-08-18/price_to_book_value|7.931|2009-07-07/peg_ratio||2009-07-21/peg_ratio||2009-08-04/peg_ratio||2009-08-18/peg_ratio||2009-07-13/dividend_yield|5.257|2009-07-27/dividend_yield|4.9102|2009-08-10/dividend_yield|4.729|2009-08-24/dividend_yield|4.6643|2009-07-15/percent_of_shares_outstanding|0.1805|2009-07-31/percent_of_shares_outstanding|0.1986|2009-08-14/percent_of_shares_outstanding|0.1883|2009-08-31/percent_of_shares_outstanding|0.1961|2009-07-31/price|38.29|2009-08-31/price|39.1|2009-07-31/total_return_price|21.6131|2009-08-31/total_return_price|22.0703|2009-07-07/enterprise_value|103372.1719|2009-07-21/enterprise_value|113178.2373|2009-08-04/enterprise_value|115306.4998|2009-08-18/enterprise_value|114995.193
adr_usa_0212|GSK|200909|27743.8659|11245.6971|6708.3807|15007.062|16886.9445|50897.6187|17790.888|33106.7307||14847.072|9121.0299||2.7774|15.6829|13.1498|1.793|2.4051|13.7864|8.0925||1.8234|4.6455|5.3146|0.1608|2554|0.8562|0.4525|11084.7353|8161.8294|3519.9529|3137.7773|2189.7191|-295.243|39.51|22.3018|117046.6308|41.16|2009-10-13/ev_revenues|2.8347|2009-10-27/ev_revenues|2.9074|2009-11-10/ev_revenues|2.9371|2009-11-24/ev_revenues|2.9944|2009-10-06/ev_free_cash_flow|12.4756|2009-10-20/ev_free_cash_flow|13.116|2009-11-03/ev_free_cash_flow|12.7993|2009-11-17/ev_free_cash_flow|13.1798|2009-10-13/ps_ratio|2.4063|2009-10-27/ps_ratio|2.4778|2009-11-10/ps_ratio|2.5069|2009-11-24/ps_ratio|2.5633|2009-10-13/pe_ratio|13.3431|2009-10-27/pe_ratio|13.7398|2009-11-10/pe_ratio|13.9011|2009-11-24/pe_ratio|14.2138|2009-10-13/price_to_book_value|6.9354|2009-10-27/price_to_book_value|7.1416|2009-11-10/price_to_book_value|7.226|2009-11-24/price_to_book_value|7.3885|2009-10-13/peg_ratio||2009-10-27/peg_ratio||2009-11-10/peg_ratio||2009-11-24/peg_ratio||2009-10-06/dividend_yield|4.6857|2009-10-20/dividend_yield|4.4221|2009-11-03/dividend_yield|4.549|2009-11-17/dividend_yield|4.4342|2009-10-15/percent_of_shares_outstanding|0.1689|2009-10-30/percent_of_shares_outstanding|0.1802|2009-11-13/percent_of_shares_outstanding|0.1707|2009-11-30/percent_of_shares_outstanding|0.1916|2009-10-30/price|41.16|2009-11-30/price|41.47|2009-10-30/total_return_price|23.2331|2009-11-30/total_return_price|23.6952|2009-10-13/enterprise_value|119362.4976|2009-10-27/enterprise_value|122423.8356|2009-11-10/enterprise_value|123676.916|2009-11-24/enterprise_value|126089.8408
adr_usa_0212|GSK|200912|28412.447|11225.9082|6571.8944|15158.6954|18667.8024|51941.252|19596.0178|32345.2342||16179.0855|10221.6891||2.9964|14.4609|13.3502|1.8166|2.5651|14.2239|7.3942||1.6249|4.3694|4.207|0.1425|2555.5|1.0389|0.4867|13221.4325|9760.0765|4825.3165|3675.3426|2662.5815|-339.765|42.25|24.1409|126174.2266|39.01|2010-01-05/ev_revenues|2.804|2010-01-19/ev_revenues|2.8209|2010-02-02/ev_revenues|2.6677|2010-02-16/ev_revenues|2.6537|2010-01-12/ev_free_cash_flow|13.3196|2010-01-26/ev_free_cash_flow|13.0669|2010-02-09/ev_free_cash_flow|12.4207|2010-02-23/ev_free_cash_flow|12.1292|2010-01-05/ps_ratio|2.4001|2010-01-19/ps_ratio|2.4167|2010-02-02/ps_ratio|2.2658|2010-02-16/ps_ratio|2.2521|2010-01-05/pe_ratio|12.2801|2010-01-19/pe_ratio|12.3652|2010-02-02/pe_ratio|11.5931|2010-02-16/pe_ratio|11.5227|2010-01-05/price_to_book_value|6.7104|2010-01-19/price_to_book_value|6.7569|2010-02-02/price_to_book_value|6.3355|2010-02-16/price_to_book_value|6.297|2010-01-05/peg_ratio|3.2605|2010-01-19/peg_ratio|3.2831|2010-02-02/peg_ratio|3.0781|2010-02-16/peg_ratio|3.0594|2010-01-12/dividend_yield|4.447|2010-01-26/dividend_yield|4.5461|2010-02-09/dividend_yield|4.8215|2010-02-23/dividend_yield|5.1682|2010-01-15/percent_of_shares_outstanding|0.1396|2010-01-29/percent_of_shares_outstanding|0.1274|2010-02-12/percent_of_shares_outstanding|0.1416|2010-02-26/percent_of_shares_outstanding|0.1322|2010-01-29/price|39.01|2010-02-26/price|37.14|2010-01-29/total_return_price|22.2896|2010-02-26/total_return_price|21.5424|2010-01-05/enterprise_value|124823.478|2010-01-19/enterprise_value|125576.1635|2010-02-02/enterprise_value|118757.4617|2010-02-16/enterprise_value|118134.5048
adr_usa_0212|GSK|201003|27864.408|11088.99|6310.326|14469.576|18118.848|50292.858|18448.254|31844.604||16197.06|10355.796||2.5943|12.5104|12.5627|1.6963|2.1935|11.2232|6.1335|2.9799|1.5233|4.9614|4.8348|0.1421|2562|0.814|0.5893|11472.058|8428.228|3664.447|3011.0839|2089.5144|-293.1558|38.52|22.3428|115490.2676|37.29|2010-04-13/ev_revenues|2.5346|2010-04-27/ev_revenues|2.4263|2010-05-11/ev_revenues|2.3035|2010-05-25/ev_revenues|2.166|2010-04-06/ev_free_cash_flow|11.292|2010-04-20/ev_free_cash_flow|11.4675|2010-05-04/ev_free_cash_flow|10.8374|2010-05-18/ev_free_cash_flow|10.0009|2010-04-13/ps_ratio|2.1821|2010-04-27/ps_ratio|2.0755|2010-05-11/ps_ratio|1.9545|2010-05-25/ps_ratio|1.8191|2010-04-13/pe_ratio|11.024|2010-04-27/pe_ratio|10.4852|2010-05-11/pe_ratio|9.8739|2010-05-25/pe_ratio|9.1899|2010-04-13/price_to_book_value|6.3296|2010-04-27/price_to_book_value|6.0203|2010-05-11/price_to_book_value|5.6695|2010-05-25/price_to_book_value|5.2768|2010-04-13/peg_ratio|0.5283|2010-04-27/peg_ratio|0.5024|2010-05-11/peg_ratio|0.4731|2010-05-25/peg_ratio|0.4404|2010-04-06/dividend_yield|4.9921|2010-04-20/dividend_yield|4.9048|2010-05-04/dividend_yield|5.234|2010-05-18/dividend_yield|5.8971|2010-04-15/percent_of_shares_outstanding|0.1266|2010-04-30/percent_of_shares_outstanding|0.2043|2010-05-14/percent_of_shares_outstanding|0.0857|2010-05-28/percent_of_shares_outstanding|0.1148|2010-04-30/price|37.29|2010-05-28/price|33.46|2010-04-30/total_return_price|21.6294|2010-05-28/total_return_price|19.6527|2010-04-13/enterprise_value|117253.107|2010-04-27/enterprise_value|112242.5887|2010-05-11/enterprise_value|106561.3686|2010-05-25/enterprise_value|100200.5688
adr_usa_0212|GSK|201006|25519.4418|10359.2886|6081.394|13716.756|17815.3466|50069.1478|17933.3884|32135.7594||13102.6398|7342.4988||2.2861|15.7139|10.0442|1.585|1.9373|9.7873|5.6199|0.469|1.7449|5.8675|5.9842|0.11|2563|-0.1789|0.447|10471.8859|8001.8624|6263.7529|-144.594|-453.1606|-253.4122|34.01|19.9757|105757.4372|35.17|2010-07-06/ev_revenues|2.2113|2010-07-20/ev_revenues|2.3371|2010-08-03/ev_revenues|2.3331|2010-08-17/ev_revenues|2.4353|2010-08-31/ev_revenues|2.395|2010-07-13/ev_free_cash_flow|10.087|2010-07-27/ev_free_cash_flow|10.2101|2010-08-10/ev_free_cash_flow|10.5006|2010-08-24/ev_free_cash_flow|10.4465|2010-07-06/ps_ratio|1.8881|2010-07-20/ps_ratio|2.012|2010-08-03/ps_ratio|2.0082|2010-08-17/ps_ratio|2.1089|2010-08-31/ps_ratio|2.069|2010-07-06/pe_ratio|13.4891|2010-07-20/pe_ratio|14.3744|2010-08-03/pe_ratio|14.3467|2010-08-17/pe_ratio|15.066|2010-08-31/pe_ratio|14.7815|2010-07-06/price_to_book_value|6.7629|2010-07-20/price_to_book_value|7.2068|2010-08-03/price_to_book_value|7.193|2010-08-17/price_to_book_value|7.5536|2010-08-31/price_to_book_value|7.4111|2010-07-06/peg_ratio||2010-07-20/peg_ratio||2010-08-03/peg_ratio||2010-08-17/peg_ratio||2010-08-31/peg_ratio||2010-07-13/dividend_yield|5.557|2010-07-27/dividend_yield|5.4803|2010-08-10/dividend_yield|5.2976|2010-08-24/dividend_yield|5.3289|2010-07-15/percent_of_shares_outstanding|0.1249|2010-07-30/percent_of_shares_outstanding|0.1337|2010-08-13/percent_of_shares_outstanding|0.0977|2010-08-31/percent_of_shares_outstanding|0.1116|2010-07-30/price|35.17|2010-08-31/price|37.4|2010-07-30/total_return_price|20.9212|2010-08-31/total_return_price|22.2477|2010-07-06/enterprise_value|102273.4968|2010-07-20/enterprise_value|108089.2289|2010-08-03/enterprise_value|107908.4238|2010-08-17/enterprise_value|112633.7532|2010-08-31/enterprise_value|110766.8568
adr_usa_0212|GSK|201009|26521.1849|10518.138|6434.0682|14453.7536|18719.4429|50592.8755|17756.0699|32836.8056||15491.3537|9221.5327||2.5454|18.6592|11.227|1.7437|2.2173|15.8407|7.9422||1.5534|4.9103|4.8783|0.1655|2563|0.7776|0.4512|10553.6965|7601.2019|3160.0677|2786.7459|1995.18|-271.0842|39.52|23.5088|117725.2107|39.04|2010-10-12/ev_revenues|2.679|2010-10-26/ev_revenues|2.6057|2010-11-09/ev_revenues|2.5745|2010-11-23/ev_revenues|2.5404|2010-10-05/ev_free_cash_flow|13.9121|2010-10-19/ev_free_cash_flow|13.9633|2010-11-02/ev_free_cash_flow|13.4638|2010-11-16/ev_free_cash_flow|13.3104|2010-11-30/ev_free_cash_flow|13.2325|2010-10-12/ps_ratio|2.3223|2010-10-26/ps_ratio|2.2501|2010-11-09/ps_ratio|2.2187|2010-11-23/ps_ratio|2.1851|2010-10-12/pe_ratio|16.9113|2010-10-26/pe_ratio|16.3851|2010-11-09/pe_ratio|16.1567|2010-11-23/pe_ratio|15.9119|2010-10-12/price_to_book_value|6.95|2010-10-26/price_to_book_value|6.7338|2010-11-09/price_to_book_value|6.6415|2010-11-23/price_to_book_value|6.5409|2010-10-12/peg_ratio||2010-10-26/peg_ratio||2010-11-09/peg_ratio||2010-11-23/peg_ratio||2010-10-05/dividend_yield|4.8861|2010-10-19/dividend_yield|4.8657|2010-11-02/dividend_yield|5.1181|2010-11-16/dividend_yield|5.1859|2010-11-30/dividend_yield|5.2211|2010-10-15/percent_of_shares_outstanding|0.2029|2010-10-29/percent_of_shares_outstanding|0.1744|2010-11-15/percent_of_shares_outstanding|0.1495|2010-11-30/percent_of_shares_outstanding|0.1646|2010-10-29/price|39.04|2010-11-30/price|38.28|2010-10-29/total_return_price|23.5204|2010-11-30/total_return_price|23.0625|2010-10-12/enterprise_value|122480.8558|2010-10-26/enterprise_value|119130.918|2010-11-09/enterprise_value|117701.6832|2010-11-23/enterprise_value|116143.1939
adr_usa_0212|GSK|201012|24749.9624|9632.3594|5922.0258|13960.053|18733.7892|50137.349|19746.2596|30391.0894||13716.1958|7375.9086||2.545|45.9935|13.4912|1.7935|2.1896|15.9446|6.5545||1.6991|5.1064|5.7399|0.1469|2564|-0.4297|0.4994|11368.7588|7604.4469|6563.456|-751.9146|-1089.9602|-274.8595|39.22|23.6288|116353.6702|36.33|2011-01-04/ev_revenues|2.7027|2011-01-18/ev_revenues|2.6032|2011-02-01/ev_revenues|2.5565|2011-02-15/ev_revenues|2.6086|2011-01-11/ev_free_cash_flow|14.487|2011-01-25/ev_free_cash_flow|14.0822|2011-02-08/ev_free_cash_flow|14.6148|2011-02-22/ev_free_cash_flow|14.3145|2011-01-04/ps_ratio|2.3289|2011-01-18/ps_ratio|2.2308|2011-02-01/ps_ratio|2.1846|2011-02-15/ps_ratio|2.236|2011-01-04/pe_ratio|40.5471|2011-01-18/pe_ratio|38.8381|2011-02-01/pe_ratio|38.0345|2011-02-15/pe_ratio|38.9297|2011-01-04/price_to_book_value|7.5503|2011-01-18/price_to_book_value|7.2321|2011-02-01/price_to_book_value|7.0827|2011-02-15/price_to_book_value|7.2494|2011-01-04/peg_ratio||2011-01-18/peg_ratio||2011-02-01/peg_ratio||2011-02-15/peg_ratio||2011-01-11/dividend_yield|5.1778|2011-01-25/dividend_yield|5.3497|2011-02-08/dividend_yield|5.126|2011-02-22/dividend_yield|5.3592|2011-01-14/percent_of_shares_outstanding|0.1617|2011-01-31/percent_of_shares_outstanding|0.1312|2011-02-15/percent_of_shares_outstanding|0.227|2011-02-28/percent_of_shares_outstanding|0.1581|2011-01-31/price|36.33|2011-02-28/price|38.61|2011-01-31/total_return_price|21.8877|2011-02-28/total_return_price|23.6343|2011-01-04/enterprise_value|118558.7593|2011-01-18/enterprise_value|114193.8976|2011-02-01/enterprise_value|112145.0038|2011-02-15/enterprise_value|114431.4455
adr_usa_0212|GSK|201103|26999.207|10715.476|6484.245|14495.14|19753.244|52534.437|21069.377|31465.06||14577.097|8010.895||2.5968|39.4313|14.2621|1.6684|2.2284|38.7974|7.2114||1.6632|5.3719|6.0948|0.1452|2569.5|0.9483|0.6123|10548.7245|7549.9071|3332.0193|3947.1613|2442.9468|-278.7362|38.41|23.5118|113910.3214|43.66|2011-04-12/ev_revenues|2.7684|2011-04-26/ev_revenues|2.8576|2011-05-10/ev_revenues|2.9216|2011-05-24/ev_revenues|2.9228|2011-04-05/ev_free_cash_flow|18.5944|2011-04-19/ev_free_cash_flow|19.0248|2011-05-03/ev_free_cash_flow|20.1822|2011-05-17/ev_free_cash_flow|19.9857|2011-05-31/ev_free_cash_flow|20.1302|2011-04-12/ps_ratio|2.4034|2011-04-26/ps_ratio|2.4918|2011-05-10/ps_ratio|2.5593|2011-05-24/ps_ratio|2.5605|2011-04-12/pe_ratio|36.0114|2011-04-26/pe_ratio|37.3359|2011-05-10/pe_ratio|38.3471|2011-05-24/pe_ratio|38.365|2011-04-12/price_to_book_value|7.1376|2011-04-26/price_to_book_value|7.4001|2011-05-10/price_to_book_value|7.5889|2011-05-24/price_to_book_value|7.5924|2011-04-12/peg_ratio||2011-04-26/peg_ratio||2011-05-10/peg_ratio||2011-05-24/peg_ratio||2011-04-05/dividend_yield|5.1495|2011-04-19/dividend_yield|5.0166|2011-05-03/dividend_yield|4.6837|2011-05-17/dividend_yield|4.8892|2011-05-31/dividend_yield|4.8464|2011-04-15/percent_of_shares_outstanding|0.1324|2011-04-29/percent_of_shares_outstanding|0.1495|2011-05-13/percent_of_shares_outstanding|0.1993|2011-05-31/percent_of_shares_outstanding|0.1532|2011-04-29/price|43.66|2011-05-31/price|43.46|2011-04-29/total_return_price|26.7255|2011-05-31/total_return_price|26.9285|2011-04-12/enterprise_value|118885.6196|2011-04-26/enterprise_value|122712.3234|2011-05-10/enterprise_value|125464.5018|2011-05-24/enterprise_value|125516.1348
adr_usa_0212|GSK|201106|26213.4557|9663.0876|6864.7783|14496.2387|19687.8177|52467.0939|21893.0333|30574.0606||13952.9713|7240.8865||2.8389|24.5062|19.4634|1.867|2.4787|37.139|7.3452||1.7588|5.0353|5.9661|0.1389|2560|0.7048|0.5144|10963.28|8118.0478|3662.5839|2597.2532|1804.3732|-306.7108|42.9|26.5815|121912.6868|44.42|2011-07-05/ev_revenues|2.9284|2011-07-19/ev_revenues|2.9053|2011-08-02/ev_revenues|2.9628|2011-08-16/ev_revenues|2.8323|2011-08-30/ev_revenues|2.8523|2011-07-12/ev_free_cash_flow|23.5768|2011-07-26/ev_free_cash_flow|24.2597|2011-08-09/ev_free_cash_flow|22.2767|2011-08-23/ev_free_cash_flow|23.4138|2011-07-05/ps_ratio|2.5538|2011-07-19/ps_ratio|2.5308|2011-08-02/ps_ratio|2.6016|2011-08-16/ps_ratio|2.4706|2011-08-30/ps_ratio|2.4907|2011-07-05/pe_ratio|21.6183|2011-07-19/pe_ratio|21.4234|2011-08-02/pe_ratio|22.0231|2011-08-16/pe_ratio|20.9137|2011-08-30/pe_ratio|21.0836|2011-07-05/price_to_book_value|7.9628|2011-07-19/price_to_book_value|7.891|2011-08-02/price_to_book_value|8.07|2011-08-16/price_to_book_value|7.6635|2011-08-30/price_to_book_value|7.7257|2011-07-05/peg_ratio||2011-07-19/peg_ratio||2011-08-02/peg_ratio||2011-08-16/peg_ratio||2011-08-30/peg_ratio||2011-07-12/dividend_yield|4.8475|2011-07-26/dividend_yield|4.692|2011-08-09/dividend_yield|5.3032|2011-08-23/dividend_yield|5.0083|2011-07-15/percent_of_shares_outstanding|0.1892|2011-07-29/percent_of_shares_outstanding|0.3607|2011-08-15/percent_of_shares_outstanding|0.2187|2011-08-31/percent_of_shares_outstanding|0.2394|2011-07-29/price|44.42|2011-08-31/price|42.83|2011-07-29/total_return_price|27.5233|2011-08-31/total_return_price|26.8557|2011-07-05/enterprise_value|127193.8218|2011-07-19/enterprise_value|126192.184|2011-08-02/enterprise_value|128689.5536|2011-08-16/enterprise_value|123017.3714|2011-08-30/enterprise_value|123886.084
adr_usa_0212|GSK|201109|25564.8835|8708.248|6292.5825|13640.9465|18077.724|51742.6505|20438.807|31303.8435||11607.3585|4907.7465||2.8362|22.4319|22.6722|1.8675|2.4907|21.0836|7.6758||2.0262|5.1632|7.6473|0.2346|2529.5|0.8759|0.5113|11438.7318|8084.723|3241.2961|3125.363|2218.8306|-276.9513|41.29|25.89|123188.8437|44.79|2011-10-11/ev_revenues|2.8382|2011-10-25/ev_revenues|2.8765|2011-11-08/ev_revenues|2.9355|2011-11-22/ev_revenues|2.787|2011-10-04/ev_free_cash_flow|17.7647|2011-10-18/ev_free_cash_flow|18.634|2011-11-01/ev_free_cash_flow|18.8146|2011-11-15/ev_free_cash_flow|19.0918|2011-11-29/ev_free_cash_flow|18.3989|2011-10-11/ps_ratio|2.4993|2011-10-25/ps_ratio|2.5379|2011-11-08/ps_ratio|2.5985|2011-11-22/ps_ratio|2.4485|2011-10-11/pe_ratio|20.644|2011-10-25/pe_ratio|20.9631|2011-11-08/pe_ratio|21.4633|2011-11-22/pe_ratio|20.2248|2011-10-11/price_to_book_value|9.4552|2011-10-25/price_to_book_value|9.6014|2011-11-08/price_to_book_value|9.8264|2011-11-22/price_to_book_value|9.2595|2011-10-11/peg_ratio||2011-10-25/peg_ratio||2011-11-08/peg_ratio||2011-11-22/peg_ratio||2011-10-04/dividend_yield|5.2826|2011-10-18/dividend_yield|5.0002|2011-11-01/dividend_yield|4.9432|2011-11-15/dividend_yield|4.9411|2011-11-29/dividend_yield|5.1547|2011-10-14/percent_of_shares_outstanding|0.2514|2011-10-31/percent_of_shares_outstanding|0.2497|2011-11-15/percent_of_shares_outstanding|0.2649|2011-11-30/percent_of_shares_outstanding|0.2111|2011-10-31/price|44.79|2011-11-30/price|44.48|2011-10-31/total_return_price|28.0846|2011-11-30/total_return_price|28.2395|2011-10-11/enterprise_value|125789.1531|2011-10-25/enterprise_value|127485.7913|2011-11-08/enterprise_value|130098.5603|2011-11-22/enterprise_value|123517.2539
adr_usa_0212|GSK|201112|24910.1136|9087.6384|5967.5184|13478.9184|17805.4848|49695.4224|23127.408|26568.0144||12375.7056|5192.496||2.9363|15.4319|19.4447|2.0561|2.6083|21.5443|9.8295||1.8434|4.8223|7.7404|0.204|2516.5|0.7825|0.5296|10964.9136|7902.3431|3412.9826|2672.8745|1967.3362|-257.7022|45.63|28.9697|130134.1362|44.54|2012-01-03/ev_revenues|3.0009|2012-01-17/ev_revenues|2.902|2012-01-31/ev_revenues|2.9022|2012-02-14/ev_revenues|2.951|2012-02-28/ev_revenues|2.9217|2012-01-10/ev_free_cash_flow|15.8818|2012-01-24/ev_free_cash_flow|16.1505|2012-02-07/ev_free_cash_flow|16.2314|2012-02-21/ev_free_cash_flow|16.1738|2012-01-03/ps_ratio|2.6808|2012-01-17/ps_ratio|2.5812|2012-01-31/ps_ratio|2.58|2012-02-14/ps_ratio|2.6293|2012-02-28/ps_ratio|2.5997|2012-01-03/pe_ratio|13.9751|2012-01-17/pe_ratio|13.4557|2012-01-31/pe_ratio|13.4497|2012-02-14/pe_ratio|13.7064|2012-02-28/pe_ratio|13.5524|2012-01-03/price_to_book_value|9.4407|2012-01-17/price_to_book_value|9.0898|2012-01-31/price_to_book_value|9.0904|2012-02-14/price_to_book_value|9.2638|2012-02-28/price_to_book_value|9.1598|2012-01-03/peg_ratio|0.059|2012-01-17/peg_ratio|0.0568|2012-01-31/peg_ratio|0.0568|2012-02-14/peg_ratio|0.0579|2012-02-28/peg_ratio|0.0572|2012-01-10/dividend_yield|5.0439|2012-01-24/dividend_yield|4.9488|2012-02-07/dividend_yield|4.9234|2012-02-21/dividend_yield|5.0511|2012-01-13/percent_of_shares_outstanding|0.1988|2012-01-31/percent_of_shares_outstanding|0.2529|2012-02-15/percent_of_shares_outstanding|0.3356|2012-02-29/percent_of_shares_outstanding|0.2914|2012-01-31/price|44.54|2012-02-29/price|44.31|2012-01-31/total_return_price|28.2776|2012-02-29/total_return_price|28.65|2012-01-03/enterprise_value|131785.2883|2012-01-17/enterprise_value|127443.1095|2012-01-31/enterprise_value|127450.0489|2012-02-14/enterprise_value|129596.9891|2012-02-28/enterprise_value|128308.825
adr_usa_0212|GSK|201203|25971.549|9316.1245|6394.764|13746.828|17971.712|49821.083|23187.4015|26633.6815||14002.108|6311.798||2.9643|15.9944|16.4524|1.9766|2.6438|13.7819|9.3109|0.0582|1.6767|4.9523|7.8114|0.2998|2517.5|0.8168|0.6545|10429.6973|7574.0964|3364.5198|2915.2889|2054.5247|-263.8839|44.91|29.038|130179.5753|46.23|2012-04-10/ev_revenues|2.9455|2012-04-24/ev_revenues|3.0704|2012-05-08/ev_revenues|3.0356|2012-05-22/ev_revenues|2.9123|2012-04-03/ev_free_cash_flow|16.4811|2012-04-17/ev_free_cash_flow|16.5479|2012-05-01/ev_free_cash_flow|16.7656|2012-05-15/ev_free_cash_flow|16.4124|2012-05-29/ev_free_cash_flow|16.072|2012-04-10/ps_ratio|2.6027|2012-04-24/ps_ratio|2.7281|2012-05-08/ps_ratio|2.6911|2012-05-22/ps_ratio|2.5675|2012-04-10/pe_ratio|14.1633|2012-04-24/pe_ratio|14.8457|2012-05-08/pe_ratio|14.6445|2012-05-22/pe_ratio|13.9715|2012-04-10/price_to_book_value|8.1106|2012-04-24/price_to_book_value|8.5014|2012-05-08/price_to_book_value|8.3924|2012-05-22/price_to_book_value|8.0067|2012-04-10/peg_ratio|0.0767|2012-04-24/peg_ratio|0.0804|2012-05-08/peg_ratio|0.0793|2012-05-22/peg_ratio|0.0757|2012-04-03/dividend_yield|4.9296|2012-04-17/dividend_yield|4.907|2012-05-01/dividend_yield|4.8385|2012-05-15/dividend_yield|5.0067|2012-05-29/dividend_yield|5.1274|2012-04-13/percent_of_shares_outstanding|0.3519|2012-04-30/percent_of_shares_outstanding|0.2539|2012-05-15/percent_of_shares_outstanding|0.167|2012-05-31/percent_of_shares_outstanding|0.0875|2012-04-30/price|46.23|2012-05-31/price|44.11|2012-04-30/total_return_price|29.8915|2012-05-31/total_return_price|28.861|2012-04-10/enterprise_value|129003.4138|2012-04-24/enterprise_value|134474.9241|2012-05-08/enterprise_value|132949.103|2012-05-22/enterprise_value|127549.1967
adr_usa_0212|GSK|201206|26786.4771|11781.1469|6142.7052|13441.3375|17681.8057|53779.3144|23897.4352|29881.8792||10941.7422|3182.2906||2.9865|15.8344|16.5231|1.9711|2.657|14.4589|8.2389|0.0783|2.4434|4.9404|7.7172|0.0705|2498|0.782|0.5616|10229.4255|7063.4009|3482.6271|2420.4258|1959.7692|-291.2743|45.57|29.8163|130800.2733|46|2012-07-03/ev_revenues|3.0432|2012-07-17/ev_revenues|3.0078|2012-07-31/ev_revenues|3.0391|2012-08-14/ev_revenues|3.0779|2012-08-28/ev_revenues|3.0315|2012-07-10/ev_free_cash_flow|15.1082|2012-07-24/ev_free_cash_flow|15.0524|2012-08-07/ev_free_cash_flow|15.7421|2012-08-21/ev_free_cash_flow|15.4192|2012-07-03/ps_ratio|2.6899|2012-07-17/ps_ratio|2.6542|2012-07-31/ps_ratio|2.6869|2012-08-14/ps_ratio|2.7261|2012-08-28/ps_ratio|2.6794|2012-07-03/pe_ratio|14.1376|2012-07-17/pe_ratio|13.9504|2012-07-31/pe_ratio|14.1223|2012-08-14/pe_ratio|14.328|2012-08-28/pe_ratio|14.0824|2012-07-03/price_to_book_value|10.5047|2012-07-17/price_to_book_value|10.3655|2012-07-31/price_to_book_value|10.4885|2012-08-14/price_to_book_value|10.6412|2012-08-28/price_to_book_value|10.4588|2012-07-03/peg_ratio|0.2252|2012-07-17/peg_ratio|0.2222|2012-07-31/peg_ratio|0.225|2012-08-14/peg_ratio|0.2282|2012-08-28/peg_ratio|0.2243|2012-07-10/dividend_yield|5.0601|2012-07-24/dividend_yield|5.0816|2012-08-07/dividend_yield|4.8263|2012-08-21/dividend_yield|4.9563|2012-07-13/percent_of_shares_outstanding|0.083|2012-07-31/percent_of_shares_outstanding|0.111|2012-08-15/percent_of_shares_outstanding|0.12|2012-08-31/percent_of_shares_outstanding|0.118|2012-07-31/price|46|2012-08-31/price|45.49|2012-07-31/total_return_price|30.0976|2012-08-31/total_return_price|30.1008|2012-07-03/enterprise_value|131047.7379|2012-07-17/enterprise_value|129525.1986|2012-07-31/enterprise_value|130870.4536|2012-08-14/enterprise_value|132541.9863|2012-08-28/enterprise_value|130546.1263
adr_usa_0212|GSK|201209|21897.7897|5870.0293|6550.0244|13932.5965|21393.0678|54245.4325|22662.1756|31583.2569||10099.3067|1731.6343||3.0912|17.8796|15.6806|2.1042|2.7483|14.4446|10.6938|0.2301|2.8097|4.8469|7.056|0.1449|2486|0.7011|0.528|10306.1075|7007.5847|3530.6353|2347.9672|1744.7907|-281.0613|46.24|30.5971|133117.238|44.9|2012-10-09/ev_revenues|3.2911|2012-10-23/ev_revenues|3.2097|2012-11-06/ev_revenues|3.1958|2012-11-20/ev_revenues|3.054|2012-10-02/ev_free_cash_flow|28.0265|2012-10-16/ev_free_cash_flow|27.9173|2012-10-31/ev_free_cash_flow|26.9718|2012-11-14/ev_free_cash_flow|25.4888|2012-11-28/ev_free_cash_flow|25.9398|2012-10-09/ps_ratio|2.7583|2012-10-23/ps_ratio|2.6759|2012-11-06/ps_ratio|2.6705|2012-11-20/ps_ratio|2.5338|2012-10-09/pe_ratio|14.9818|2012-10-23/pe_ratio|14.5341|2012-11-06/pe_ratio|14.5049|2012-11-20/pe_ratio|13.762|2012-10-09/price_to_book_value|11.3062|2012-10-23/price_to_book_value|10.9683|2012-11-06/price_to_book_value|10.9106|2012-11-20/price_to_book_value|10.3218|2012-10-09/peg_ratio|0.32|2012-10-23/peg_ratio|0.3104|2012-11-06/peg_ratio|0.3098|2012-11-20/peg_ratio|0.2939|2012-10-02/dividend_yield|4.8707|2012-10-16/dividend_yield|4.8937|2012-10-31/dividend_yield|5.0855|2012-11-14/dividend_yield|5.5355|2012-11-28/dividend_yield|5.3964|2012-10-15/percent_of_shares_outstanding|0.1316|2012-10-31/percent_of_shares_outstanding|0.1205|2012-11-15/percent_of_shares_outstanding|0.1768|2012-11-30/percent_of_shares_outstanding|0.1389|2012-10-31/price|44.9|2012-11-30/price|43.01|2012-10-31/total_return_price|29.7104|2012-11-30/total_return_price|28.85|2012-10-09/enterprise_value|137997.3319|2012-10-23/enterprise_value|134585.1483|2012-11-06/enterprise_value|134001.9167|2012-11-20/enterprise_value|128056.1609
adr_usa_0212|GSK|201212|22126.272|6892.24|6413.904|14182.016|23464.32|56146.304|22325.04|33821.264||9372.8|1037.472||3.1485|18.3465|26.1555|1.9488|2.6359|14.3168|10.7142|0.3058|3.1424|5.3355|7.7317|0.1371|2455.5|0.5651|0.5796|10919.3609|7679.8328|3549.3542|2773.9864|1361.3082|-306.6154|43.47|29.1585|132018.8612|45.61|2013-01-02/ev_revenues|3.1575|2013-01-16/ev_revenues|3.1458|2013-01-30/ev_revenues|3.2436|2013-02-13/ev_revenues|3.2418|2013-02-27/ev_revenues|3.1663|2013-01-09/ev_free_cash_flow|29.3144|2013-01-23/ev_free_cash_flow|29.6124|2013-02-06/ev_free_cash_flow|29.9378|2013-02-20/ev_free_cash_flow|29.8836|2013-01-02/ps_ratio|2.6227|2013-01-16/ps_ratio|2.6108|2013-01-30/ps_ratio|2.7101|2013-02-13/ps_ratio|2.7077|2013-02-27/ps_ratio|2.631|2013-01-02/pe_ratio|15.4035|2013-01-16/pe_ratio|15.3337|2013-01-30/pe_ratio|15.9166|2013-02-13/pe_ratio|15.9026|2013-02-27/pe_ratio|15.4523|2013-01-02/price_to_book_value|11.5416|2013-01-16/price_to_book_value|11.4893|2013-01-30/price_to_book_value|11.926|2013-02-13/price_to_book_value|11.9183|2013-02-27/price_to_book_value|11.5809|2013-01-02/peg_ratio||2013-01-16/peg_ratio||2013-01-30/peg_ratio||2013-02-13/peg_ratio||2013-02-27/peg_ratio||2013-01-09/dividend_yield|5.2379|2013-01-23/dividend_yield|5.1737|2013-02-06/dividend_yield|5.1065|2013-02-20/dividend_yield|5.1753|2013-01-15/percent_of_shares_outstanding|0.1289|2013-01-31/percent_of_shares_outstanding|0.1329|2013-02-15/percent_of_shares_outstanding|0.1234|2013-02-28/percent_of_shares_outstanding|0.1424|2013-01-31/price|45.61|2013-02-28/price|44.03|2013-01-31/total_return_price|30.594|2013-02-28/total_return_price|29.9838|2013-01-02/enterprise_value|132252.0211|2013-01-16/enterprise_value|131761.7566|2013-01-30/enterprise_value|135855.4649|2013-02-13/enterprise_value|135783.1807|2013-02-27/enterprise_value|132620.2453
adr_usa_0212|GSK|201303|21452.1932|5949.234|6377.7612|13899.7812|22651.1576|53603.89|18247.3568|35356.5332||10172.2024|1969.4016||3.293|21.1064|30.2181|2.1238|2.7564|16.1888|12.1468||2.8863|5.1099|6.5627|0.1323|2423.5|0.6089|0.7062|10051.8563|6982.3974|3231.0093|2191.8048|1492.7884|-279.6066|46.91|31.945|137925.0677|51.64|2013-04-10/ev_revenues|3.4219|2013-04-24/ev_revenues|3.6348|2013-05-08/ev_revenues|3.6106|2013-05-22/ev_revenues|3.7402|2013-04-03/ev_free_cash_flow|29.3151|2013-04-17/ev_free_cash_flow|31.0459|2013-05-01/ev_free_cash_flow|31.7157|2013-05-15/ev_free_cash_flow|32.2266|2013-05-29/ev_free_cash_flow|31.9998|2013-04-10/ps_ratio|2.8366|2013-04-24/ps_ratio|3.0505|2013-05-08/ps_ratio|3.0178|2013-05-22/ps_ratio|3.145|2013-04-10/pe_ratio|17.9709|2013-04-24/pe_ratio|19.3258|2013-05-08/pe_ratio|19.1188|2013-05-22/pe_ratio|19.9242|2013-04-10/price_to_book_value|11.5232|2013-04-24/price_to_book_value|12.392|2013-05-08/price_to_book_value|12.2936|2013-05-22/price_to_book_value|12.8222|2013-04-10/peg_ratio||2013-04-24/peg_ratio||2013-05-08/peg_ratio||2013-05-22/peg_ratio||2013-04-03/dividend_yield|4.9935|2013-04-17/dividend_yield|4.6592|2013-05-01/dividend_yield|4.5543|2013-05-15/dividend_yield|4.4731|2013-05-29/dividend_yield|4.5118|2013-04-15/percent_of_shares_outstanding|0.2329|2013-04-30/percent_of_shares_outstanding|0.1673|2013-05-15/percent_of_shares_outstanding|0.0971|2013-05-31/percent_of_shares_outstanding|0.119|2013-04-30/price|51.64|2013-05-31/price|51.77|2013-04-30/total_return_price|35.1661|2013-05-31/total_return_price|35.6373|2013-04-10/enterprise_value|142030.1338|2013-04-24/enterprise_value|150867.4052|2013-05-08/enterprise_value|149866.2777|2013-05-22/enterprise_value|155243.3828
adr_usa_0212|GSK|201306|20495.2744|4443.4902|6319.7322|13687.4142|22537.785|53065.6152|19032.4158|34033.1994||9780.8648|631.5156||3.6482|23.5882|30.7967|2.281|3.0582|19.3747|12.4468||2.906|4.7129|5.4844|0.0994|2459|0.6513|0.555|10165.3225|7136.3083|3403.8009|1978.3825|1605.1318|-285.6981|49.97|34.3982|151425.3188|50.96|2013-07-03/ev_revenues|3.6083|2013-07-17/ev_revenues|3.6991|2013-07-31/ev_revenues|3.6272|2013-08-14/ev_revenues|3.6822|2013-08-28/ev_revenues|3.6631|2013-07-10/ev_free_cash_flow|33.7821|2013-07-24/ev_free_cash_flow|33.4394|2013-08-07/ev_free_cash_flow|33.3938|2013-08-21/ev_free_cash_flow|33.508|2013-07-03/ps_ratio|2.9993|2013-07-17/ps_ratio|3.0905|2013-07-31/ps_ratio|3.02|2013-08-14/ps_ratio|3.0769|2013-08-28/ps_ratio|3.0603|2013-07-03/pe_ratio|20.033|2013-07-17/pe_ratio|20.6426|2013-07-31/pe_ratio|20.1715|2013-08-14/pe_ratio|20.5515|2013-08-28/pe_ratio|20.4407|2013-07-03/price_to_book_value|12.7033|2013-07-17/price_to_book_value|13.088|2013-07-31/price_to_book_value|12.7834|2013-08-14/price_to_book_value|13.0163|2013-08-28/price_to_book_value|12.9355|2013-07-03/peg_ratio||2013-07-17/peg_ratio||2013-07-31/peg_ratio||2013-08-14/peg_ratio||2013-08-28/peg_ratio||2013-07-10/dividend_yield|4.4876|2013-07-24/dividend_yield|4.5423|2013-08-07/dividend_yield|4.5966|2013-08-21/dividend_yield|4.5736|2013-07-15/percent_of_shares_outstanding|0.138|2013-07-31/percent_of_shares_outstanding|0.1047|2013-08-15/percent_of_shares_outstanding|0.1148|2013-08-30/percent_of_shares_outstanding|0.1952|2013-07-31/price|50.96|2013-08-30/price|50.89|2013-07-31/total_return_price|35.0797|2013-08-30/total_return_price|35.4091|2013-07-03/enterprise_value|149538.6445|2013-07-17/enterprise_value|153301.3407|2013-07-31/enterprise_value|150322.1783|2013-08-14/enterprise_value|152599.8142|2013-08-28/enterprise_value|151809.9459
adr_usa_0212|GSK|201309|21778.8352|5365.4954|6736.3722|14171.1156|22925.0046|55463.9294|20744.2112|34719.7182||9657.5684|-208.5414||3.6232|24.5836|33.1476|2.2053|3.0265|20.2151|12.7664||3.0812|4.6262|5.5491|0.167|2461.5|0.611|0.5629|10094.7183|6821.3004|3076.4856|2174.0085|1502.5779|-280.6673|50.17|34.9081|150155.6596|52.63|2013-10-09/ev_revenues|3.5397|2013-10-23/ev_revenues|3.6185|2013-11-06/ev_revenues|3.7686|2013-11-20/ev_revenues|3.7293|2013-10-02/ev_free_cash_flow|18.1841|2013-10-16/ev_free_cash_flow|18.163|2013-10-30/ev_free_cash_flow|18.8188|2013-11-13/ev_free_cash_flow|18.6343|2013-11-27/ev_free_cash_flow|18.7804|2013-10-09/ps_ratio|2.9299|2013-10-23/ps_ratio|3.0161|2013-11-06/ps_ratio|3.1688|2013-11-20/ps_ratio|3.1289|2013-10-09/pe_ratio|20.2404|2013-10-23/pe_ratio|20.8356|2013-11-06/pe_ratio|21.8905|2013-11-20/pe_ratio|21.6155|2013-10-09/price_to_book_value|12.448|2013-10-23/price_to_book_value|12.7846|2013-11-06/price_to_book_value|13.4254|2013-11-20/price_to_book_value|13.2575|2013-10-09/peg_ratio||2013-10-23/peg_ratio||2013-11-06/peg_ratio||2013-11-20/peg_ratio||2013-10-02/dividend_yield|4.723|2013-10-16/dividend_yield|4.7164|2013-10-30/dividend_yield|4.5127|2013-11-13/dividend_yield|4.6381|2013-11-27/dividend_yield|4.5938|2013-10-15/percent_of_shares_outstanding|0.1349|2013-10-31/percent_of_shares_outstanding|0.1244|2013-11-15/percent_of_shares_outstanding|0.2347|2013-11-29/percent_of_shares_outstanding|0.2385|2013-10-31/price|52.63|2013-11-29/price|52.92|2013-10-31/total_return_price|36.6198|2013-11-29/total_return_price|37.2615|2013-10-09/enterprise_value|145945.7274|2013-10-23/enterprise_value|149196.3917|2013-11-06/enterprise_value|155385.2956|2013-11-20/enterprise_value|153763.3907
adr_usa_0212|GSK|201312|25109.323|9234.4|6431.1|14629.928|22241.712|56517.826|22553.373|33964.453||11538.053|1505.537||3.6468|17.6679|18.736|2.1853|3.0505|21.0737|12.9055||2.5961|4.6009|5.4324|0.2056|2443|1.6316|0.6093|11178.4746|7089.7363|3561.0547|4121.1115|3983.5253|-255.7485|53.39|37.5924|150363.9864|51.54|2014-01-02/ev_revenues|3.6202|2014-01-16/ev_revenues|3.6723|2014-01-30/ev_revenues|3.5717|2014-02-13/ev_revenues|3.7543|2014-02-27/ev_revenues|3.8183|2014-01-09/ev_free_cash_flow|17.4029|2014-01-23/ev_free_cash_flow|17.9818|2014-02-06/ev_free_cash_flow|17.2586|2014-02-20/ev_free_cash_flow|18.3635|2014-01-02/ps_ratio|3.1131|2014-01-16/ps_ratio|3.1656|2014-01-30/ps_ratio|3.0642|2014-02-13/ps_ratio|3.247|2014-02-27/ps_ratio|3.3101|2014-01-02/pe_ratio|15.071|2014-01-16/pe_ratio|15.3251|2014-01-30/pe_ratio|14.834|2014-02-13/pe_ratio|15.7191|2014-02-27/pe_ratio|16.0245|2014-01-02/price_to_book_value|11.106|2014-01-16/price_to_book_value|11.2932|2014-01-30/price_to_book_value|10.9314|2014-02-13/price_to_book_value|11.5881|2014-02-27/price_to_book_value|11.8182|2014-01-02/peg_ratio|0.677|2014-01-16/peg_ratio|0.6884|2014-01-30/peg_ratio|0.6663|2014-02-13/peg_ratio|0.7061|2014-02-27/peg_ratio|0.7198|2014-01-09/dividend_yield|4.5591|2014-01-23/dividend_yield|4.388|2014-02-06/dividend_yield|4.6061|2014-02-20/dividend_yield|4.3919|2014-01-15/percent_of_shares_outstanding|0.1948|2014-01-31/percent_of_shares_outstanding|0.2136|2014-02-14/percent_of_shares_outstanding|0.2111|2014-02-28/percent_of_shares_outstanding|0.2228|2014-01-31/price|51.54|2014-02-28/price|55.94|2014-01-31/total_return_price|36.2898|2014-02-28/total_return_price|39.916|2014-01-02/enterprise_value|150205.3533|2014-01-16/enterprise_value|152365.7273|2014-01-30/enterprise_value|148190.6225|2014-02-13/enterprise_value|155767.3322|2014-02-27/enterprise_value|158422.6089
adr_usa_0212|GSK|201403|22046.3025|5957.2455|6812.7985|14652.5935|22003.0255|53723.402|19419.7215|34303.6805||11012.332|795.631||3.6889|18.7765|17.747|2.3286|3.1797|15.3936|11.3531|0.6914|2.6057|4.5708|5.9652|0.2585|2433|0.4534|0.7431|9287.176|6403.2373|3261.1836|1494.0887|1105.2616|-271.3517|53.43|38.125|153055.8705|55.37|2014-04-10/ev_revenues|3.7265|2014-04-24/ev_revenues|3.9031|2014-05-08/ev_revenues|3.8681|2014-05-22/ev_revenues|3.8814|2014-04-03/ev_free_cash_flow|18.6726|2014-04-17/ev_free_cash_flow|18.61|2014-05-01/ev_free_cash_flow|19.4775|2014-05-15/ev_free_cash_flow|19.4995|2014-05-29/ev_free_cash_flow|19.1598|2014-04-10/ps_ratio|3.1602|2014-04-24/ps_ratio|3.3382|2014-05-08/ps_ratio|3.3015|2014-05-22/ps_ratio|3.3166|2014-04-10/pe_ratio|15.6997|2014-04-24/pe_ratio|16.5841|2014-05-08/pe_ratio|16.4018|2014-05-22/pe_ratio|16.4765|2014-04-10/price_to_book_value|11.5934|2014-04-24/price_to_book_value|12.2464|2014-05-08/price_to_book_value|12.1171|2014-05-22/price_to_book_value|12.1661|2014-04-10/peg_ratio|0.6045|2014-04-24/peg_ratio|0.6385|2014-05-08/peg_ratio|0.6315|2014-05-22/peg_ratio|0.6344|2014-04-03/dividend_yield|4.6835|2014-04-17/dividend_yield|4.7022|2014-05-01/dividend_yield|4.4569|2014-05-15/dividend_yield|4.6116|2014-05-29/dividend_yield|4.7057|2014-04-15/percent_of_shares_outstanding|0.3055|2014-04-30/percent_of_shares_outstanding|0.2838|2014-05-15/percent_of_shares_outstanding|0.3791|2014-05-30/percent_of_shares_outstanding|0.4322|2014-04-30/price|55.37|2014-05-30/price|53.94|2014-04-30/total_return_price|39.5093|2014-05-30/total_return_price|38.9378|2014-04-10/enterprise_value|151763.8625|2014-04-24/enterprise_value|158955.1825|2014-05-08/enterprise_value|157531.2827|2014-05-22/enterprise_value|158071.2311
adr_usa_0212|GSK|201406|23083.063|5496.1296|7001.7319|14761.3744|20572.5904|54525.2844|20867.2388|33658.0455||10419.9941|-269.1009||3.8326|20.053|18.9232|2.3311|3.2733|16.2614|11.9857|0.6261|2.8849|4.7679|6.1295|0.4038|2437|0.451|0.6427|9358.4531|6460.5469|3458.3027|1659.3121|1100.5985|-267.5767|53.48|38.6057|156084.4389|48.37|2014-07-03/ev_revenues|3.9266|2014-07-17/ev_revenues|3.8399|2014-07-31/ev_revenues|3.5841|2014-08-14/ev_revenues|3.5021|2014-08-28/ev_revenues|3.6145|2014-07-10/ev_free_cash_flow|22.8973|2014-07-24/ev_free_cash_flow|21.3787|2014-08-07/ev_free_cash_flow|20.2219|2014-08-21/ev_free_cash_flow|20.701|2014-07-03/ps_ratio|3.3374|2014-07-17/ps_ratio|3.2493|2014-07-31/ps_ratio|2.961|2014-08-14/ps_ratio|2.8783|2014-08-28/ps_ratio|2.9916|2014-07-03/pe_ratio|17.3248|2014-07-17/pe_ratio|16.8672|2014-07-31/pe_ratio|15.3705|2014-08-14/pe_ratio|14.9415|2014-08-28/pe_ratio|15.5294|2014-07-03/price_to_book_value|12.5679|2014-07-17/price_to_book_value|12.2359|2014-07-31/price_to_book_value|11.2559|2014-08-14/price_to_book_value|10.9417|2014-08-28/price_to_book_value|11.3722|2014-07-03/peg_ratio|0.7053|2014-07-17/peg_ratio|0.6866|2014-07-31/peg_ratio|0.6257|2014-08-14/peg_ratio|0.6082|2014-08-28/peg_ratio|0.6322|2014-07-10/dividend_yield|4.704|2014-07-24/dividend_yield|5.1097|2014-08-07/dividend_yield|5.7259|2014-08-21/dividend_yield|5.5638|2014-07-15/percent_of_shares_outstanding|0.4264|2014-07-31/percent_of_shares_outstanding|0.4216|2014-08-15/percent_of_shares_outstanding|0.3645|2014-08-29/percent_of_shares_outstanding|0.4963|2014-07-31/price|48.37|2014-08-29/price|49.1|2014-07-31/total_return_price|34.9169|2014-08-29/total_return_price|35.9222|2014-07-03/enterprise_value|156744.737|2014-07-17/enterprise_value|153285.857|2014-07-31/enterprise_value|143073.6042|2014-08-14/enterprise_value|139800.1708|2014-08-28/enterprise_value|144285.987
adr_usa_0212|GSK|201409|24135.1557|6773.9543|6941.2324|14337.2017|19655.9982|56116.1452|24799.3962|31316.749||8190.1346|-1932.6314||3.4815|19.7812|20.5559|2.0728|2.8575|14.8335|10.8628|0.6038|3.7595|5.6121|6.3779|0.2541|2432.5|0.2738|0.6401|9426.334|6372.7093|3360.8237|914.9187|669.4934|-275.4773|45.97|33.6323|138978.2806|45.49|2014-10-09/ev_revenues|3.3856|2014-10-23/ev_revenues|3.4193|2014-11-06/ev_revenues|3.412|2014-11-20/ev_revenues|3.513|2014-10-02/ev_free_cash_flow|23.6607|2014-10-16/ev_free_cash_flow|22.5008|2014-10-30/ev_free_cash_flow|23.454|2014-11-13/ev_free_cash_flow|23.8846|2014-11-28/ev_free_cash_flow|24.2214|2014-10-09/ps_ratio|2.7815|2014-10-23/ps_ratio|2.8156|2014-11-06/ps_ratio|2.7777|2014-11-20/ps_ratio|2.8789|2014-10-09/pe_ratio|15.9478|2014-10-23/pe_ratio|16.1436|2014-11-06/pe_ratio|15.9265|2014-11-20/pe_ratio|16.5066|2014-10-09/price_to_book_value|13.1528|2014-10-23/price_to_book_value|13.3142|2014-11-06/price_to_book_value|13.2792|2014-11-20/price_to_book_value|13.7629|2014-10-09/peg_ratio|1.04|2014-10-23/peg_ratio|1.0528|2014-11-06/peg_ratio|1.0386|2014-11-20/peg_ratio|1.0765|2014-10-02/dividend_yield|5.8162|2014-10-16/dividend_yield|6.1892|2014-10-30/dividend_yield|5.8794|2014-11-13/dividend_yield|5.8056|2014-11-28/dividend_yield|5.7069|2014-10-15/percent_of_shares_outstanding|0.2123|2014-10-31/percent_of_shares_outstanding|0.2153|2014-11-14/percent_of_shares_outstanding|0.1781|2014-11-28/percent_of_shares_outstanding|0.1746|2014-10-31/price|45.49|2014-11-28/price|46.45|2014-10-31/total_return_price|33.2811|2014-11-28/total_return_price|34.4469|2014-10-09/enterprise_value|132888.0497|2014-10-23/enterprise_value|134210.2497|2014-11-06/enterprise_value|133923.63|2014-11-20/enterprise_value|137885.1245
adr_usa_0212|GSK|201412|22845.7199|6859.3192|6585.3823|14089.0759|18746.0042|55588.9689|20693.1357|34895.8332||6635.189|-3228.098||3.3231|28.2139|22.8241|2.0109|2.6871|15.4069|12.8529|1.0048|4.3863|6.1433|6.5911|0.1813|2405.5|0.6739|0.6062|9786.0826|6576.2602|3491.4136|840.0275|1634.1777|-257.8615|42.74|31.6956|130431.6525|44|2015-01-02/ev_revenues|3.337|2015-01-16/ev_revenues|3.4224|2015-01-30/ev_revenues|3.4417|2015-02-13/ev_revenues|3.6949|2015-02-27/ev_revenues|3.662|2015-01-09/ev_free_cash_flow|22.5619|2015-01-23/ev_free_cash_flow|23.5138|2015-02-06/ev_free_cash_flow|23.9412|2015-02-20/ev_free_cash_flow|24.5228|2015-01-02/ps_ratio|2.7163|2015-01-16/ps_ratio|2.8015|2015-01-30/ps_ratio|2.8207|2015-02-13/ps_ratio|3.0733|2015-02-27/ps_ratio|3.04|2015-01-02/pe_ratio|22.8768|2015-01-16/pe_ratio|23.5949|2015-01-30/pe_ratio|23.7569|2015-02-13/pe_ratio|25.8842|2015-02-27/pe_ratio|25.6035|2015-01-02/price_to_book_value|15.5292|2015-01-16/price_to_book_value|16.0167|2015-01-30/price_to_book_value|16.1266|2015-02-13/price_to_book_value|17.5715|2015-02-27/price_to_book_value|17.3839|2015-01-02/peg_ratio||2015-01-16/peg_ratio||2015-01-30/peg_ratio||2015-02-13/peg_ratio||2015-02-27/peg_ratio||2015-01-09/dividend_yield|6.1936|2015-01-23/dividend_yield|5.8895|2015-02-06/dividend_yield|5.7627|2015-02-20/dividend_yield|5.4836|2015-01-15/percent_of_shares_outstanding|0.2703|2015-01-30/percent_of_shares_outstanding|0.2698|2015-02-13/percent_of_shares_outstanding|0.2687|2015-02-27/percent_of_shares_outstanding|0.2481|2015-01-30/price|44|2015-02-27/price|47.42|2015-01-30/total_return_price|32.63|2015-02-27/total_return_price|35.6863|2015-01-02/enterprise_value|126331.6286|2015-01-16/enterprise_value|129566.0431|2015-01-30/enterprise_value|130295.6103|2015-02-13/enterprise_value|139882.6573|2015-02-27/enterprise_value|138637.6949
adr_usa_0212|GSK|201503|30895.4112|15345.5304|6779.1024|14277.8736|33015.9168|68987.5104|23375.9088|45611.6016||11008.2672|1639.2456||3.6363|8.2557|25.1553|1.5059|3.0144|25.3875|17.2372||2.4833|5.3196|6.3577|0.2125|2430.5|5.0445|0.6826|8521.6493|5333.9886|3372.5844|15040.9687|12261.0496|-241.0072|46.15|34.7306|137664.7277|46.15|2015-04-10/ev_revenues|3.6221|2015-04-24/ev_revenues|3.5153|2015-05-08/ev_revenues|3.4521|2015-05-22/ev_revenues|3.4508|2015-04-06/ev_free_cash_flow|27.9769|2015-04-20/ev_free_cash_flow|28.0232|2015-05-04/ev_free_cash_flow|27.8111|2015-05-18/ev_free_cash_flow|26.9408|2015-04-10/ps_ratio|3.1549|2015-04-24/ps_ratio|3.0476|2015-05-08/ps_ratio|2.962|2015-05-22/ps_ratio|2.9606|2015-04-10/pe_ratio|7.4854|2015-04-24/pe_ratio|7.2309|2015-05-08/pe_ratio|7.0275|2015-05-22/pe_ratio|7.0244|2015-04-10/price_to_book_value|10.5807|2015-04-24/price_to_book_value|10.2209|2015-05-08/price_to_book_value|10.008|2015-05-22/price_to_book_value|10.0036|2015-04-10/peg_ratio|0.0809|2015-04-24/peg_ratio|0.0782|2015-05-08/peg_ratio|0.076|2015-05-22/peg_ratio|0.0759|2015-04-06/dividend_yield|5.5233|2015-04-20/dividend_yield|5.5127|2015-05-04/dividend_yield|5.6031|2015-05-18/dividend_yield|5.6932|2015-04-15/percent_of_shares_outstanding|0.2236|2015-04-30/percent_of_shares_outstanding|0.2115|2015-05-15/percent_of_shares_outstanding|0.238|2015-05-29/percent_of_shares_outstanding|0.2099|2015-04-30/price|46.15|2015-05-29/price|44.37|2015-04-30/total_return_price|34.7306|2015-05-29/total_return_price|33.829|2015-04-10/enterprise_value|134351.6676|2015-04-24/enterprise_value|130391.0676|2015-05-08/enterprise_value|128047.1622|2015-05-22/enterprise_value|127998.5001
adr_usa_0212|GSK|201506|28487.41|11974.5875|7543.2825|14654.1275|34101.235|68507.535|21694.21|46813.325||10724.45|874.31||3.3065|8.2629|25.5787|1.4363|2.8167|6.683|9.5175|0.0723|2.5173|6.0495|6.4506|0.1269|2437|0.095|0.5862|9018.9276|5947.7744|3892.1697|232.8256|228.2303|-278.778|41.65|31.7552|122647.3638|43.44|2015-07-06/ev_revenues|3.3457|2015-07-20/ev_revenues|3.4165|2015-08-03/ev_revenues|3.449|2015-08-17/ev_revenues|3.492|2015-08-31/ev_revenues|3.2783|2015-07-13/ev_free_cash_flow|33.3883|2015-07-27/ev_free_cash_flow|32.5515|2015-08-10/ev_free_cash_flow|34.8484|2015-08-24/ev_free_cash_flow|31.6246|2015-07-06/ps_ratio|2.7695|2015-07-20/ps_ratio|2.8401|2015-08-03/ps_ratio|2.8725|2015-08-17/ps_ratio|2.9154|2015-08-31/ps_ratio|2.7021|2015-07-06/pe_ratio|6.8915|2015-07-20/pe_ratio|7.0673|2015-08-03/pe_ratio|7.1478|2015-08-17/pe_ratio|7.2546|2015-08-31/pe_ratio|6.724|2015-07-06/price_to_book_value|9.5177|2015-07-20/price_to_book_value|9.7605|2015-08-03/price_to_book_value|9.8719|2015-08-17/price_to_book_value|10.0194|2015-08-31/price_to_book_value|9.2868|2015-07-06/peg_ratio|0.0738|2015-07-20/peg_ratio|0.0756|2015-08-03/peg_ratio|0.0765|2015-08-17/peg_ratio|0.0776|2015-08-31/peg_ratio|0.072|2015-07-13/dividend_yield|5.9282|2015-07-27/dividend_yield|6.112|2015-08-10/dividend_yield|5.6327|2015-08-24/dividend_yield|6.152|2015-07-15/percent_of_shares_outstanding|0.1449|2015-07-31/percent_of_shares_outstanding|0.1445|2015-08-14/percent_of_shares_outstanding|0.1734|2015-08-31/percent_of_shares_outstanding|0.1512|2015-07-31/price|43.44|2015-08-31/price|40.93|2015-07-31/total_return_price|33.12|2015-08-31/total_return_price|31.6135|2015-07-06/enterprise_value|122963.1844|2015-07-20/enterprise_value|125566.7028|2015-08-03/enterprise_value|126761.544|2015-08-17/enterprise_value|128343.1591|2015-08-31/enterprise_value|120486.356
adr_usa_0212|GSK|201509|25733.0074|9060.5766|7355.7516|14540.263|33085.7282|66357.8506|19321.35|47036.5006||8230.1374|-1025.9258||3.0565|7.68|30.6653|1.427|2.481|6.1704|8.5267|0.0661|3.0436|6.3873|7.5265|0.1015|2438.5|0.3409|0.5799|9494.1722|6078.9355|3049.5399|1343.4711|833.6649|-238.6327|38.45|29.698|112334.7417|43.06|2015-10-12/ev_revenues|3.2465|2015-10-26/ev_revenues|3.3575|2015-11-09/ev_revenues|3.3401|2015-11-23/ev_revenues|3.2654|2015-10-06/ev_free_cash_flow|49.221|2015-10-20/ev_free_cash_flow|50.6223|2015-11-03/ev_free_cash_flow|52.2466|2015-11-17/ev_free_cash_flow|50.3494|2015-10-12/ps_ratio|2.6626|2015-10-26/ps_ratio|2.774|2015-11-09/ps_ratio|2.739|2015-11-23/ps_ratio|2.6645|2015-10-13/pe_ratio|6.5174|2015-10-27/pe_ratio|6.7839|2015-11-10/pe_ratio|6.6555|2015-11-24/pe_ratio|6.5629|2015-10-12/price_to_book_value|11.8636|2015-10-26/price_to_book_value|12.3601|2015-11-09/price_to_book_value|12.2823|2015-11-23/price_to_book_value|11.9482|2015-10-12/peg_ratio|0.0551|2015-10-26/peg_ratio|0.0574|2015-11-09/peg_ratio|0.0567|2015-11-23/peg_ratio|0.0552|2015-10-06/dividend_yield|6.2139|2015-10-20/dividend_yield|6.004|2015-11-03/dividend_yield|5.8147|2015-11-17/dividend_yield|5.9249|2015-10-15/percent_of_shares_outstanding|0.1402|2015-10-30/percent_of_shares_outstanding|0.1541|2015-11-13/percent_of_shares_outstanding|0.1624|2015-11-30/percent_of_shares_outstanding|0.1758|2015-10-30/price|43.06|2015-11-30/price|40.51|2015-10-30/total_return_price|33.2587|2015-11-30/total_return_price|31.7082|2015-10-12/enterprise_value|119537.8854|2015-10-26/enterprise_value|123624.3054|2015-11-09/enterprise_value|122983.8979|2015-11-23/enterprise_value|120234.1174
adr_usa_0212|GSK|201512|24573.6405|8748.2575|6986.754|14323.142|32347.071|66027.492|19877.2855|46150.2065||7576.391|-2069.6555||3.2265|9.355|50.9186|1.5106|2.6256|6.4833|11.774|0.0544|3.2386|5.8443|7.2795|0.1434|2466.5|-0.2215|0.5538|9534.7824|5680.5218|3789.037|-631.0006|-536.9572|-235.1084|40.35|31.583|118800.8601|41.29|2016-01-04/ev_revenues|3.2775|2016-01-19/ev_revenues|3.1996|2016-02-02/ev_revenues|3.3076|2016-02-16/ev_revenues|3.2783|2016-01-12/ev_free_cash_flow|115.0224|2016-01-26/ev_free_cash_flow|118.3139|2016-02-09/ev_free_cash_flow|114.7658|2016-02-23/ev_free_cash_flow|113.0961|2016-01-04/ps_ratio|2.7024|2016-01-19/ps_ratio|2.6242|2016-02-02/ps_ratio|2.7324|2016-02-16/ps_ratio|2.703|2016-01-05/pe_ratio|7.7355|2016-01-19/pe_ratio|7.4693|2016-02-02/pe_ratio|7.7773|2016-02-16/pe_ratio|7.6936|2016-01-04/price_to_book_value|12.9998|2016-01-19/price_to_book_value|12.6238|2016-02-02/price_to_book_value|13.1452|2016-02-16/price_to_book_value|13.0038|2016-01-04/peg_ratio|0.0418|2016-01-19/peg_ratio|0.0406|2016-02-02/peg_ratio|0.0423|2016-02-16/peg_ratio|0.0418|2016-01-12/dividend_yield|6.1021|2016-01-26/dividend_yield|5.8958|2016-02-09/dividend_yield|6.1191|2016-02-23/dividend_yield|6.1286|2016-01-15/percent_of_shares_outstanding|0.1857|2016-01-29/percent_of_shares_outstanding|0.1985|2016-02-12/percent_of_shares_outstanding|0.2263|2016-02-29/percent_of_shares_outstanding|0.1499|2016-01-29/price|41.29|2016-02-29/price|38.67|2016-01-29/total_return_price|32.3187|2016-02-29/total_return_price|31.2143|2016-01-04/enterprise_value|119856.2466|2016-01-19/enterprise_value|117007.4185|2016-02-02/enterprise_value|120958.0479|2016-02-16/enterprise_value|119886.6282
adr_usa_0212|GSK|201603|22747.8559|6448.2677|7383.8198|14474.4712|33105.0356|68891.6998|20002.9949|48888.7049||4035.3768|-5317.27||3.2638|131.4582|115.8686|1.5592|2.6883|7.6518|12.9339|0.0416|6.0477|5.95|8.2474|0.1623|2445|0.1661|0.6776|8916.9128|5863.4893|3133.5884|801.6489|403.6875|-233.3371|40.55|32.7318|119356.6283|42.91|2016-04-12/ev_revenues|3.4165|2016-04-26/ev_revenues|3.4448|2016-05-10/ev_revenues|3.4657|2016-05-24/ev_revenues|3.4452|2016-04-05/ev_free_cash_flow|143.543|2016-04-19/ev_free_cash_flow|151.9654|2016-05-03/ev_free_cash_flow|151.5535|2016-05-17/ev_free_cash_flow|148.506|2016-05-31/ev_free_cash_flow|149.3483|2016-04-12/ps_ratio|2.7986|2016-04-26/ps_ratio|2.827|2016-05-10/ps_ratio|2.8476|2016-05-24/ps_ratio|2.827|2016-04-12/pe_ratio|111.1254|2016-04-26/pe_ratio|112.2556|2016-05-10/pe_ratio|113.0704|2016-05-24/pe_ratio|112.2556|2016-04-12/price_to_book_value|25.5162|2016-04-26/price_to_book_value|25.7757|2016-05-10/price_to_book_value|25.9668|2016-05-24/price_to_book_value|25.7797|2016-04-12/peg_ratio||2016-04-26/peg_ratio||2016-05-10/peg_ratio||2016-05-24/peg_ratio||2016-04-05/dividend_yield|5.8674|2016-04-19/dividend_yield|5.4703|2016-05-03/dividend_yield|5.4893|2016-05-17/dividend_yield|5.4233|2016-05-31/dividend_yield|5.3862|2016-04-15/percent_of_shares_outstanding|0.1421|2016-04-29/percent_of_shares_outstanding|0.1641|2016-05-13/percent_of_shares_outstanding|0.1988|2016-05-31/percent_of_shares_outstanding|0.2217|2016-04-29/price|42.91|2016-05-31/price|42.37|2016-04-29/total_return_price|34.6368|2016-05-31/total_return_price|34.6032|2016-04-12/enterprise_value|126288.6432|2016-04-26/enterprise_value|127335.8517|2016-05-10/enterprise_value|128107.0603|2016-05-24/enterprise_value|127351.979
adr_usa_0212|GSK|201606|22723.3496|6290.6524|7395.858|14187.2856|32394.2349|71886.8242|24375.1002|47511.724||772.7016|-8186.0598||3.3756|1728.405|146.3581|1.6831|2.7569|109.4696|25.1416||34.1167|5.5218|6.7812|0.2553|2429.5|-0.2586|0.4907|9382.8145|6331.8197|3122.8167|-456.7874|-624.8506|-237.0123|43.34|35.3954|124777.2268|45.07|2016-07-05/ev_revenues|3.5083|2016-07-19/ev_revenues|3.522|2016-08-02/ev_revenues|3.6397|2016-08-16/ev_revenues|3.5633|2016-08-30/ev_revenues|3.5006|2016-07-12/ev_free_cash_flow|58.7012|2016-07-26/ev_free_cash_flow|59.1797|2016-08-09/ev_free_cash_flow|59.4649|2016-08-23/ev_free_cash_flow|59.4757|2016-07-05/ps_ratio|2.8491|2016-07-19/ps_ratio|2.8628|2016-08-02/ps_ratio|2.9794|2016-08-16/ps_ratio|2.9028|2016-08-30/ps_ratio|2.8399|2016-07-05/pe_ratio|1614.4596|2016-07-19/pe_ratio|1622.2536|2016-08-02/pe_ratio|1688.3165|2016-08-16/pe_ratio|1644.8931|2016-08-30/pe_ratio|1609.2637|2016-07-05/price_to_book_value|137.147|2016-07-19/price_to_book_value|137.8091|2016-08-02/price_to_book_value|143.4929|2016-08-16/price_to_book_value|139.8022|2016-08-30/price_to_book_value|136.774|2016-07-05/peg_ratio||2016-07-19/peg_ratio||2016-08-02/peg_ratio||2016-08-16/peg_ratio||2016-08-30/peg_ratio||2016-07-12/dividend_yield|5.2199|2016-07-26/dividend_yield|5.1679|2016-08-09/dividend_yield|5.14|2016-08-23/dividend_yield|4.8904|2016-07-15/percent_of_shares_outstanding|0.2416|2016-07-29/percent_of_shares_outstanding|0.26|2016-08-15/percent_of_shares_outstanding|0.322|2016-08-31/percent_of_shares_outstanding|0.29|2016-07-29/price|45.07|2016-08-31/price|43.46|2016-07-29/total_return_price|36.8083|2016-08-31/total_return_price|35.8703|2016-07-05/enterprise_value|130961.3375|2016-07-19/enterprise_value|131472.9348|2016-08-02/enterprise_value|135864.7698|2016-08-16/enterprise_value|133013.016|2016-08-30/enterprise_value|130673.1154
adr_usa_0212|GSK|201609|22830.6117|6091.3607|6965.0736|14221.817|31547.0002|71023.5286|23511.1745|47512.3541||178.8908|-8490.8305||3.4984|425.9824|58.0139|1.6949|2.8373|1607.7791|136.6685||140.3043|5.0437|6.6682|0.2716|2451|0.4335|0.4692|9906.5864|6589.9422|3010.5935|1673.4276|1061.3261|-214.1042|43.13|35.5979|130591.5917|40.01|2016-10-11/ev_revenues|3.3583|2016-10-25/ev_revenues|3.2408|2016-11-08/ev_revenues|3.1647|2016-11-22/ev_revenues|3.0936|2016-10-04/ev_free_cash_flow|34.4018|2016-10-18/ev_free_cash_flow|33.3172|2016-11-01/ev_free_cash_flow|32.0855|2016-11-15/ev_free_cash_flow|31.4916|2016-11-29/ev_free_cash_flow|31.0655|2016-10-11/ps_ratio|2.7333|2016-10-25/ps_ratio|2.6153|2016-11-08/ps_ratio|2.5387|2016-11-22/ps_ratio|2.4674|2016-10-11/pe_ratio|352.6301|2016-10-25/pe_ratio|337.4002|2016-11-08/pe_ratio|327.5259|2016-11-22/pe_ratio|318.321|2016-10-04/price_to_book_value|592.0067|2016-10-18/price_to_book_value|569.1115|2016-11-01/price_to_book_value|543.1093|2016-11-15/price_to_book_value|530.5708|2016-11-29/price_to_book_value|521.5758|2016-10-11/peg_ratio||2016-10-25/peg_ratio||2016-11-08/peg_ratio||2016-11-22/peg_ratio||2016-10-04/dividend_yield|4.9996|2016-10-18/dividend_yield|5.2007|2016-11-01/dividend_yield|5.45|2016-11-15/dividend_yield|5.3554|2016-11-29/dividend_yield|5.4478|2016-10-14/percent_of_shares_outstanding|0.2668|2016-10-31/percent_of_shares_outstanding|0.3453|2016-11-15/percent_of_shares_outstanding|0.3138|2016-11-30/percent_of_shares_outstanding|0.29|2016-10-31/price|40.01|2016-11-30/price|37.79|2016-10-31/total_return_price|33.0228|2016-11-30/total_return_price|31.5564|2016-10-11/enterprise_value|126746.7631|2016-10-25/enterprise_value|122309.6941|2016-11-08/enterprise_value|119437.7704|2016-11-22/enterprise_value|116755.8889
adr_usa_0212|GSK|201612|20529.6306|6125.3509|6267.858|13277.7361|30394.5659|66484.5042|23342.9185|43141.5857||1380.8452|-6624.1259||3.1276|100.1728|31.2436|1.6001|2.4843|320.4967|525.3374||16.6601|5.4464|7.3063|0.225|2478.5|0.1292|0.47|9423.0386|6307.6971|3367.5003|525.4344|319.2356|-212.4096|38.51|32.1576|118038.6629|39.31|2017-01-03/ev_revenues|3.108|2017-01-17/ev_revenues|3.138|2017-01-31/ev_revenues|3.1388|2017-02-14/ev_revenues|3.191|2017-02-28/ev_revenues|3.284|2017-01-10/ev_free_cash_flow|21.0428|2017-01-24/ev_free_cash_flow|20.7762|2017-02-07/ev_free_cash_flow|21.0963|2017-02-21/ev_free_cash_flow|22.0449|2017-01-03/ps_ratio|2.5299|2017-01-17/ps_ratio|2.5598|2017-01-31/ps_ratio|2.5605|2017-02-14/ps_ratio|2.6126|2017-02-28/ps_ratio|2.7018|2017-01-03/pe_ratio|82.613|2017-01-17/pe_ratio|83.5914|2017-01-31/pe_ratio|83.6127|2017-02-14/pe_ratio|85.3143|2017-02-28/pe_ratio|88.2283|2017-01-10/price_to_book_value|69.944|2017-01-24/price_to_book_value|68.8595|2017-02-07/price_to_book_value|70.1614|2017-02-21/price_to_book_value|74.0198|2017-01-03/peg_ratio||2017-01-17/peg_ratio||2017-01-31/peg_ratio||2017-02-14/peg_ratio||2017-02-28/peg_ratio||2017-01-10/dividend_yield|5.2996|2017-01-24/dividend_yield|5.3831|2017-02-07/dividend_yield|5.2835|2017-02-21/dividend_yield|5.0081|2017-01-13/percent_of_shares_outstanding|0.2312|2017-01-31/percent_of_shares_outstanding|0.2854|2017-02-15/percent_of_shares_outstanding|0.3288|2017-02-28/percent_of_shares_outstanding|0.2551|2017-01-31/price|39.31|2017-02-28/price|41.48|2017-01-31/total_return_price|32.8257|2017-02-28/total_return_price|35.1196|2017-01-03/enterprise_value|116950.3174|2017-01-17/enterprise_value|118079.6427|2017-01-31/enterprise_value|118109.7714|2017-02-14/enterprise_value|120073.929|2017-02-28/enterprise_value|123572.9893
adr_usa_0212|GSK|201703|20945.1399|5735.6769|6758.7909|13490.1324|30834.4101|66929.1234|23403.1089|43526.0145||2138.5578|-6121.2162||3.3447|60.9312|22.3712|1.6911|2.7624|90.2064|75.3467||10.7001|4.7258|5.0202|0.2334|2459|0.5276|0.5688|9145.4066|6032.9463|3036.9091|1919.7427|1295.5167|-214.2681|42.16|35.6953|125859.3592|40.9|2017-04-11/ev_revenues|3.2769|2017-04-25/ev_revenues|3.2575|2017-05-09/ev_revenues|3.304|2017-05-23/ev_revenues|3.3709|2017-04-04/ev_free_cash_flow|18.6557|2017-04-18/ev_free_cash_flow|18.3779|2017-05-02/ev_free_cash_flow|18.5265|2017-05-16/ev_free_cash_flow|19.2622|2017-05-30/ev_free_cash_flow|19.2585|2017-04-11/ps_ratio|2.7088|2017-04-25/ps_ratio|2.6893|2017-05-09/ps_ratio|2.7185|2017-05-23/ps_ratio|2.7853|2017-04-11/pe_ratio|50.234|2017-04-25/pe_ratio|49.8733|2017-05-09/pe_ratio|50.4143|2017-05-23/pe_ratio|51.6527|2017-04-04/price_to_book_value|48.0248|2017-04-18/price_to_book_value|47.1566|2017-05-02/price_to_book_value|47.6209|2017-05-16/price_to_book_value|49.9203|2017-05-30/price_to_book_value|49.9088|2017-04-11/peg_ratio|0.4236|2017-04-25/peg_ratio|0.4205|2017-05-09/peg_ratio|0.4251|2017-05-23/peg_ratio|0.4355|2017-04-04/dividend_yield|4.7573|2017-04-18/dividend_yield|4.8448|2017-05-02/dividend_yield|4.8285|2017-05-16/dividend_yield|4.5834|2017-05-30/dividend_yield|4.5845|2017-04-13/percent_of_shares_outstanding|0.2335|2017-04-28/percent_of_shares_outstanding|0.1869|2017-05-15/percent_of_shares_outstanding|0.198|2017-05-31/percent_of_shares_outstanding|0.2347|2017-04-28/price|40.9|2017-05-31/price|44.23|2017-04-28/total_return_price|34.6285|2017-05-31/total_return_price|37.891|2017-04-11/enterprise_value|124055.5094|2017-04-25/enterprise_value|123322.6094|2017-05-09/enterprise_value|125080.9397|2017-05-23/enterprise_value|127613.4174
adr_usa_0212|GSK|201706|21370.5545|5296.4524|7471.7579|13871.4752|31652.5156|70006.5852|37453.7638|32552.8214||1055.1272|-7616.1711||3.3984|53.1471|19.4439|1.7158|2.8125|52.1577|50.488|0.4398|23.2688|4.5323|4.5457|0.1862|2443.5|-0.0946|0.4894|9357.3687|6009.4249|3041.1448|-227.5426|-230.0992|-226.2642|43.12|36.9401|128655.2617|40.52|2017-07-05/ev_revenues|3.4062|2017-07-19/ev_revenues|3.3906|2017-08-02/ev_revenues|3.2821|2017-08-16/ev_revenues|3.1839|2017-08-30/ev_revenues|3.2164|2017-07-11/ev_free_cash_flow|20.7638|2017-07-25/ev_free_cash_flow|20.7437|2017-08-08/ev_free_cash_flow|20.0177|2017-08-22/ev_free_cash_flow|19.6085|2017-07-05/ps_ratio|2.7717|2017-07-19/ps_ratio|2.7561|2017-08-02/ps_ratio|2.6476|2017-08-16/ps_ratio|2.5495|2017-08-30/ps_ratio|2.5819|2017-07-05/pe_ratio|42.8455|2017-07-19/pe_ratio|42.6044|2017-08-02/pe_ratio|40.9272|2017-08-16/pe_ratio|39.4106|2017-08-30/pe_ratio|39.9128|2017-07-11/price_to_book_value|97.9137|2017-07-25/price_to_book_value|97.7971|2017-08-08/price_to_book_value|93.5797|2017-08-22/price_to_book_value|91.2023|2017-07-05/peg_ratio|0.0119|2017-07-19/peg_ratio|0.0118|2017-08-02/peg_ratio|0.0114|2017-08-11/peg_ratio|0.0108|2017-08-18/peg_ratio|0.0108|2017-08-21/peg_ratio|0.0108|2017-07-11/dividend_yield|4.7372|2017-07-25/dividend_yield|4.7429|2017-08-08/dividend_yield|4.9567|2017-08-22/dividend_yield|5.1741|2017-07-14/percent_of_shares_outstanding|0.1643|2017-07-31/percent_of_shares_outstanding|0.1653|2017-08-15/percent_of_shares_outstanding|0.1366|2017-08-31/percent_of_shares_outstanding|0.1649|2017-07-31/price|40.52|2017-08-31/price|40.23|2017-07-31/total_return_price|34.7127|2017-08-31/total_return_price|34.8998|2017-07-05/enterprise_value|128865.5372|2017-07-19/enterprise_value|128275.327|2017-08-02/enterprise_value|124169.6787|2017-08-16/enterprise_value|120456.2275|2017-08-30/enterprise_value|121685.8471
adr_usa_0212|GSK|201709|23710.419|6479.5408|7602.2135|14279.162|31806.8233|72455.3661|36846.7646|35608.6016||1737.7255|-7183.2256||3.2587|41.4296|19.9256|1.5594|2.6242|40.5656|93.0444|0.0112|14.7094|5.0717|5.1501|0.2806|2467.5|0.644|0.5077|10266.7299|6795.1798|3021.2435|2239.752|1586.5455|-236.9346|40.6|35.2208|123285.2371|36.43|2017-10-11/ev_revenues|3.2397|2017-10-25/ev_revenues|3.0687|2017-11-08/ev_revenues|2.973|2017-11-22/ev_revenues|2.8815|2017-10-03/ev_free_cash_flow|19.3455|2017-10-17/ev_free_cash_flow|19.3035|2017-10-31/ev_free_cash_flow|17.7057|2017-11-14/ev_free_cash_flow|17.149|2017-11-28/ev_free_cash_flow|17.5099|2017-10-11/ps_ratio|2.6341|2017-10-25/ps_ratio|2.462|2017-11-08/ps_ratio|2.3517|2017-11-22/ps_ratio|2.2602|2017-10-11/pe_ratio|33.8735|2017-10-25/pe_ratio|31.6601|2017-11-08/pe_ratio|30.2424|2017-11-22/pe_ratio|29.0652|2017-10-03/price_to_book_value|57.6031|2017-10-17/price_to_book_value|57.4483|2017-10-31/price_to_book_value|51.5581|2017-11-14/price_to_book_value|49.5059|2017-11-28/price_to_book_value|50.8363|2017-10-03/peg_ratio|0.0373|2017-10-17/peg_ratio|0.0372|2017-10-31/peg_ratio|0.0332|2017-11-14/peg_ratio|0.0319|2017-11-28/peg_ratio|0.0327|2017-10-03/dividend_yield|4.9453|2017-10-17/dividend_yield|4.9586|2017-10-31/dividend_yield|5.5576|2017-11-14/dividend_yield|5.9369|2017-11-28/dividend_yield|5.7815|2017-10-13/percent_of_shares_outstanding|0.3327|2017-10-31/percent_of_shares_outstanding|0.5847|2017-11-15/percent_of_shares_outstanding|0.5444|2017-11-30/percent_of_shares_outstanding|0.4228|2017-10-31/price|36.43|2017-11-30/price|35.06|2017-10-31/total_return_price|31.6033|2017-11-30/total_return_price|30.8496|2017-10-11/enterprise_value|123731.295|2017-10-25/enterprise_value|117203.145|2017-11-08/enterprise_value|113545.3511|2017-11-22/enterprise_value|110053.087
adr_usa_0212|GSK|201712|21496.7198|5285.3254|7509.7298|14676.204|31482.2144|71478.2488|35905.3466|35572.9022||-91.8952|-8753.0178||2.9184|57.3224|17.407|1.4497|2.2789|29.3057|50.457|0.0322|-250.3382|5.8714|6.3444|0.3235|2485.5|-0.2975|0.509|10143.9691|6747.1537|3363.6174|586.94|-725.0435|-180.5969|35.47|31.2104|111459.4563|37.51|2018-01-03/ev_revenues|2.9226|2018-01-17/ev_revenues|3.0092|2018-01-31/ev_revenues|2.9686|2018-02-14/ev_revenues|2.9246|2018-02-28/ev_revenues|2.8924|2018-01-09/ev_free_cash_flow|18.7423|2018-01-23/ev_free_cash_flow|19.4506|2018-02-06/ev_free_cash_flow|18.3522|2018-02-20/ev_free_cash_flow|18.8977|2018-01-03/ps_ratio|2.3294|2018-01-17/ps_ratio|2.4155|2018-01-31/ps_ratio|2.375|2018-02-14/ps_ratio|2.3313|2018-02-28/ps_ratio|2.299|2018-01-03/pe_ratio|47.1901|2018-01-17/pe_ratio|48.9345|2018-01-31/pe_ratio|48.1136|2018-02-14/pe_ratio|47.2286|2018-02-28/pe_ratio|46.5744|2018-01-09/price_to_book_value||2018-01-23/price_to_book_value||2018-02-06/price_to_book_value||2018-02-20/price_to_book_value||2018-01-09/peg_ratio|0.72|2018-01-23/peg_ratio|0.7539|2018-02-06/peg_ratio|0.7013|2018-02-20/peg_ratio|0.7274|2018-01-09/dividend_yield|5.6204|2018-01-23/dividend_yield|5.3676|2018-02-06/dividend_yield|5.7703|2018-02-20/dividend_yield|5.5631|2018-01-12/percent_of_shares_outstanding|0.3566|2018-01-31/percent_of_shares_outstanding|0.4146|2018-02-15/percent_of_shares_outstanding|0.4102|2018-02-28/percent_of_shares_outstanding|0.4077|2018-01-31/price|37.51|2018-02-28/price|36.31|2018-01-31/total_return_price|33.0054|2018-02-28/total_return_price|32.5192|2018-01-03/enterprise_value|113727.9364|2018-01-17/enterprise_value|117099.3409|2018-01-31/enterprise_value|115517.4338|2018-02-14/enterprise_value|113806.8566|2018-02-28/enterprise_value|112554.7097
adr_usa_0212|GSK|201803|23016.8345|5718.12|7931.0885|14941.3915||73675.4535|37738.1905|35937.263||-96.7035|-8903.7295||3.088|85.928|18.6677|1.5228|2.4934|50.5122||0.7163|-253|5.8685|5.1758|0.3962|2472.5|0.3087|0.6517|10042.2142|6717.521|3213.4529|1539.2871|763.3863|-197.4515|39.07|34.991|120166.57|40.11|2018-04-11/ev_revenues|3.1031|2018-04-25/ev_revenues|3.0136|2018-05-09/ev_revenues|3.1049|2018-05-23/ev_revenues|3.1024|2018-04-03/ev_free_cash_flow|20.4224|2018-04-17/ev_free_cash_flow|20.9184|2018-05-01/ev_free_cash_flow|20.8965|2018-05-15/ev_free_cash_flow|20.766|2018-05-29/ev_free_cash_flow|20.7913|2018-04-11/ps_ratio|2.5143|2018-04-25/ps_ratio|2.4245|2018-05-09/ps_ratio|2.4926|2018-05-23/ps_ratio|2.4902|2018-04-11/pe_ratio|72.3579|2018-04-25/pe_ratio|69.7718|2018-05-09/pe_ratio|71.7337|2018-05-23/pe_ratio|71.6623|2018-04-03/price_to_book_value||2018-04-17/price_to_book_value||2018-05-01/price_to_book_value||2018-05-15/price_to_book_value||2018-05-29/price_to_book_value||2018-04-03/peg_ratio||2018-04-17/peg_ratio||2018-05-01/peg_ratio||2018-05-15/peg_ratio||2018-05-29/peg_ratio||2018-04-03/dividend_yield|5.492|2018-04-17/dividend_yield|5.3305|2018-05-01/dividend_yield|5.3877|2018-05-15/dividend_yield|5.4623|2018-05-29/dividend_yield|5.454|2018-04-13/percent_of_shares_outstanding|0.4885|2018-04-30/percent_of_shares_outstanding|0.4809|2018-05-15/percent_of_shares_outstanding|0.4709|2018-05-31/percent_of_shares_outstanding|0.3427|2018-04-30/price|40.11|2018-05-31/price|40.52|2018-04-30/total_return_price|35.9224|2018-05-31/total_return_price|36.7495|2018-04-11/enterprise_value|123536.159|2018-04-25/enterprise_value|119974.234|2018-05-09/enterprise_value|123607.5293|2018-05-23/enterprise_value|123508.3432
adr_usa_0212|GSK|201806|22283.1552|5395.5985|7769.8188|14149.882|30164.1021|71399.1827|23791.8832|47607.2995||4809.8878|-3503.8052||3.1555|58.5848|20.9014|1.7306|2.5428|73.1783|||7.6276|5.4186|2.5815|0.2888|2480.5|0.2426|0.5163|9961.4591|6813.5835|3348.1949|836.7081|600.9581|-227.5737|40.31|36.559|125620.5437|41.59|2018-07-05/ev_revenues|3.2524|2018-07-19/ev_revenues|3.2499|2018-08-02/ev_revenues|3.2438|2018-08-16/ev_revenues|3.2586|2018-08-30/ev_revenues|3.2837|2018-07-10/ev_free_cash_flow|19.9083|2018-07-24/ev_free_cash_flow|19.8268|2018-08-07/ev_free_cash_flow|19.9125|2018-08-21/ev_free_cash_flow|19.9347|2018-07-05/ps_ratio|2.4958|2018-07-19/ps_ratio|2.4934|2018-08-02/ps_ratio|2.4873|2018-08-16/ps_ratio|2.502|2018-08-30/ps_ratio|2.5271|2018-07-05/pe_ratio|45.3642|2018-07-19/pe_ratio|45.3196|2018-08-02/pe_ratio|45.2082|2018-08-16/pe_ratio|45.4756|2018-08-30/pe_ratio|45.9322|2018-07-10/price_to_book_value|21.3609|2018-07-24/price_to_book_value|21.2475|2018-08-07/price_to_book_value|21.3667|2018-08-21/price_to_book_value|21.3976|2018-07-10/peg_ratio||2018-07-24/peg_ratio||2018-08-07/peg_ratio||2018-08-21/peg_ratio||2018-07-10/dividend_yield|5.2381|2018-07-24/dividend_yield|5.2661|2018-08-07/dividend_yield|5.2369|2018-08-21/dividend_yield|5.2162|2018-07-13/percent_of_shares_outstanding|0.3072|2018-07-31/percent_of_shares_outstanding|0.3213|2018-08-15/percent_of_shares_outstanding|0.245|2018-08-31/percent_of_shares_outstanding|0.2776|2018-07-31/price|41.59|2018-08-31/price|40.5|2018-07-31/total_return_price|37.7199|2018-08-31/total_return_price|37.1741|2018-07-05/enterprise_value|131442.4273|2018-07-19/enterprise_value|131343.23|2018-08-02/enterprise_value|131098.0008|2018-08-16/enterprise_value|131693.2012|2018-08-30/enterprise_value|132710.0019
adr_usa_0212|GSK|201809|22693.9122|5046.1317|7541.1852|14231.5767|30111.3219|71504.4549|23966.8455|47537.6094||5831.7804|-2711.3349||3.2391|51.831|19.2424|1.6878|2.4824|45.1191|20.4347||6.1908|5.4623|3.0054|0.2852|2486|0.7425|0.4962|10540.882|7107.1493|3291.746|2220.9842|1847.1293|-290.4865|40.17|36.8712|130905.9445|39.06|2018-10-11/ev_revenues|3.0646|2018-10-25/ev_revenues|3.1287|2018-11-08/ev_revenues|3.2531|2018-11-23/ev_revenues|3.2177|2018-10-02/ev_free_cash_flow|18.7442|2018-10-16/ev_free_cash_flow|18.6118|2018-10-30/ev_free_cash_flow|18.5439|2018-11-13/ev_free_cash_flow|19.3093|2018-11-27/ev_free_cash_flow|18.9522|2018-10-11/ps_ratio|2.3458|2018-10-25/ps_ratio|2.4105|2018-11-08/ps_ratio|2.5148|2018-11-23/ps_ratio|2.4794|2018-10-11/pe_ratio|38.6128|2018-10-25/pe_ratio|39.6768|2018-11-08/pe_ratio|41.3931|2018-11-23/pe_ratio|40.811|2018-10-02/price_to_book_value|16.9413|2018-10-16/price_to_book_value|16.7853|2018-10-30/price_to_book_value|16.7052|2018-11-13/price_to_book_value|17.6076|2018-11-27/price_to_book_value|17.1866|2018-10-02/peg_ratio||2018-10-16/peg_ratio||2018-10-30/peg_ratio||2018-11-13/peg_ratio||2018-11-27/peg_ratio||2018-10-02/dividend_yield|5.3889|2018-10-16/dividend_yield|5.439|2018-10-30/dividend_yield|5.4651|2018-11-13/dividend_yield|5.2288|2018-11-27/dividend_yield|5.2991|2018-10-15/percent_of_shares_outstanding|0.2796|2018-10-31/percent_of_shares_outstanding|0.3046|2018-11-15/percent_of_shares_outstanding|0.3078|2018-11-30/percent_of_shares_outstanding|0.2419|2018-10-31/price|39.06|2018-11-30/price|41.87|2018-10-31/total_return_price|35.8524|2018-11-30/total_return_price|38.8985|2018-10-11/enterprise_value|124693.1086|2018-10-25/enterprise_value|127300.1786|2018-11-08/enterprise_value|132362.9609|2018-11-23/enterprise_value|130924.3975
adr_usa_0212|GSK|201812|21478.6703|5022.3062|6948.4964|14031.4962|29173.2799|69020.5466|28538.8299|40481.7167||4797.7109|-3446.3324||3.0303|25.6924|18.0846|1.6649|2.2916|37.7195|16.1636||6.8754|5.6352|3.9344|0.318|2493|0.6278|0.494|10545.7957|6809.6739|3370.7435|1767.7105|1563.1501|-249.5894|38.21|35.4983|123297.0052|39.2|2019-01-04/ev_revenues|3.0102|2019-01-18/ev_revenues|3.0368|2019-02-01/ev_revenues|3.0454|2019-02-15/ev_revenues|3.1687|2019-01-09/ev_free_cash_flow|14.1559|2019-01-23/ev_free_cash_flow|14.1194|2019-02-06/ev_free_cash_flow|14.5725|2019-02-20/ev_free_cash_flow|14.7635|2019-01-04/ps_ratio|2.3337|2019-01-18/ps_ratio|2.3603|2019-02-01/ps_ratio|2.3688|2019-02-15/ps_ratio|2.492|2019-01-04/pe_ratio|20.098|2019-01-18/pe_ratio|20.3269|2019-02-01/pe_ratio|20.3998|2019-02-15/pe_ratio|21.4614|2019-01-09/price_to_book_value|20.2812|2019-01-23/price_to_book_value|20.214|2019-02-06/price_to_book_value|21.0489|2019-02-20/price_to_book_value|21.4007|2019-01-09/peg_ratio|0.1393|2019-01-23/peg_ratio|0.1388|2019-02-06/peg_ratio|0.1445|2019-02-20/peg_ratio|0.1469|2019-01-09/dividend_yield|5.4627|2019-01-23/dividend_yield|5.4809|2019-02-06/dividend_yield|5.264|2019-02-20/dividend_yield|5.1774|2019-01-15/percent_of_shares_outstanding|0.3244|2019-01-31/percent_of_shares_outstanding|0.4034|2019-02-15/percent_of_shares_outstanding|0.4188|2019-02-28/percent_of_shares_outstanding|0.3632|2019-01-31/price|39.2|2019-02-28/price|40.36|2019-01-31/total_return_price|36.418|2019-02-28/total_return_price|38.0449|2019-01-04/enterprise_value|123689.4616|2019-01-18/enterprise_value|124781.6431|2019-02-01/enterprise_value|125138.1911|2019-02-15/enterprise_value|130202.4121
adr_usa_0212|GSK|201903|22856.5532|5495.0159|7405.8154|14728.1556|34993.0647|76945.8742|31903.178|45042.6962||5235.4602|-3179.8834||3.2135|27.1837|14.6124|1.7019|2.5253|21.7476|21.1224|0.145|7.9116|5.1133|1.3147|0.3425|2489|0.4351|0.584|9980.3225|6419.9229|3226.8971|1687.0536|1081.2776|-247.5214|41.79|39.3928|132042.5128|41.13|2019-04-12/ev_revenues|3.3024|2019-04-26/ev_revenues|3.2903|2019-05-10/ev_revenues|3.258|2019-05-24/ev_revenues|3.2975|2019-04-03/ev_free_cash_flow|16.087|2019-04-17/ev_free_cash_flow|15.5752|2019-05-01/ev_free_cash_flow|15.797|2019-05-15/ev_free_cash_flow|15.5563|2019-05-29/ev_free_cash_flow|15.3534|2019-04-12/ps_ratio|2.4612|2019-04-26/ps_ratio|2.449|2019-05-10/ps_ratio|2.3963|2019-05-24/ps_ratio|2.4357|2019-04-12/pe_ratio|19.8241|2019-04-26/pe_ratio|19.7264|2019-05-10/pe_ratio|19.3016|2019-05-24/pe_ratio|19.619|2019-04-03/price_to_book_value|19.7256|2019-04-17/price_to_book_value|18.8848|2019-05-01/price_to_book_value|19.2492|2019-05-15/price_to_book_value|18.8538|2019-05-29/price_to_book_value|18.5204|2019-04-03/peg_ratio|0.0769|2019-04-17/peg_ratio|0.0736|2019-05-01/peg_ratio|0.0744|2019-05-15/peg_ratio|0.0729|2019-05-29/peg_ratio|0.0716|2019-04-03/dividend_yield|4.997|2019-04-17/dividend_yield|5.2194|2019-05-01/dividend_yield|5.1639|2019-05-15/dividend_yield|5.2722|2019-05-29/dividend_yield|5.2894|2019-04-15/percent_of_shares_outstanding|0.3068|2019-04-30/percent_of_shares_outstanding|0.2729|2019-05-15/percent_of_shares_outstanding|0.2688|2019-05-31/percent_of_shares_outstanding|0.2298|2019-04-30/price|41.13|2019-05-31/price|38.64|2019-04-30/total_return_price|38.7707|2019-05-31/total_return_price|36.8641|2019-04-12/enterprise_value|135490.7743|2019-04-26/enterprise_value|134996.1743|2019-05-10/enterprise_value|133670.5606|2019-05-24/enterprise_value|135291.591
adr_usa_0212|GSK|201906|23099.9798|5331.447|7551.7215|14457.1302|34419.3248|76879.5412|32669.2111|44210.3301||4579.9499|-3553.4531||3.3031|23.7441|15.7162|1.6873|2.4411|19.663|19.1165|0.0739|9.2584|5.1246|1.4346|0.2579|2495.5|0.4961|0.4822|10036.0072|6646.9752|3328.6283|1624.4734|1238.918|-277.5999|40.02|38.1807|135519.557|41.28|2019-07-05/ev_revenues|3.3607|2019-07-19/ev_revenues|3.3674|2019-08-02/ev_revenues|3.373|2019-08-16/ev_revenues|3.3208|2019-08-30/ev_revenues|3.4052|2019-07-10/ev_free_cash_flow|16.8579|2019-07-24/ev_free_cash_flow|16.9549|2019-08-07/ev_free_cash_flow|16.6768|2019-08-21/ev_free_cash_flow|16.7313|2019-07-05/ps_ratio|2.4755|2019-07-19/ps_ratio|2.4822|2019-08-02/ps_ratio|2.4877|2019-08-16/ps_ratio|2.4355|2019-08-30/ps_ratio|2.5198|2019-07-05/pe_ratio|17.7491|2019-07-19/pe_ratio|17.7969|2019-08-02/pe_ratio|17.836|2019-08-16/pe_ratio|17.4623|2019-08-30/pe_ratio|18.0662|2019-07-10/price_to_book_value|22.387|2019-07-24/price_to_book_value|22.5613|2019-08-07/price_to_book_value|22.0615|2019-08-21/price_to_book_value|22.1595|2019-07-10/peg_ratio|0.1143|2019-07-24/peg_ratio|0.1151|2019-08-07/peg_ratio|0.1126|2019-08-21/peg_ratio|0.1131|2019-07-10/dividend_yield|5.0025|2019-07-24/dividend_yield|4.9638|2019-08-07/dividend_yield|5.0766|2019-08-21/dividend_yield|4.9809|2019-07-15/percent_of_shares_outstanding|0.2536|2019-07-31/percent_of_shares_outstanding|0.2423|2019-08-15/percent_of_shares_outstanding|0.2505|2019-08-30/percent_of_shares_outstanding|0.2731|2019-07-31/price|41.28|2019-08-30/price|41.58|2019-07-31/total_return_price|39.3828|2019-08-30/total_return_price|40.1305|2019-07-05/enterprise_value|138134.8204|2019-07-19/enterprise_value|138409.1687|2019-08-02/enterprise_value|138639.2102|2019-08-16/enterprise_value|136494.1879|2019-08-30/enterprise_value|139963.762
adr_usa_0212|GSK|201909|25800.908|5397.4172|8329.0592|14381.64|53471.4292|80125.402|31361.8088|48763.5932||14470.1424|6471.738||3.4513|25.7805|16.8438|1.4602|2.5658|18.3965|22.3616|0.1141|2.8074|4.9361|3.907|0.2646|2503.5|0.7639|0.471|11563.8161|7565.4588|3563.405|2403.943|1912.3114|-262.45|42.68|41.1921|141859.4109|45.8|2019-10-11/ev_revenues|3.5173|2019-10-25/ev_revenues|3.6144|2019-11-08/ev_revenues|3.65|2019-11-22/ev_revenues|3.6257|2019-10-02/ev_free_cash_flow|16.8388|2019-10-16/ev_free_cash_flow|17.153|2019-10-30/ev_free_cash_flow|18.1217|2019-11-13/ev_free_cash_flow|17.8396|2019-11-27/ev_free_cash_flow|18.0674|2019-10-11/ps_ratio|2.4985|2019-10-25/ps_ratio|2.5956|2019-11-08/ps_ratio|2.6311|2019-11-22/ps_ratio|2.6068|2019-10-11/pe_ratio|18.1578|2019-10-25/pe_ratio|18.8638|2019-11-08/pe_ratio|19.1221|2019-11-22/pe_ratio|18.9456|2019-10-02/price_to_book_value|7.1003|2019-10-16/price_to_book_value|7.2882|2019-10-30/price_to_book_value|7.8674|2019-11-13/price_to_book_value|7.6988|2019-11-27/price_to_book_value|7.835|2019-10-02/peg_ratio|0.1332|2019-10-16/peg_ratio|0.1367|2019-10-30/peg_ratio|0.1475|2019-11-13/peg_ratio|0.1444|2019-11-27/peg_ratio|0.1469|2019-10-02/dividend_yield|4.9205|2019-10-16/dividend_yield|4.7936|2019-10-30/dividend_yield|4.4407|2019-11-13/dividend_yield|4.5382|2019-11-27/dividend_yield|4.4791|2019-10-15/percent_of_shares_outstanding|0.2578|2019-10-31/percent_of_shares_outstanding|0.3027|2019-11-15/percent_of_shares_outstanding|0.2496|2019-11-29/percent_of_shares_outstanding|0.2689|2019-10-31/price|45.8|2019-11-29/price|45.48|2019-10-31/total_return_price|44.2033|2019-11-29/total_return_price|44.3913|2019-10-11/enterprise_value|148167.8208|2019-10-25/enterprise_value|152258.5748|2019-11-08/enterprise_value|153759.4653|2019-11-22/enterprise_value|152736.7374
adr_usa_0212|GSK|201912|25556.0145|6275.2596|7797.528|14834.5774|54435.8449|80420.612|31533.6385|48886.9734||14953.8939|5939.6001||3.8219|26.826|18.4894|1.5163|2.8029|20.3705|8.0873|0.1517|2.5654|4.3397|3.8914|0.2914|2530.5|0.6673|0.4988|11464.1208|7279.8906|4435.4386|2204.1927|1673.4344|-284.7029|46.99|45.8652|161002.9723|46.8|2020-01-03/ev_revenues|3.6511|2020-01-17/ev_revenues|3.7329|2020-01-31/ev_revenues|3.6702|2020-02-14/ev_revenues|3.506|2020-02-28/ev_revenues|3.3192|2020-01-09/ev_free_cash_flow|21.0715|2020-01-23/ev_free_cash_flow|21.4618|2020-02-06/ev_free_cash_flow|20.237|2020-02-20/ev_free_cash_flow|19.8505|2020-01-03/ps_ratio|2.7045|2020-01-17/ps_ratio|2.7866|2020-01-31/ps_ratio|2.7232|2020-02-14/ps_ratio|2.5451|2020-02-28/ps_ratio|2.3583|2020-01-03/pe_ratio|19.6745|2020-01-17/pe_ratio|20.2713|2020-01-31/pe_ratio|19.8099|2020-02-14/pe_ratio|18.5147|2020-02-28/pe_ratio|17.1559|2020-01-09/price_to_book_value|7.7827|2020-01-23/price_to_book_value|7.9779|2020-02-06/price_to_book_value|7.3654|2020-02-20/price_to_book_value|7.1721|2020-01-09/peg_ratio|0.8607|2020-01-23/peg_ratio|0.8823|2020-02-06/peg_ratio|0.8144|2020-02-20/peg_ratio|0.7889|2020-01-09/dividend_yield|4.3638|2020-01-23/dividend_yield|4.2571|2020-02-06/dividend_yield|4.612|2020-02-20/dividend_yield|4.6906|2020-01-15/percent_of_shares_outstanding|0.2667|2020-01-31/percent_of_shares_outstanding|0.3111|2020-02-14/percent_of_shares_outstanding|0.2184|2020-02-28/percent_of_shares_outstanding|0.2067|2020-01-31/price|46.8|2020-02-28/price|40.53|2020-01-17/total_return_price|46.7436|2020-01-31/total_return_price|45.6797|2020-02-28/total_return_price|40.0824|2020-01-03/enterprise_value|157160.4218|2020-01-17/enterprise_value|160678.0871|2020-01-31/enterprise_value|157981.1369|2020-02-14/enterprise_value|150911.1628|2020-02-28/enterprise_value|142872.0921
adr_usa_0212|GSK|202003|27242.451|6005.635|7362.624|14104.274|52446.326|79520.545|31339.395|48181.15||16197.278|7858.661||3.0808|20.1003|16.7998|1.3153|2.1203|15.4247|5.6465|0.621|2.4443|5.9587|3.8411|0.4001|2505|0.7998|0.5669|11650.8887|7550.6475|3737.5128|2351.9671|2005.9011|-240.9645|37.89|37.4715|132612.2886|42.07|2020-04-13/ev_revenues|3.1294|2020-04-27/ev_revenues|3.3364|2020-05-11/ev_revenues|3.305|2020-05-26/ev_revenues|3.231|2020-04-02/ev_free_cash_flow|17.5256|2020-04-16/ev_free_cash_flow|18.8431|2020-04-30/ev_free_cash_flow|18.9299|2020-05-14/ev_free_cash_flow|18.5411|2020-05-28/ev_free_cash_flow|18.7596|2020-04-13/ps_ratio|2.1846|2020-04-27/ps_ratio|2.3917|2020-05-11/ps_ratio|2.3602|2020-05-26/ps_ratio|2.2862|2020-04-13/pe_ratio|14.2787|2020-04-27/pe_ratio|15.6318|2020-05-11/pe_ratio|15.4265|2020-05-26/pe_ratio|14.9424|2020-04-02/price_to_book_value|5.8387|2020-04-16/price_to_book_value|6.4737|2020-04-30/price_to_book_value|6.5156|2020-05-14/price_to_book_value|6.3282|2020-05-28/price_to_book_value|6.4335|2020-04-02/peg_ratio|0.4169|2020-04-16/peg_ratio|0.4622|2020-04-30/peg_ratio|0.4652|2020-05-14/peg_ratio|0.4518|2020-05-28/peg_ratio|0.4594|2020-04-02/dividend_yield|5.3201|2020-04-16/dividend_yield|4.7983|2020-04-30/dividend_yield|4.7675|2020-05-14/dividend_yield|4.9062|2020-05-28/dividend_yield|4.8259|2020-04-15/percent_of_shares_outstanding|0.3805|2020-04-30/percent_of_shares_outstanding|0.401|2020-05-15/percent_of_shares_outstanding|0.4465|2020-05-29/percent_of_shares_outstanding|0.3449|2020-04-30/price|42.07|2020-05-29/price|41.92|2020-04-30/total_return_price|41.6054|2020-05-29/total_return_price|41.92|2020-04-13/enterprise_value|139930.3447|2020-04-27/enterprise_value|149186.7909|2020-05-11/enterprise_value|147782.8431|2020-05-26/enterprise_value|144471.5682
adr_usa_0212|GSK|202006|28283.3904|10158.5352|7872.7724|14070.3036|52018.6423|79396.0977|29447.8124|49948.2853||16731.4878|8150.9536||3.2781|16.579|18.6249|1.3364|2.3333|15.2505|6.3685|0.4547|2.3313|4.8752|5.3327|0.3801|2511.5|1.1161|0.4743|9454.5765|6417.5542|3359.4501|3275.1228|2806.3624|-282.7444|40.79|40.79|146580.623|40.32|2020-07-07/ev_revenues|3.1315|2020-07-21/ev_revenues|3.1991|2020-08-04/ev_revenues|3.1804|2020-08-18/ev_revenues|3.1719|2020-07-09/ev_free_cash_flow|14.183|2020-07-23/ev_free_cash_flow|14.165|2020-08-06/ev_free_cash_flow|14.3377|2020-08-20/ev_free_cash_flow|14.2398|2020-07-07/ps_ratio|2.2989|2020-07-21/ps_ratio|2.3667|2020-08-04/ps_ratio|2.3479|2020-08-18/ps_ratio|2.3394|2020-07-07/pe_ratio|12.064|2020-07-21/pe_ratio|12.4195|2020-08-04/pe_ratio|12.3209|2020-08-18/pe_ratio|12.2761|2020-07-09/price_to_book_value|6.0529|2020-07-23/price_to_book_value|6.0424|2020-08-06/price_to_book_value|6.1429|2020-08-20/price_to_book_value|6.086|2020-07-09/peg_ratio|0.2655|2020-07-23/peg_ratio|0.265|2020-08-06/peg_ratio|0.2694|2020-08-20/peg_ratio|0.2669|2020-07-09/dividend_yield|4.9658|2020-07-23/dividend_yield|4.9744|2020-08-06/dividend_yield|4.893|2020-08-20/dividend_yield|4.9389|2020-07-15/percent_of_shares_outstanding|0.4029|2020-07-31/percent_of_shares_outstanding|0.4129|2020-08-14/percent_of_shares_outstanding|0.3913|2020-08-31/percent_of_shares_outstanding|0.3977|2020-07-31/price|40.32|2020-08-31/price|39.6|2020-07-31/total_return_price|40.32|2020-08-31/total_return_price|39.6|2020-07-07/enterprise_value|138202.0267|2020-07-21/enterprise_value|141187.3033|2020-08-04/enterprise_value|140361.0165|2020-08-18/enterprise_value|139984.7154
adr_usa_0212|GSK|202009|||||||||||||2.9638||13.9514||2.131|11.1827|5.918|0.2596||5.079||0.4418||||||||||37.64|37.64|130803.2804|35.29|2020-10-13/ev_revenues|2.9502|2020-10-22/ev_revenues|2.8308|2020-10-01/ev_free_cash_flow|13.3515|2020-10-15/ev_free_cash_flow|13.0528|2020-10-22/ev_free_cash_flow|12.8236|2020-10-13/ps_ratio|2.1173|2020-10-23/ps_ratio|2.0092|2020-10-13/pe_ratio|11.111|2020-10-23/pe_ratio|10.5434|2020-10-01/price_to_book_value|5.5687|2020-10-15/price_to_book_value|5.3948|2020-10-23/price_to_book_value|5.2913|2020-10-01/peg_ratio|0.2442|2020-10-15/peg_ratio|0.2366|2020-10-23/peg_ratio|0.2321|2020-10-01/dividend_yield|5.3976|2020-10-15/dividend_yield|5.5717|2020-10-23/dividend_yield|5.6806|2020-10-23/price|35.29|2020-10-23/total_return_price|35.29|2020-10-13/enterprise_value|130201.4049|2020-10-22/enterprise_value|124933.161